[
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Niaspan", "approval_status": "October 28, 1999", "company": "Kos Pharmaceuticals", "specific_treatment": "Treatment for increasing HDL cholesterol (\"good cholesterol\") in patients with dyslipidemia"},
{"therapeutic_areas": ["Immunology", "Otolaryngology (Ear, Nose, Throat)", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "Cedax (ceftibuten)", "approval_status": "Approved December 1995", "company": "Schering-Plough", "specific_treatment": "chronic bronchitis, infection of the middle ear, pharyngitis/tonsillitis"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Sleep"], "name": "Silenor (doxepin)", "approval_status": "Approved March 2010", "company": "Somaxon Pharma", "specific_treatment": "insomnia"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Family Medicine", "Orthopedics/Orthopedic Surgery"], "name": "Amrix (cyclobenzaprine hydrochloride extended release)", "approval_status": "Approved February 2007", "company": "Cephalon", "specific_treatment": "muscle spasm associated with acute, painful musculoskeletal conditions"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Zyrtec (cetirizine HCl)", "approval_status": "Approved December 1995", "company": "Pfizer", "specific_treatment": "allergy"},
{"therapeutic_areas": ["Otolaryngology (Ear, Nose, Throat)"], "name": "Bactroban Nasal 2% (mupirocin calcium ointment)", "approval_status": "Approved April 1996", "company": "SmithKline Beecham", "specific_treatment": "nasal bacteria"},
{"therapeutic_areas": ["Gastroenterology", "Neurology", "Pediatrics/Neonatology", "Infections and Infectious Diseases", "Vaccines"], "name": "Merrem I.V. (meropenem)", "approval_status": "Approved June 1996", "company": "AstraZeneca", "specific_treatment": "intra-abdominal infections and bacterial meningitis"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases", "Vaccines"], "name": "Havrix", "approval_status": "Approved March 1996", "company": "SmithKline Beecham", "specific_treatment": "hepatitis A"},
{"therapeutic_areas": ["Immunology", "Oncology", "Family Medicine"], "name": "Intron A (Interferon alfa-2b, recombinant)", "approval_status": "Approved December 1995", "company": "Schering-Plough", "specific_treatment": "malignant melanoma"},
{"therapeutic_areas": ["Immunology", "Ophthalmology", "Family Medicine"], "name": "Vitrasert Implant", "approval_status": "Approved March 1996", "company": "Chiron", "specific_treatment": "cytomegalovirus (CMV)"},
{"therapeutic_areas": ["Immunology", "Ophthalmology", "Family Medicine"], "name": "Vistide (cidofovir)", "approval_status": "Approved June 1996", "company": "Gilead", "specific_treatment": "CMV retinitis"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine"], "name": "Ocuflox (ofloxacin opthalmic solution) 0.3%", "approval_status": "Approved May 1996", "company": "Allergan", "specific_treatment": "corneal ulcers"},
{"therapeutic_areas": ["Otolaryngology (Ear, Nose, Throat)", "Pediatrics/Neonatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Floxin otic", "approval_status": "Approved December 1997", "company": "Daiichi Sankyo", "specific_treatment": "otitis media (ear infections)"},
{"therapeutic_areas": ["Nephrology", "Family Medicine", "Urology"], "name": "Caverject (alprostadil)", "approval_status": "Approved on July 6, 1995", "company": "Upjohn", "specific_treatment": "impotence"},
{"therapeutic_areas": ["Nephrology", "Family Medicine", "Urology"], "name": "Monurol", "approval_status": "Approved December 1996", "company": "Forest Laboratories", "specific_treatment": "uncomplicated urinary tract infection"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine"], "name": "Alphagan (brimonidine)", "approval_status": "Approved September 1996", "company": "Allergan", "specific_treatment": "open-angle glaucoma and ocular hypertension"},
{"therapeutic_areas": ["Ophthalmology", "Infections and Infectious Diseases"], "name": "AK-Con-A (naphazoline ophthalmic)", "approval_status": "Approved January 1996", "company": "Akorn", "specific_treatment": "antihistamine product"},
{"therapeutic_areas": ["Nephrology", "Family Medicine", "Urology"], "name": "FLOMAX", "approval_status": "Approved October 1997", "company": "Boehringer Ingelheim", "specific_treatment": "benign prostatic hypertrophy (BPH)"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine", "Genetic Disease"], "name": "Tegretol (carbamazepine)", "approval_status": "Approved March 1996", "company": "Ciba Pharmaceuticals", "specific_treatment": "epilepsy"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Children's Advil (pediatric ibuprofen)", "approval_status": "Approved July 1996", "company": "Whitehall-Robins Healthcare", "specific_treatment": "pain due to colds, flu, sore throat, headache, and toothache"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Naprelan (naproxen sodium)", "approval_status": "Approved January 1996", "company": "Elan Pharmaceuticals, Wyeth", "specific_treatment": "osteoarthritis, rheumatoid arthritis"},
{"therapeutic_areas": ["Endocrinology", "Rheumatology", "Family Medicine"], "name": "Lodine (etodolac)", "approval_status": "Approved July 1996", "company": "Wyeth", "specific_treatment": "rheumatoid arthritis"},
{"therapeutic_areas": ["Endocrinology", "Rheumatology", "Family Medicine"], "name": "Azulfidine EN-tabs Tablets (sulfasalazine delayed release tablets, USP)", "approval_status": "Approved October 1996", "company": "Pharmacia & Upjohn", "specific_treatment": "rheumatoid arthritis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Tolmetin Sodium", "approval_status": "Approved March 1997", "company": "Teva Pharmaceutical", "specific_treatment": "arthritis"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology"], "name": "Nuplazid (pimavanserin)", "approval_status": "Approved May 2016", "company": "Acadia Pharmaceuticals", "specific_treatment": "hallucinations and delusions associated with Parkinson\u2019s disease psychosis"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Zyprexa", "approval_status": "Approved September 1996", "company": "Eli Lilly", "specific_treatment": "psychotic disorders"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Risperdal Oral Formulation", "approval_status": "Approved July 1996", "company": "Janssen Pharmaceuticals", "specific_treatment": "schizophrenia"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Urology"], "name": "SPORANOX (itraconazole)", "approval_status": "Approved March 1997", "company": "Janssen Pharmaceuticals", "specific_treatment": "oral thrush"},
{"therapeutic_areas": ["Endocrinology", "Gastroenterology", "Hematology", "Nephrology", "Pharmacology/Toxicology", "Family Medicine", "Nutrition and Weight Loss"], "name": "Nascobal Gel (Cyanocobalamin, USP)", "approval_status": "Approved November 1996", "company": "Questcor Pharmaceuticals", "specific_treatment": "vitamin B-12 deficiency"},
{"therapeutic_areas": ["Nephrology", "Family Medicine", "Urology"], "name": "Interstim Continence Control Therapy", "approval_status": "Approved September 1997", "company": "Medtronic", "specific_treatment": "urinary incontinence"},
{"therapeutic_areas": ["Psychiatry/Psychology", "Family Medicine"], "name": "Paxil (paroxetine hydrochloride)", "approval_status": "Approved May 1996", "company": "SmithKline Beecham", "specific_treatment": "panic disorder, obsessive-compulsive disorders"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Nicorette (nicotine polacrilex)", "approval_status": "Approved February 1996", "company": "SmithKline Beecham", "specific_treatment": "smoking cessation"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "NicoDerm CQ", "approval_status": "Approved August 1996", "company": "SmithKline Beecham, Hoechst Marion Roussel, Alza", "specific_treatment": "smoking cessation"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Family Medicine"], "name": "Lithobid (Lithium Carbonate)", "approval_status": "Approved January 1996", "company": "Solvay Pharmaceuticals", "specific_treatment": "manic depression"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology", "Family Medicine"], "name": "Depakote (divalproex sodium)", "approval_status": "Approved March 1996", "company": "Abbott Laboratories", "specific_treatment": "migraine headaches"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology", "Family Medicine"], "name": "ARICEPT (donepezil hydrochloride)", "approval_status": "Approved December 1996", "company": "Eisai", "specific_treatment": "Alzheimer's Disease"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Zyban Sustained-Release Tablets", "approval_status": "Approved May 1997", "company": "GlaxoSmithKline", "specific_treatment": "smoking cessation"},
{"therapeutic_areas": ["Psychiatry/Psychology", "Family Medicine"], "name": "Zoloft (sertraline HCl)", "approval_status": "Approved July 1997", "company": "Pfizer", "specific_treatment": "panic disorder"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Family Medicine"], "name": "Trazadone 150mg", "approval_status": "Approved  May 1997", "company": "Teva Pharmaceutical", "specific_treatment": "depression"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Seroquel (R)  (quetiapine fumarate) Tablets", "approval_status": "Approved September 1997", "company": "AstraZeneca", "specific_treatment": "psychotic disorders"},
{"therapeutic_areas": ["Endocrinology", "Neurology", "Psychiatry/Psychology", "Nutrition and Weight Loss"], "name": "Redux (dexfenfluramine hydrochloride)", "approval_status": "Approved May 1996", "company": "Wyeth", "specific_treatment": "obesity"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Family Medicine"], "name": "Remeron (Mirtazapine)", "approval_status": "Approved June 1996", "company": "Organon", "specific_treatment": "depression"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Nicotrol nasal spray", "approval_status": "Approved March 1996", "company": "Pharmacia & Upjohn", "specific_treatment": "smoking cessation"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Prochlorperazine", "approval_status": "Approved January 1998", "company": "IVAX", "specific_treatment": "Severe nausea and vomiting, and management of psychotic disorders"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology", "Family Medicine"], "name": "Naltrexone Hydrochloride Tablets", "approval_status": "Approved May 1998", "company": "Barr Laboratories", "specific_treatment": "alcohol dependence"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Family Medicine"], "name": "Marplan Tablets", "approval_status": "Approved August 1998", "company": "Roche", "specific_treatment": "Depression"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Family Medicine"], "name": "Clomipramine hydrochloride", "approval_status": "Approved April 1998", "company": "Mylan Laboratories", "specific_treatment": "depression"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Family Medicine"], "name": "Celexa", "approval_status": "Approved July 1998", "company": "Forest Laboratories", "specific_treatment": "Depression"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology"], "name": "Sonata", "approval_status": "Approved August 1999", "company": "American Home Products", "specific_treatment": "Neurology; Psychiatry"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Paxil CR (paroxetine hydrochloride)", "approval_status": "Approved March 1999", "company": "SmithKline Beecham", "specific_treatment": "Psychiatry"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Effexor (venlafaxin HCL)", "approval_status": "Approved March 1999", "company": "Wyeth", "specific_treatment": "Psychiatry/Psychology"},
{"therapeutic_areas": ["Psychiatry/Psychology", "Family Medicine"], "name": "Concerta", "approval_status": "Approved August 2000", "company": "Alza", "specific_treatment": "For the treatment of Attention Deficit Hyperactivity Disorder"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Ziprasidone (ziprasidone hydrochloride)", "approval_status": "Approved February 2001", "company": "Pfizer", "specific_treatment": "Schizophrenia"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Generic Transdermal Nicotine Patch", "approval_status": "Approved October 1997", "company": "Sano", "specific_treatment": "smoking cessation"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Family Medicine"], "name": "Remeron SolTab (mirtazapine)", "approval_status": "Approved January 2001", "company": "Organon", "specific_treatment": "Depression"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Family Medicine"], "name": "Prozac Weekly (fluoxetine HCl)", "approval_status": "Approved February 2001", "company": "Eli Lilly", "specific_treatment": "Depression"},
{"therapeutic_areas": ["Psychiatry/Psychology", "Family Medicine"], "name": "Paxil CR (paroxetine hydrochloride)", "approval_status": "Approved February 2002", "company": "GlaxoSmithKline", "specific_treatment": "Depression, panic disorder"},
{"therapeutic_areas": ["Psychiatry/Psychology", "Family Medicine"], "name": "Lexapro (escitalopram oxalate)", "approval_status": "Approved August 2002", "company": "Forest Laboratories", "specific_treatment": "major depression"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Geodon (ziprasidone mesylate)", "approval_status": "Approved June 2002", "company": "Pfizer", "specific_treatment": "Schizophrenia"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Abilify (aripiprazole)", "approval_status": "Approved November 2002", "company": "Bristol-Myers Squibb, Otsuka America Pharmaceutical", "specific_treatment": "Schizophrenia"},
{"therapeutic_areas": ["Psychiatry/Psychology", "Family Medicine"], "name": "Cymbalta (duloxetine)", "approval_status": "Approved August 2004", "company": "Eli Lilly", "specific_treatment": "Depression"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology"], "name": "Invega (paliperidone)", "approval_status": "Approved December 2006", "company": "Janssen Pharmaceuticals", "specific_treatment": "Schizophrenia"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Chantix (varenicline)", "approval_status": "Approved May 2006", "company": "Pfizer", "specific_treatment": "Smoking Cessation"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology", "Family Medicine"], "name": "Vivitrol (naltrexone for extended-release injectable suspension)", "approval_status": "Approved April 2006", "company": "Alkermes", "specific_treatment": "alcohol dependence"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology", "Family Medicine", "Genetic Disease"], "name": "Stavzor (valproic acid delayed release)", "approval_status": "Approved July 2008", "company": "Banner Pharmacaps", "specific_treatment": "bipolar manic disorder, seizures and migraine headaches"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Aplenzin (bupropion hydrobromide)", "approval_status": "Approved April 2008", "company": "Biovail Laboratories", "specific_treatment": "Major depressive disorder"},
{"therapeutic_areas": ["Psychiatry/Psychology", "Family Medicine", "Genetic Disease"], "name": "Saphris (asenapine)", "approval_status": "Approved August of 2009", "company": "Schering-Plough", "specific_treatment": "schizophrenia and manic or mixed bipolar 1 episodes"},
{"therapeutic_areas": ["Psychiatry/Psychology", "Family Medicine"], "name": "LUVOX  (fluvoxamine maleate)", "approval_status": "Approved April 1997", "company": "Solvay Pharmaceuticals, Pharmacia & Upjohn", "specific_treatment": "obsessive compulsive disorder"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology"], "name": "Edluar (zolpidem tartrate)", "approval_status": "Approved March 2009", "company": "Orexo", "specific_treatment": "insomnia"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology", "Family Medicine"], "name": "Vivitrol (naltrexone for extended-release injectable suspension)", "approval_status": "Approved October 2010", "company": "Alkermes", "specific_treatment": "opioid dependence"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Latuda (lurasidone)", "approval_status": "Approved October 2010", "company": "Sunovion", "specific_treatment": "schizophrenia"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology", "Family Medicine"], "name": "Viibryd (vilazodone hydrochloride)", "approval_status": "Approved January 2011", "company": "Clinical Data", "specific_treatment": "major depressive disorder"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology"], "name": "Zubsolv (buprenorphine and naloxone)", "approval_status": "Approved July 2013", "company": "Orexo AB", "specific_treatment": "maintenance treatment of opioid dependence"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology"], "name": "Fetzima (levomilnacipran)", "approval_status": "Approved July 2013", "company": "Forest Laboratories", "specific_treatment": "major depressive disorder"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Brintellix (vortioxetine)", "approval_status": "Approved October 2013", "company": "Takeda Pharmaceuticals USA", "specific_treatment": "Major Depressive Disorder"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology"], "name": "Vraylar (cariprazine)", "approval_status": "Approved September 2015", "company": "Allergan", "specific_treatment": "schizophrenia and bipolar disorder"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Rexulti (brexpiprazole)", "approval_status": "Approved July 2015", "company": "Otsuka", "specific_treatment": "depression and schizophrenia"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology"], "name": "Aristada (aripiprazole lauroxil) extended-release injectable", "approval_status": "Approved October 2015", "company": "Alkermes", "specific_treatment": "schizophrenia"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Synvisc, Synvisc-One (Hylan GF 20)", "approval_status": "Approved August 1997", "company": "Genzyme", "specific_treatment": "pain associated with osteoarthritis of the knee"},
{"therapeutic_areas": ["Dermatology", "Endocrinology", "Family Medicine", "Podiatry"], "name": "REGRANEX (becaplermin) Gel", "approval_status": "Approved December 1997", "company": "RW Johnson", "specific_treatment": "diabetic foot ulcers"},
{"therapeutic_areas": ["Endocrinology", "Oncology"], "name": "Leukine (sargramostim)", "approval_status": "Approved on November 24, 1995", "company": "Immunex", "specific_treatment": "transplantation"},
{"therapeutic_areas": ["Endocrinology", "Rheumatology", "Family Medicine"], "name": "Etodolac", "approval_status": "Approved April 1997", "company": "Royce Laboratories", "specific_treatment": "rheumatoid arthritis"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Family Medicine"], "name": "Effexor XR (venlafaxin HCI)", "approval_status": "Approved October 1997", "company": "Wyeth", "specific_treatment": "depression"},
{"therapeutic_areas": ["Psychiatry/Psychology", "Family Medicine"], "name": "Oleptro (trazodone hydrochloride)", "approval_status": "Approved February 2010", "company": "Labopharm", "specific_treatment": "major depressive disorder"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Arthrotec", "approval_status": "Approved December 1997", "company": "Searle", "specific_treatment": "arthritis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Lodine XL (etodolac)", "approval_status": "Approved February 1998", "company": "Wyeth", "specific_treatment": "arthritis"},
{"therapeutic_areas": ["Rheumatology"], "name": "Lodine XL (etodolac)", "approval_status": "Approved May 1999", "company": "Wyeth", "specific_treatment": "Rheumatology"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Mobic (meloxicam) Tablets", "approval_status": "Approved April 2000", "company": "Boehringer Ingelheim", "specific_treatment": "For relief of the signs and symptoms of osteoarthritis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Supartz", "approval_status": "Approved January 2001", "company": "Smith & Nephew Orthopaedics", "specific_treatment": "Osteoarthritis"},
{"therapeutic_areas": ["Endocrinology", "Rheumatology", "Family Medicine"], "name": "Remicade (infliximab)", "approval_status": "Approved January 2001", "company": "Centocor Ortho Biotech", "specific_treatment": "Rheumatoid arthritis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Kineret", "approval_status": "Approved November 2001", "company": "Amgen", "specific_treatment": "Rheumatoid arthritis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Remicade (infliximab)", "approval_status": "Approved February 2002", "company": "Centocor Ortho Biotech", "specific_treatment": "Rheumatoid arthritis"},
{"therapeutic_areas": ["Rheumatology", "Family Medicine"], "name": "Humira (adalimumab)", "approval_status": "Approved December 2002", "company": "Abbott Laboratories", "specific_treatment": "Rheumatoid Arthritis"},
{"therapeutic_areas": ["Rheumatology", "Family Medicine"], "name": "Enbrel (etanercept)", "approval_status": "Approved January 2002", "company": "Immunex", "specific_treatment": "Psoriatic arthritis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Vioxx (rofecoxib)", "approval_status": "Approved April 2002 -- UPDATED: WITHDRAWN OCTOBER 2004", "company": "Merck", "specific_treatment": "Rheumatoid arthritis"},
{"therapeutic_areas": ["Rheumatology", "Family Medicine"], "name": "Orencia (abatacept)", "approval_status": "Approved December 2005", "company": "Bristol-Myers Squibb", "specific_treatment": "Rheumatoid Arthritis"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Fanapt (iloperidone)", "approval_status": "Approved May of 2009", "company": "Vanda", "specific_treatment": "schizophrenia"},
{"therapeutic_areas": ["Dermatology", "Gastroenterology", "Rheumatology", "Family Medicine"], "name": "Stelara (ustekinumab)", "approval_status": "Approved September 2009", "company": "Janssen Biotech", "specific_treatment": "plaque psoriasis, psoriatic arthritis and Crohn's disease"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Simponi (golimumab)", "approval_status": "Approved April 2009", "company": "Centocor Ortho Biotech", "specific_treatment": "rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Pennsaid (diclofenac sodium topical solution)", "approval_status": "Approved November 2009", "company": "Nuvo Research", "specific_treatment": "osteoarthritis of the knee"},
{"therapeutic_areas": ["Psychiatry/Psychology"], "name": "Nicotrol transdermal patch", "approval_status": "Approved July 1996", "company": "McNeil Consumer Products", "specific_treatment": "smoking cessation"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Etodolac", "approval_status": "Approved December 1997", "company": "Royce Laboratories", "specific_treatment": "osteoarthritis"},
{"therapeutic_areas": ["Gastroenterology", "Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Vimovo (naproxen + esomeprazole)", "approval_status": "Approved April 2010", "company": "AstraZeneca", "specific_treatment": "arthritis in patients at risk for NSAID-associated ulcers"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Krystexxa (pegloticase)", "approval_status": "Approved September 2010", "company": "Savient Pharma", "specific_treatment": "chronic gout (hyperuricemia)"},
{"therapeutic_areas": ["Endocrinology", "Rheumatology", "Family Medicine"], "name": "Arava", "approval_status": "Approved September 1998", "company": "Hoechst Marion Roussel", "specific_treatment": "Rheumatoid Arthritis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Actemra (tocilizumab)", "approval_status": "Approved January 2010", "company": "Genentech", "specific_treatment": "rheumatoid arthritis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Xeljanz (tofacitinib)", "approval_status": "Approved November 2012", "company": "Pfizer", "specific_treatment": "moderately to severely active rheumatoid arthritis"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Adderall (mixed salts of a single-entity amphetamine)", "approval_status": "Supplemental NDA Approved February 1996", "company": "Richwood Pharmaceutical", "specific_treatment": "Attention Deficit/Hyperactivity Disorder (ADHD)"},
{"therapeutic_areas": ["Endocrinology", "Immunology", "Pediatrics/Neonatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Zerit (stavudine)", "approval_status": "Approved January 1997", "company": "Bristol-Myers Squibb", "specific_treatment": "HIV"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "VIRACEPT (nelfinavir mesylate)", "approval_status": "Approved March 1997", "company": "Agouron Pharmaceuticals", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology"], "name": "VERSED (midazolam HCI)", "approval_status": "Approved March 1997", "company": "Roche", "specific_treatment": "sedative for children undergoing painful surgeries"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Infections and Infectious Diseases"], "name": "Timentin", "approval_status": "Approved December 1997", "company": "SmithKline Beecham", "specific_treatment": "septicemia"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Norvir (ritonavir)", "approval_status": "Approved March 1996/March 1997", "company": "Abbott Laboratories", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Rheumatology"], "name": "Uloric (febuxostat)", "approval_status": "Approved February 2009", "company": "Takeda", "specific_treatment": "hyperuricemia"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology"], "name": "Timentin", "approval_status": "Approved January 1998", "company": "SmithKline Beecham", "specific_treatment": "Infections in children"},
{"therapeutic_areas": ["Pediatrics/Neonatology"], "name": "Desmopressin Acetate (DDAVP)", "approval_status": "Approved March 1998", "company": "Rhone Poulenc Rorer", "specific_treatment": "nocturnal enuresis"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology", "Family Medicine"], "name": "Cimzia (certolizumab pegol)", "approval_status": "Approved May of 2009", "company": "UCB", "specific_treatment": "rheumatoid arthritis"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology"], "name": "Topamax (topiramate)", "approval_status": "Approved July 1999", "company": "Ortho-McNeil Pharmaceutical", "specific_treatment": "Neurology"},
{"therapeutic_areas": ["Pediatrics/Neonatology"], "name": "Amoxil (amoxicillin)", "approval_status": "Approved July 1999", "company": "SmithKline Beecham", "specific_treatment": "Pediatrics"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Zoloft (sertraline HCl)", "approval_status": "Approved October 1997", "company": "Pfizer", "specific_treatment": "panic disorder/obsessive compulsive disorder"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine"], "name": "Neurontin (gabapentin) oral solution", "approval_status": "Approved October 2000", "company": "Parke-Davis", "specific_treatment": "As an adjunctive therapy in the treatment of partial seizures in pediatric patients three years of age and older"},
{"therapeutic_areas": ["Endocrinology", "Pediatrics/Neonatology", "Family Medicine"], "name": "Lantus (insulin glargine [rDNA origin] injection)", "approval_status": "Approved April 2000", "company": "Sanofi-aventis", "specific_treatment": "For adults and children w/Type 1 diabetes, or adults w/Type 2 diabetes requiring basal insulin to control hyperglycemia"},
{"therapeutic_areas": ["Endocrinology", "Pediatrics/Neonatology", "Family Medicine"], "name": "Lantus (insulin glargine [rDNA origin] injection)", "approval_status": "Approved April 2000", "company": "Sanofi-aventis", "specific_treatment": "type I and type II diabetes mellitus in adults and pediatrics"},
{"therapeutic_areas": ["Hematology", "Pediatrics/Neonatology", "Genetic Disease"], "name": "Kogenate FS (Antihemophilic Factor Recombinant)", "approval_status": "Approved June 2000", "company": "Bayer", "specific_treatment": "hemophilia A"},
{"therapeutic_areas": ["Musculoskeletal", "Rheumatology"], "name": "Ketoprofen", "approval_status": "Approved December 1997", "company": "Schein Pharmaceutical", "specific_treatment": "anti-inflammatory"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Psychiatry/Psychology"], "name": "Cylert", "approval_status": "Approved October 1998", "company": "Abbott Laboratories", "specific_treatment": "Neurology, Pediatrics, Psychiatry"},
{"therapeutic_areas": ["Gastroenterology", "Musculoskeletal", "Rheumatology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Duexis (ibuprofen and famotidine)", "approval_status": "Approved April 2011", "company": "Horizon Pharma", "specific_treatment": "relief of rheumatoid arthritis and osteoarthritis and prevention of gastric ulcers"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Strattera (atomoxetine HCl)", "approval_status": "December 2002", "company": "Eli Lilly", "specific_treatment": "Attention-Deficit/Hyperactivity Disorder (ADHD)"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Ritalin LA (methylphenidate HCl)", "approval_status": "Approved June 2002", "company": "Novartis", "specific_treatment": "Attention-Deficit/Hyperactivity Disorder"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Metadate CD", "approval_status": "Approved April 2001", "company": "Celltech Pharmaceuticals", "specific_treatment": "Attention Deficit Hyperactivity Disorder"},
{"therapeutic_areas": ["Gastroenterology", "Pediatrics/Neonatology"], "name": "Orfadin (nitisinone)", "approval_status": "Approved January 2002", "company": "Orphan Pharmaceuticals", "specific_treatment": "Hereditary tyrosinemia type I"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Pediatrics/Neonatology"], "name": "Genotropin (somatropin) injection", "approval_status": "Approved July 2001", "company": "Pharmacia & Upjohn", "specific_treatment": "Growth failure in children who were born small for gestational age (SGA)"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Pediatrics/Neonatology"], "name": "Alinia (nitazoxanide)", "approval_status": "December 2002", "company": "Romark Laboratories", "specific_treatment": "Diarrhea caused by Cryptosporidium and Giardia in children."},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Focalin (dexmethylphenidate HCl)", "approval_status": "Approved November 2001", "company": "Celgene", "specific_treatment": "Attention deficit hyperactivity disorder"},
{"therapeutic_areas": ["Pediatrics/Neonatology"], "name": "Myozyme (alglucosidase alfa)", "approval_status": "Approved April 2006", "company": "Genzyme", "specific_treatment": "Pompe disease"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Rheumatology"], "name": "Elaprase (idursulfase)", "approval_status": "Approved July 2006", "company": "Shire Pharmaceuticals", "specific_treatment": "Mucopolysaccharidosis II"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Adderall XR", "approval_status": "Approved October 2001", "company": "Shire Pharmaceuticals", "specific_treatment": "Attention deficit/hyperactivity disorder (ADHD)"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology"], "name": "Zingo (lidocaine hydrochloride monohydrate)", "approval_status": "Approved August 2007", "company": "Powder Pharmaceuticals", "specific_treatment": "local analgesia prior to venipuncture or peripheral intravenous cannulation"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Vyvanse (Lisdexamfetamine Dimesylate)", "approval_status": "Approved February 2007", "company": "New River", "specific_treatment": "Attention-Deficit/Hyperactivity Disorder"},
{"therapeutic_areas": ["Endocrinology", "Pediatrics/Neonatology"], "name": "Supprelin LA (histrelin acetate)", "approval_status": "Approved May 2007", "company": "Indevus Pharmaceuticals", "specific_treatment": "central precocious puberty"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine", "Genetic Disease"], "name": "Trileptal (oxcarbazepine) Tablets", "approval_status": "Approved January 2000", "company": "Novartis", "specific_treatment": "Adjunctive & monotherapy in adults; adjunctive therapy for children ages 4-16 with partial epileptic seizures"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Pediatrics/Neonatology"], "name": "Altabax (retapamulin)", "approval_status": "Approved April 2007", "company": "GlaxoSmithKline", "specific_treatment": "impetigo due to Staphylococcus aureus or Streptococcus pyogenes"},
{"therapeutic_areas": ["Musculoskeletal", "Pediatrics/Neonatology", "Rheumatology"], "name": "Orencia (abatacept)", "approval_status": "Approved April 2008", "company": "Bristol-Myers Squibb", "specific_treatment": "Juvenile Idiopathic Arthritis"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology"], "name": "Cinryze (C1 Inhibitor (Human))", "approval_status": "Approved October 2008", "company": "Lev Pharmaceuticals", "specific_treatment": "angioedema attacks in adolescents/adults with Hereditary Angioedema"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine", "Genetic Disease"], "name": "Banzel (rufinamide)", "approval_status": "Approved November 2008", "company": "Elan Pharmaceuticals", "specific_treatment": "seizures associated with Lennox-Gastaut syndrome in pediatrics and adults"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Aptivus (tipranavir)", "approval_status": "Approved June 2008", "company": "Boehringer Ingelheim", "specific_treatment": "HIV"},
{"therapeutic_areas": ["Endocrinology", "Pediatrics/Neonatology"], "name": "Geref (sermorelin acetate for injection)", "approval_status": "Approved October 1997", "company": "Serono Laboratories", "specific_treatment": "pediatric growth disorders"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Pediatrics/Neonatology", "Family Medicine", "Genetic Disease"], "name": "Sabril (vigabatrin)", "approval_status": "Approved August 2009", "company": "Lundbeck", "specific_treatment": "infantile spasms and complex partial seizures"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Intuniv (guanfacine extended-release)", "approval_status": "Approved September 2009", "company": "Shire Pharmaceuticals", "specific_treatment": "ADHD in children and adolescents"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology"], "name": "Daptacel", "approval_status": "Approved May 2002", "company": "Sanofi Pasteur", "specific_treatment": "Pediatric Immunology"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Genetic Disease"], "name": "Berinert (C1 Esterase Inhibitor (Human))", "approval_status": "Approved October 2009", "company": "CSL Behring", "specific_treatment": "abdominal or facial attacks of hereditary angioedema"},
{"therapeutic_areas": ["Dermatology", "Pediatrics/Neonatology", "Family Medicine"], "name": "Veltin (clindamycin phosphate and tretinoin)", "approval_status": "Approved July 2010", "company": "Stiefel", "specific_treatment": "acne vulgaris"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Pediatrics/Neonatology"], "name": "Rotarix (Rotavirus Vaccine, Live, Oral)", "approval_status": "Approved April 2008", "company": "GlaxoSmithKline", "specific_treatment": "rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in pediatrics"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine"], "name": "Cuvposa (glycopyrrolate)", "approval_status": "Approved July 2010", "company": "Shionogi", "specific_treatment": "chronic severe drooling in pediatrics with neurologic conditions"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine", "Genetic Disease"], "name": "Onfi (clobazam)", "approval_status": "Approved October 2011", "company": "Lundbeck", "specific_treatment": "seizures associated with Lennox-Gastaut syndrome"},
{"therapeutic_areas": ["Endocrinology", "Pediatrics/Neonatology"], "name": "Accretropin (somatropin rDNA Original)", "approval_status": "Approved January 2008", "company": "Cangene", "specific_treatment": "growth failure in pediatrics"},
{"therapeutic_areas": ["Dermatology", "Pediatrics/Neonatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Sklice (ivermectin) lotion", "approval_status": "Approved February 2012", "company": "Sanofi Pasteur", "specific_treatment": "head lice"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Psychiatry/Psychology", "Family Medicine"], "name": "Quillivant XR (methylphenidate hydrochloride)", "approval_status": "Approved September 2012", "company": "NextWave Pharmaceuticals", "specific_treatment": "Attention Deficit Hyperactivity Disorder"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine", "Genetic Disease"], "name": "Oxtellar XR (oxcarbazepine extended release)", "approval_status": "Approved October 2012", "company": "Supernus Pharmaceuticals", "specific_treatment": "partial seizures in adults and in children 6 years to 17 years of age"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine", "Genetic Disease"], "name": "Fycompa (perampanel)", "approval_status": "Approved October 2012", "company": "Eisai", "specific_treatment": "partial-onset seizures with or without secondarily generalized seizures"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology"], "name": "Trokendi XR (topiramate)", "approval_status": "Approved August 2013", "company": "Supernus Pharmaceuticals", "specific_treatment": "partial onset, tonic-clonic and Lennox-Gastaut Syndrome seizures"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology"], "name": "Tivicay (dolutegravir)", "approval_status": "Approved August 2013", "company": "ViiV HealthCare", "specific_treatment": "HIV-1 in adults and children over 12 years of age"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine"], "name": "Kapvay (clonidine hydrochloride)", "approval_status": "Approved October 2010", "company": "Shionogi", "specific_treatment": "attention deficit hyperactivity disorder"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Genetic Disease"], "name": "Kineret, anakinra", "approval_status": "Approved January 2013", "company": "Swedish Orphan Biovitrum", "specific_treatment": "Cryopyrin-Associated Periodic Syndromes"},
{"therapeutic_areas": ["Musculoskeletal", "Pediatrics/Neonatology", "Rheumatology", "Family Medicine"], "name": "Ilaris (canakinumab)", "approval_status": "Approved May 2013", "company": "Novartis", "specific_treatment": "Systemic Juvenile Idiopathic Arthritis"},
{"therapeutic_areas": ["Musculoskeletal", "Pediatrics/Neonatology", "Rheumatology"], "name": "Actemra (tocilizumab)", "approval_status": "Approved April 2011", "company": "Genentech", "specific_treatment": "systemic juvenile idiopathic arthritis"},
{"therapeutic_areas": ["Endocrinology", "Pediatrics/Neonatology"], "name": "Norditropin  (somatropin (rDNA origin) for injection)", "approval_status": "Approved February 1997", "company": "Novo Nordisk", "specific_treatment": "Growth failure in children"},
{"therapeutic_areas": ["Musculoskeletal", "Pediatrics/Neonatology", "Genetic Disease"], "name": "Vimizim (elosulfase alfa)", "approval_status": "Approved February 2014", "company": "BioMarin", "specific_treatment": "Mucopolysaccharidosis type IVA"},
{"therapeutic_areas": ["Neurology", "Pediatrics/Neonatology", "Family Medicine", "Genetic Disease"], "name": "Qudexy XR (topiramate)", "approval_status": "Approved March 2014", "company": "Upsher-Smith Laboratories", "specific_treatment": "partial onset and primary generalized tonic-clonic seizures and Lennox-Gastaut Syndrome"},
{"therapeutic_areas": ["Hematology", "Pediatrics/Neonatology", "Family Medicine", "Genetic Disease"], "name": "Alprolix [Coagulation Factor IX (Recombinant), Fc Fusion Protein]", "approval_status": "Approved March 2014", "company": "Biogen Idec", "specific_treatment": "hemophilia B"},
{"therapeutic_areas": ["Gastroenterology", "Pediatrics/Neonatology", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Cholbam (cholic acid)", "approval_status": "Approved March 2015 ", "company": "Asklepion Pharmaceuticals", "specific_treatment": "bile acid synthesis and peroxisomal disorders"},
{"therapeutic_areas": ["Hematology", "Pediatrics/Neonatology"], "name": "Kovaltry [Antihemophilic Factor (Recombinant)]", "approval_status": "Approved March 2016", "company": "Bayer ", "specific_treatment": "hemophillia A"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Pediatrics/Neonatology"], "name": "Exondys 51 (eteplirsen)", "approval_status": "Approved September 2016", "company": "Sarepta Therapeutics", "specific_treatment": "Duchenne muscular dystrophy with mutated DMD gene amenable to exon 51 skipping"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Family Medicine", "Urology"], "name": " INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)", "approval_status": "January 1997", "company": "SmithKline Beecham", "specific_treatment": "diphtheria, tetanus and pertussis"},
{"therapeutic_areas": ["Nephrology", "Family Medicine", "Urology"], "name": "Dutasteride", "approval_status": "Approved November 2001", "company": "GlaxoSmithKline", "specific_treatment": "Symptomatic benign prostatic hyperplasia"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Urology"], "name": "Cialis (tadalafil)", "approval_status": "Approved December 2003", "company": "Eli Lilly", "specific_treatment": "Erectile Dysfunction"},
{"therapeutic_areas": ["Immunology", "Nephrology", "Family Medicine", "Urology"], "name": "Doribax (doripenem)", "approval_status": "Approved October 2007", "company": "Johnson & Johnson", "specific_treatment": "intra-abdominal infections and urinary tract infections"},
{"therapeutic_areas": ["Hematology", "Pediatrics/Neonatology", "Genetic Disease"], "name": "Ravicti (glycerol phenylbutyrate)", "approval_status": "Approved February 2013", "company": "Hyperion Therapeutics", "specific_treatment": "pediatrics and adults with urea cycle disorders"},
{"therapeutic_areas": ["Nephrology", "Family Medicine", "Urology"], "name": "Jalyn (dutasteride + tamsulosin)", "approval_status": "Approved June 2010", "company": "GlaxoSmithKline", "specific_treatment": "benign prostatic hyperplasia"},
{"therapeutic_areas": ["Nephrology", "Family Medicine", "Urology"], "name": "Anturol (oxybutynin) Gel", "approval_status": "Approved December 2011", "company": "Antares Pharma", "specific_treatment": "overactive bladder"},
{"therapeutic_areas": ["Musculoskeletal", "Nephrology", "Rheumatology", "Family Medicine", "Urology"], "name": "Stendra (avanafil)", "approval_status": "Approved April 2012", "company": "Vivus", "specific_treatment": "erectile dysfunction"},
{"therapeutic_areas": ["Musculoskeletal", "Nephrology", "Family Medicine", "Urology"], "name": "Myrbetriq (mirabegron)", "approval_status": "Approved June 2012", "company": "Astellas Pharma US, Inc", "specific_treatment": "overactive bladder"},
{"therapeutic_areas": ["Endocrinology", "Urology"], "name": "Bio-T-Gel (testosterone gel)", "approval_status": "Approved February 2012", "company": "Teva Pharmaceutical", "specific_treatment": "hypogonadism"},
{"therapeutic_areas": ["Family Medicine", "Urology"], "name": "Xiaflex (collagenase clostridium histolyticum)", "approval_status": "Approved December of 2013", "company": "Auxilium", "specific_treatment": "Peyronie's disease"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine", "Infections and Infectious Diseases", "Urology"], "name": "Zerbaxa (ceftolozane + tazobactam) ", "approval_status": "Approved December 2014", "company": "Cubist Pharmaceuticals", "specific_treatment": "complicated intra-abdominal and urinary tract infections"},
{"therapeutic_areas": ["Urology", "Genetic Disease"], "name": "Xuriden (uridine triacetate)", "approval_status": "Approved September 2015", "company": "Wellstat Therapeutics", "specific_treatment": "hereditary orotic aciduria"},
{"therapeutic_areas": ["Musculoskeletal", "Pediatrics/Neonatology", "Rheumatology", "Family Medicine"], "name": "Actemra (ocilizumab)", "approval_status": "Approved May 2013", "company": "Genentech", "specific_treatment": "Polyarticular Juvenile Idiopathic Arthritis"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Acular (ketorolac tromethamine ophthalmic solution) 0.5%", "approval_status": "Approved November 1997", "company": "Allergan", "specific_treatment": "post-surgical inflammation following cataract extraction"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Acular (ketorolac tromethamine ophthalmic solution) 0.5%", "approval_status": "Approved January 1997", "company": "Allergan", "specific_treatment": "Treatment for postoperative inflammation in patients who have undergone cataract extraction"},
{"therapeutic_areas": ["Immunology", "Ophthalmology", "Pediatrics/Neonatology", "Infections and Infectious Diseases"], "name": "Viroptic", "approval_status": "Approved February 1998", "company": "King Pharmaceuticals", "specific_treatment": "inflammation of the cornea due to herpes simplex virus"},
{"therapeutic_areas": ["Dermatology", "Ophthalmology", "Rheumatology"], "name": "Salagen Tablets", "approval_status": "Approved February 1998", "company": "MGI Pharma", "specific_treatment": "Sjogren's Syndrome"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Lotemax", "approval_status": "Approved March 1998", "company": "Bausch & Lomb,  Pharmos", "specific_treatment": "post-operative eye inflammation"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine"], "name": "Cosopt", "approval_status": "Approved April 1998", "company": "Merck", "specific_treatment": "glaucoma or ocular hypertension"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Alrex", "approval_status": "Approved March 1998", "company": "Bausch & Lomb,  Pharmos", "specific_treatment": "seasonal allergic conjunctivitis"},
{"therapeutic_areas": ["Ophthalmology"], "name": "ZADITOR", "approval_status": "Approved July 1999", "company": "Ciba Vision", "specific_treatment": "Ophthalmology"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Alamast", "approval_status": "Approved September 1999", "company": "Santen", "specific_treatment": "Ophthalmology"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Visudyne (verteporfin for injection)", "approval_status": "Approved April 2000", "company": "QLT", "specific_treatment": "For the treatment of wet age-related macular degeneration (wet AMD)"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine"], "name": "Rescula (unoprostone isopropyl ophthalmic solution) 0.15%", "approval_status": "Approved August 2000", "company": "Ciba Vision", "specific_treatment": "For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension"},
{"therapeutic_areas": ["Gastroenterology", "Infections and Infectious Diseases", "Urology"], "name": "Avycaz  (ceftazidime-avibactam)", "approval_status": "Approved February 2015", "company": "Actavis", "specific_treatment": "complicated intra-abdominal and urinary tract infections"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Quixin (levofloxacin)", "approval_status": "Approved August 2000", "company": "Santen", "specific_treatment": "Antibacterial agent approved for the treatment of bacterial conjunctivitis"},
{"therapeutic_areas": ["Ophthalmology"], "name": "BSS Sterile Irrigating Solution", "approval_status": "Approved December 1997", "company": "Alcon", "specific_treatment": "irrigating solution during ocular surgical procedures"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine"], "name": "Betaxon", "approval_status": "Approved February 2000", "company": "Alcon", "specific_treatment": "For lowering intraocular pressure (IOP) in patients with chronic open-angle glaucoma or ocular hypertension"},
{"therapeutic_areas": ["Immunology", "Ophthalmology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Valcyte (valganciclovir HCl)", "approval_status": "Approved March 2001", "company": "Roche", "specific_treatment": "Cytomegalovirus retinitis in patients with AIDS"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine"], "name": "Travatan (travoprost ophthalmic solution)", "approval_status": "Approved March 2001", "company": "Alcon", "specific_treatment": "Glaucoma or ocular hypertension"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine"], "name": "Lumigan (bimatoprost ophthalmic solution)", "approval_status": "Approved March 2001", "company": "Allergan", "specific_treatment": "Glaucoma or ocular hypertension"},
{"therapeutic_areas": ["Immunology", "Ophthalmology"], "name": "Restasis (cyclosporine ophthalmic emulsion)", "approval_status": "December 2002", "company": "Allergan", "specific_treatment": "Low tear production due to ocular inflammation associated with keratoconjunctivitis sicca."},
{"therapeutic_areas": ["Ophthalmology"], "name": "Macugen (pegaptanib)", "approval_status": "Approved December 2004", "company": "Pfizer / Eyetech Pharmaceuticals", "specific_treatment": "Macular Degeneration"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Lucentis (ranibizumab)", "approval_status": "Approved June 2006", "company": "Genentech", "specific_treatment": "Wet Age-Related Macular Degeneration"},
{"therapeutic_areas": ["Immunology", "Ophthalmology"], "name": "AzaSite (azithromycin)", "approval_status": "Approved April 2007", "company": "InSite Vision", "specific_treatment": "bacterial conjunctivitis"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology"], "name": "Ilaris (canakinumab)", "approval_status": "Approved June 2009", "company": "Novartis", "specific_treatment": "Cryopyrin-Associated Periodic Syndromes"},
{"therapeutic_areas": ["Neurology", "Ophthalmology"], "name": "Durezol (difluprednate)", "approval_status": "Approved June 2008", "company": "Sirion Therapeutics", "specific_treatment": "inflammation and pain associated with ocular surgery"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Ozurdex (dexamethasone)", "approval_status": "Approved June 2009", "company": "Allergan", "specific_treatment": "macular edema following branch retinal vein occlusion or central retinal vein occlusion"},
{"therapeutic_areas": ["Immunology", "Ophthalmology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Bepreve (bepotastine besilate ophthalmic solution)", "approval_status": "Approved September 2009", "company": "Ista Pharmaceuticals", "specific_treatment": "itching associated with allergic conjunctivitis"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Acuvail (ketorolac tromethamine)", "approval_status": "Approved July 2009", "company": "Allergan", "specific_treatment": "pain and inflammation following cataract surgery"},
{"therapeutic_areas": ["Immunology", "Ophthalmology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Zymaxid (gatifloxacin ophthalmic solution)", "approval_status": "Approved May 2010", "company": "Allergan", "specific_treatment": "bacterial conjunctivitis"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine", "Infections and Infectious Diseases", "Genetic Disease"], "name": "Eylea (aflibercept)", "approval_status": "Approved November 2011", "company": "Regeneron Pharmaceuticals", "specific_treatment": "neovascular (wet) age-related macular degeneration"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine"], "name": "Zioptan (tafluprost ophthalmic solution)", "approval_status": "Approved February 2012", "company": "Merck", "specific_treatment": "elevated intraocular pressure"},
{"therapeutic_areas": ["Endocrinology", "Ophthalmology", "Family Medicine"], "name": "Lucentis (ranibizumab injection)", "approval_status": "Approved August 2012", "company": "Genentech", "specific_treatment": "diabetic macular edema"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Jetrea (ocriplasmin)", "approval_status": "Approved October 2012", "company": "Thrombogenics", "specific_treatment": "symptomatic vitreomacular adhesion"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Omidria (phenylephrine and ketorolac injection)", "approval_status": "Approved June 2014", "company": "Omeros", "specific_treatment": "For use during eye surgery to prevent intraoperative miosis and reduce post-operative pain"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Xiidra (lifitegrast)", "approval_status": "Approved July 2016", "company": "Shire", "specific_treatment": "dry eye disease"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine"], "name": "Vitravene Injection", "approval_status": "Approved August 1998", "company": "Isis Pharmaceuticals", "specific_treatment": "CMV Retinitis"},
{"therapeutic_areas": ["Ophthalmology"], "name": "Humira (adalimumab)", "approval_status": "Approved July 2016", "company": "Abbvie", "specific_treatment": "uveitis"},
{"therapeutic_areas": ["Endocrinology", "Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Zoladex (10.8 mg goserelin acetate implant)", "approval_status": "Approved January 1996", "company": "AstraZeneca", "specific_treatment": "prostate cancer"},
{"therapeutic_areas": ["Neurology", "Oncology", "Family Medicine"], "name": "UltraJect", "approval_status": "Approved August 1996", "company": "Mallinckrodt Group", "specific_treatment": "chronic pain"},
{"therapeutic_areas": ["Musculoskeletal", "Pediatrics/Neonatology", "Rheumatology"], "name": "Colcrys (colchicine)", "approval_status": "Approved October 2009", "company": "Mutual Pharmaceuticals", "specific_treatment": "gout flares and familial Mediterranean fever"},
{"therapeutic_areas": ["Endocrinology", "Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Lupron Depot (leuprolide acetate for depot suspension)", "approval_status": "Approved January 1996", "company": "Abbott Laboratories", "specific_treatment": "prostate cancer"},
{"therapeutic_areas": ["Immunology", "Ophthalmology"], "name": "Besivance (besifloxacin ophthalmic suspension)", "approval_status": "Approved June 2009", "company": "Bausch & Lomb", "specific_treatment": "bacterial conjunctivitis"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Oncology", "Family Medicine"], "name": "Kadian", "approval_status": "Approved July 1996", "company": "Purepac Pharmaceutical", "specific_treatment": "chronic pain"},
{"therapeutic_areas": ["Endocrinology", "Nephrology", "Oncology", "Family Medicine"], "name": "Gemzar (gemcitabine HCL)", "approval_status": "Approved May 1996", "company": "Eli Lilly", "specific_treatment": "pancreatic cancer"},
{"therapeutic_areas": ["Gastroenterology", "Oncology", "Family Medicine"], "name": "GastroMARK", "approval_status": "Approved May 1996", "company": "Advanced Magnetics", "specific_treatment": "gastrointestinal forms of cancer"},
{"therapeutic_areas": ["Oncology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Feridex I.V.", "approval_status": "Approved February 1996", "company": "Advanced Magnetics", "specific_treatment": "liver cancer"},
{"therapeutic_areas": ["Endocrinology", "Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Eulexin (flutamide)", "approval_status": "Approved June 1996", "company": "Schering-Plough", "specific_treatment": "prostate cancer"},
{"therapeutic_areas": ["Endocrinology", "Oncology"], "name": "Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection)", "approval_status": "Approved October 1996", "company": "Orphan Medical", "specific_treatment": "meningeal leukemia or lymphocytic lymphoma"},
{"therapeutic_areas": ["Endocrinology", "Oncology", "Family Medicine"], "name": "CEA-Scan", "approval_status": "Approved April 1996", "company": "Immunomedics", "specific_treatment": "colorectal cancer"},
{"therapeutic_areas": ["Endocrinology", "Oncology", "Family Medicine"], "name": "Campostar", "approval_status": "Approved June 1996", "company": "Pharmacia & Upjohn", "specific_treatment": "metastatic colorectal cancer"},
{"therapeutic_areas": ["Neurology", "Oncology", "Family Medicine"], "name": "Anexsia", "approval_status": "Approved August 1996", "company": "Mallinckrodt Group", "specific_treatment": "chronic pain"},
{"therapeutic_areas": ["Immunology", "Oncology", "Infections and Infectious Diseases"], "name": "Taxol", "approval_status": "Approved August 1997", "company": "Bristol-Myers Squibb", "specific_treatment": "Kaposi's Sarcoma"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Rituxan", "approval_status": "Approved November 1997", "company": "Biogen IDEC, Genentech", "specific_treatment": "non-hodgkin's lymphoma"},
{"therapeutic_areas": ["Neurology", "Oncology", "Family Medicine"], "name": "Quadramet (Samarium Sm 153 Lexidronam Injection)", "approval_status": "Approved March 1997", "company": "DuPont Merck Pharmaceutical Company", "specific_treatment": "pain associated with bone cancer"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Neumega", "approval_status": "Approved November 1997", "company": "Genetics Institute", "specific_treatment": "platelet deficiency"},
{"therapeutic_areas": ["Oncology"], "name": "Intron A (interferon alfa-2b, recombinant)", "approval_status": "Approved December 1997", "company": "Schering-Plough", "specific_treatment": "non-Hodgkin's lymphoma"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Photodynamic Therapy", "approval_status": "Approved January, 1996", "company": "Sanofi-aventis", "specific_treatment": "esophageal cancer"},
{"therapeutic_areas": ["Endocrinology", "Oncology", "Family Medicine"], "name": "Gliadel Wafer (polifeprosan 20 with carmustine implant)", "approval_status": "Approved February 1997", "company": "Rhone-Poulenc Rorer, Guilford Pharmaceuticals", "specific_treatment": "brain cancer"},
{"therapeutic_areas": ["Immunology", "Ophthalmology"], "name": "Zirgan (ganciclovir ophthalmic gel)", "approval_status": "Approved September 2009", "company": "Sirion Therapeutics", "specific_treatment": "acute herpetic keratitis"},
{"therapeutic_areas": ["Hematology", "Immunology", "Oncology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Leukine (sargramostim)", "approval_status": "Approved November 1996", "company": "Immunex", "specific_treatment": "replenishment of white blood cells, fungal infections"},
{"therapeutic_areas": ["Neurology", "Oncology", "Family Medicine"], "name": "Bromfenac", "approval_status": "Approved July 1997", "company": "Duract, Wyeth-Ayerst Laboratories", "specific_treatment": "acute pain"},
{"therapeutic_areas": ["Oncology"], "name": "Zofran", "approval_status": "Approved April 1998", "company": "GlaxoSmithKline", "specific_treatment": "postoperative vomiting and nausea in adults"},
{"therapeutic_areas": ["Oncology"], "name": "Valstar", "approval_status": "Approved October 1998", "company": "Anthra Pharmaceuticals", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Photofrin", "approval_status": "Approved January 1998", "company": "QLT", "specific_treatment": "Non-small cell lung cancer"},
{"therapeutic_areas": ["Oncology"], "name": "Nolvadex", "approval_status": "Approved October 1998", "company": "AstraZeneca", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Neupogen", "approval_status": "Approval April 1998", "company": "Amgen", "specific_treatment": "slow white blood cell recovery following chemotherapy"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Gemzar (gemcitabine HCL)", "approval_status": "Approved August 1998", "company": "Eli Lilly", "specific_treatment": "Lung cancer"},
{"therapeutic_areas": ["Oncology"], "name": "Anzemet", "approval_status": "Approved February 1998", "company": "Hoechst Marion Roussel", "specific_treatment": "prevention of nausea and vomiting associated with chemotherapy and surgery"},
{"therapeutic_areas": ["Oncology"], "name": "Actiq", "approval_status": "Approved November 1998", "company": "Anesta Corporation", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Oncology"], "name": "Zofran", "approval_status": "Approved January 1999", "company": "GlaxoSmithKline", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Oncology"], "name": "UVADEX Sterile Solution", "approval_status": "Approved February 1999", "company": "Therakos", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Oncology"], "name": "Temodar", "approval_status": "Approved August 1999", "company": "Schering-Plough", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Dermatology", "Pediatrics/Neonatology", "Family Medicine"], "name": "Desonate (desonide)", "approval_status": "Approved October 2006", "company": "Dow Pharm", "specific_treatment": "atopic dermatitis"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Busulflex", "approval_status": "Approved February 1999", "company": "Orphan Medical", "specific_treatment": "Oncology/Hematology"},
{"therapeutic_areas": ["Endocrinology", "Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Viadur (leuprolide acetate implant)", "approval_status": "Approved March 2000", "company": "Alza", "specific_treatment": "For the palliative treatment of advanced prostate cancer"},
{"therapeutic_areas": ["Oncology"], "name": "Anzemet", "approval_status": "Approved September 1997", "company": "Hoechst Marion Roussel", "specific_treatment": "Treatment for chemotherapy induced emesis"},
{"therapeutic_areas": ["Oncology"], "name": "Trisenox (arsenic trioxide)", "approval_status": "Approved September 2000", "company": "Cell Therapeutics", "specific_treatment": "Acute Promyelocytic Leukemia"},
{"therapeutic_areas": ["Endocrinology", "Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Trelstar Depot (triptorelin pamoate)", "approval_status": "Approved June 2000", "company": "Debio Rechereche Pharmaceutique, Target Research Associates", "specific_treatment": "For the palliative treatment of advanced prostate cancer"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Proleukin", "approval_status": "Approved January 1998", "company": "Chiron", "specific_treatment": "Metastatic melanoma"},
{"therapeutic_areas": ["Endocrinology", "Oncology"], "name": "Zometa (zoledronic acid)", "approval_status": "Approved August 2001", "company": "Novartis", "specific_treatment": "Hypercalcemia of malignancy"},
{"therapeutic_areas": ["Endocrinology", "Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Trelstar LA (triptorelin pamoate)", "approval_status": "Approved June 2001", "company": "Debiopharm", "specific_treatment": "Prostate cancer"},
{"therapeutic_areas": ["Endocrinology", "Oncology"], "name": "Gleevec (imatinib mesylate)", "approval_status": "Approved May 2001", "company": "Novartis", "specific_treatment": "chronic myeloid leukemia"},
{"therapeutic_areas": ["Oncology"], "name": "Camptosar", "approval_status": "Approved October 1998", "company": "Pharmacia & Upjohn", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Endocrinology", "Oncology"], "name": "Campath", "approval_status": "Approved May 2001", "company": "Berlex Laboratories", "specific_treatment": "Leukemia"},
{"therapeutic_areas": ["Oncology"], "name": "Zometa (zoledronic acid)", "approval_status": "Approved February 2002", "company": "Novartis", "specific_treatment": "Multiple myeloma; bone metastases from solid tumors"},
{"therapeutic_areas": ["Oncology"], "name": "Zevalin (ibritumomab tiuxetan)", "approval_status": "Approved February 2002", "company": "Biogen IDEC", "specific_treatment": "Non-Hodgkin's lymphoma"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "SecreFlo (secretin)", "approval_status": "Approved April 2002", "company": "Repligen", "specific_treatment": "Pancreatic dysfunction and gastrinoma"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Neulasta", "approval_status": "Approved January 2002", "company": "Amgen", "specific_treatment": "Neutropenia"},
{"therapeutic_areas": ["Oncology", "Family Medicine", "Urology"], "name": "Lupron Depot (leuprolide acetate for depot suspension)", "approval_status": "Approved July 1997", "company": "TAP Pharmaceuticals", "specific_treatment": "prostrate cancer"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Faslodex (fulvestrant)", "approval_status": "Approved April 2002", "company": "AstraZeneca", "specific_treatment": "Hormone receptor positive metastatic breast cancer"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "Eloxatin (oxaliplatin/5-fluorouracil/leucovorin)", "approval_status": "Approved August 2002", "company": "Sanofi-aventis", "specific_treatment": "Metastatic colon or rectum carcinomas that have recurred or progressed within six months folowing first-line treatment"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Eligard (leuprolide acetate)", "approval_status": "Approved January 2002", "company": "Atrix Laboratories", "specific_treatment": "Advanced prostate cancer"},
{"therapeutic_areas": ["Musculoskeletal", "Oncology"], "name": "Velcade (bortezomib)", "approval_status": "Approved May 2003", "company": "Millennium Pharmaceuticals", "specific_treatment": "Multiple Myeloma"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "UroXatral (alfuzosin HCl extended-release tablets)", "approval_status": "Approved June 2003", "company": "Sanofi-aventis", "specific_treatment": "Benign Prostatic Hyperplasia"},
{"therapeutic_areas": ["Oncology"], "name": "Mylotarg (gemtuzumab ozogamicin)", "approval_status": "Approved May 2000", "company": "Wyeth", "specific_treatment": "Acute Myeloid Leukemia (AML)"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "Emend (aprepitant)", "approval_status": "Approved March 2003", "company": "Merck", "specific_treatment": "Chemotherapy-induced Nausea and Vomiting"},
{"therapeutic_areas": ["Oncology"], "name": "Xeloda", "approval_status": "Approved May 2001", "company": "Roche", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Bexxar", "approval_status": "Approved  June 2003", "company": "Corixa", "specific_treatment": "Non-Hodgkin's Lymphoma"},
{"therapeutic_areas": ["Oncology"], "name": "Kytril (granisetron) solution", "approval_status": "Approved June 2001", "company": "Roche", "specific_treatment": "Nausea and vomiting associated with cancer therapy"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Tarceva (erlotinib, OSI 774)", "approval_status": "Approved November, 2004", "company": "Genentech, OSI Pharmaceuticals", "specific_treatment": "Non-small cell lung cancer"},
{"therapeutic_areas": ["Nephrology", "Oncology"], "name": "Sensipar (cinacalcet)", "approval_status": "Approved March 2004", "company": "Amgen", "specific_treatment": "Hyperparathyroidism / Hypercalcemia"},
{"therapeutic_areas": ["Gastroenterology", "Oncology", "Family Medicine"], "name": "Erbitux (cetuximab)", "approval_status": "Approved February 2004", "company": "Imclone, Bristol-Myers Squibb", "specific_treatment": "Colorectal Cancer"},
{"therapeutic_areas": ["Oncology"], "name": "Clolar (clofarabine)", "approval_status": "Approved December, 2004", "company": "Genzyme", "specific_treatment": "Lymphoblastic Leukemia"},
{"therapeutic_areas": ["Oncology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Nexavar (sorafenib)", "approval_status": "Approved December 2005", "company": "Bayer/Onyx", "specific_treatment": "Renal Cell Carcinoma"},
{"therapeutic_areas": ["Gastroenterology", "Oncology", "Family Medicine"], "name": "Avastin (bevacizumab)", "approval_status": "Approved February 2004", "company": "Genentech", "specific_treatment": "Colorectal Cancer"},
{"therapeutic_areas": ["Oncology"], "name": "Arranon (nelarabine)", "approval_status": "Approved October 2005", "company": "GlaxoSmithKline", "specific_treatment": "Lymphoblastic Leukemia"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "Gleevec (imatinib mesylate)", "approval_status": "Approved February 2002", "company": "Novartis", "specific_treatment": "Gastrointestinal stromal tumors (GISTs)"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Vectibix (panitumumab)", "approval_status": "Approved September 2006", "company": "Amgen", "specific_treatment": "colorectal cancer"},
{"therapeutic_areas": ["Immunology", "Oncology"], "name": "Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)", "approval_status": "Approved June 2006", "company": "Merck", "specific_treatment": "Cervical Cancer Caused by Human Papillomavirus"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Tykerb (lapatinib)", "approval_status": "Approved March 2007", "company": "GlaxoSmithKline", "specific_treatment": "breast cancer"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Torisel (temsirolimus)", "approval_status": "Approved May 2007", "company": "Wyeth", "specific_treatment": "renal cell carcinoma"},
{"therapeutic_areas": ["Oncology"], "name": "Tasigna (nilotinib hydrochloride monohydrate)", "approval_status": "Approved October 2007", "company": "Novartis", "specific_treatment": "chronic myelogenous leukemia"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "Aloxi (palonosetron)", "approval_status": "Approved August 2003", "company": "MGI Pharma, Helsinn Healthcare", "specific_treatment": "Chemotherapy side effects"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Hycamtin (topotecan hydrochloride)", "approval_status": "Approved October 2007", "company": "GlaxoSmithKline", "specific_treatment": "small cell lung cancer"},
{"therapeutic_areas": ["Ophthalmology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Cystaran (cysteamine hydrochloride)", "approval_status": "Approved October 2012", "company": "Sigma Tau Pharmaceuticals", "specific_treatment": "corneal cystine crystal accumulation due to cystinosis"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Mozobil (plerixafor injection)", "approval_status": "Approved December 2008", "company": "Genzyme", "specific_treatment": "non-Hodgkin\u2019s lymphoma and multiple myeloma"},
{"therapeutic_areas": ["Oncology"], "name": "Alimta (pemetrexed for injection)", "approval_status": "Approved February 2004", "company": "Eli Lilly", "specific_treatment": "Mesothelioma"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Degarelix (degarelix for injection)", "approval_status": "Approved December of 2008", "company": "Ferring Pharmaceuticals", "specific_treatment": "Prostate Cancer"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Votrient (pazopanib)", "approval_status": "Approved October of 2009", "company": "GlaxoSmithKline", "specific_treatment": "renal cell carcinoma"},
{"therapeutic_areas": ["Neurology", "Oncology", "Family Medicine"], "name": "Onsolis (fentanyl buccal)", "approval_status": "Approved July 2009", "company": "BioDelivery Sciences", "specific_treatment": "breakthrough cancer pain"},
{"therapeutic_areas": ["Oncology"], "name": "Sutent (sunitinib)", "approval_status": "Approved January 2006", "company": "Pfizer", "specific_treatment": "Kidney Cancer/Gastrointestinal Stromal Tumors"},
{"therapeutic_areas": ["Oncology"], "name": "Sprycel (dasatinib)", "approval_status": "Approved June 2006", "company": "Bristol-Myers Squibb", "specific_treatment": "Chronic Myeloid Leukemia"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Folotyn (pralatrexate injection)", "approval_status": "Approved September 2009", "company": "Allos Therapeutics", "specific_treatment": "peripheral T-cell lymphoma"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Avastin (bevacizumab)", "approval_status": "Approved July 2009", "company": "Genentech", "specific_treatment": "renal cell carcinoma"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Afinitor (everolimus)", "approval_status": "Approved March 2009", "company": "Novartis", "specific_treatment": "renal cell carcinoma"},
{"therapeutic_areas": ["Oncology", "Family Medicine", "Urology"], "name": "Plenaxis (abarelix for injectable suspension)", "approval_status": "Approved December 2003", "company": "Praecis Pharmaceuticals", "specific_treatment": "Prostate Cancer"},
{"therapeutic_areas": ["Musculoskeletal", "Oncology"], "name": "Xgeva (denosumab)", "approval_status": "Approved November 2010", "company": "Amgen", "specific_treatment": "prevention of skeletal-related events in patients with bone metastases from solid tumors"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Provenge (sipuleucel-T)", "approval_status": "Approved May 2010", "company": "Dendreon", "specific_treatment": "hormone refractory prostate cancer"},
{"therapeutic_areas": ["Oncology", "Family Medicine"], "name": "Ixempra (ixabepilone)", "approval_status": "Approved October 2007", "company": "Bristol-Myers Squibb", "specific_treatment": "Breast cancer"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Urology"], "name": "Jevtana (cabazitaxel)", "approval_status": "Approved June 2010", "company": "sanofi aventis", "specific_treatment": "prostate cancer"},
{"therapeutic_areas": ["Gastroenterology", "Oncology", "Family Medicine"], "name": "Herceptin (trastuzumab)", "approval_status": "Approved October 2010", "company": "Genentech", "specific_treatment": "gastric cancer"},
{"therapeutic_areas": ["Oncology", "Family Medicine", "Urology"], "name": "Zytiga (abiraterone acetate)", "approval_status": "Approved May 2011", "company": "Centocor Ortho Biotech", "specific_treatment": "prostate cancer"},
{"therapeutic_areas": ["Dermatology", "Oncology", "Family Medicine"], "name": "Zelboraf (vemurafenib)", "approval_status": "Approved August of 2011", "company": "Roche", "specific_treatment": "BRAF + melanoma"},
{"therapeutic_areas": ["Dermatology", "Oncology", "Family Medicine"], "name": "Yervoy (ipilimumab)", "approval_status": "Approved March 2011", "company": "Bristol-Myers Squibb", "specific_treatment": "metastatic melanoma"},
{"therapeutic_areas": ["Dermatology", "Oncology", "Family Medicine"], "name": "Sylatron (peginterferon alfa-2b)", "approval_status": "Approved April 2011", "company": "Merck", "specific_treatment": "melanoma"},
{"therapeutic_areas": ["Endocrinology", "Gastroenterology", "Oncology", "Family Medicine"], "name": "Sutent (sunitinib malate)", "approval_status": "Approved May 2011", "company": "Pfizer", "specific_treatment": "pancreatic neuroendocrine tumors"},
{"therapeutic_areas": ["Neurology", "Oncology", "Family Medicine"], "name": "Lazanda (fentanyl citrate) nasal spray", "approval_status": "Approved June 2011", "company": "Archimedes", "specific_treatment": "breakthrough cancer pain"},
{"therapeutic_areas": ["Endocrinology", "Gastroenterology", "Oncology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Afinitor (everolimus)", "approval_status": "Approved May 2011", "company": "Novartis", "specific_treatment": "advanced pancreatic neuroendocrine tumors"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Adcetris (brentuximab vedotin)", "approval_status": "Approved August 2011", "company": "Seattle Genetics", "specific_treatment": "Hodgkin lymphoma and anaplastic large cell lymphoma"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Istodax (romidepsin)", "approval_status": "Approved November 2009", "company": "Gloucester Pharmaceuticals", "specific_treatment": "cutaneous T-cell lymphoma"},
{"therapeutic_areas": ["Gastroenterology", "Oncology", "Family Medicine"], "name": "Zaltrap (ziv-aflibercept)", "approval_status": "Approved August 2012", "company": "Sanofi-aventis", "specific_treatment": "metastatic colorectal cancer"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Elitek (rasburicase)", "approval_status": "Approved October 2009", "company": "sanofi-aventis", "specific_treatment": "management of plasma uric acid levels in adults with malignancies"},
{"therapeutic_areas": ["Gastroenterology", "Oncology", "Family Medicine", "Urology"], "name": "Xtandi (enzalutamide)", "approval_status": "Approved August 2012", "company": "Medivation", "specific_treatment": "metastatic castration-resistant prostate cancer"},
{"therapeutic_areas": ["Musculoskeletal", "Oncology"], "name": "Votrient (pazopanib)", "approval_status": "Approved April 2012", "company": "GlaxoSmithKline", "specific_treatment": "soft tissue sarcoma"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Synribo (omacetaxine mepesuccinate)", "approval_status": "Approved October 2012", "company": "Teva Pharmaceutical", "specific_treatment": "chronic or accelerated phase chronic myeloid leukemia"},
{"therapeutic_areas": ["Neurology", "Oncology", "Family Medicine"], "name": "Subsys (fentanyl sublingual spray)", "approval_status": "Approved January of 2012", "company": "Insys Therapeutics", "specific_treatment": "breakthrough cancer pain"},
{"therapeutic_areas": ["Dermatology", "Oncology", "Family Medicine"], "name": "Picato (ingenol mebutate) gel", "approval_status": "Approved January 2012", "company": "LEO Pharma", "specific_treatment": "actinic keratosis"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Neutroval (tbo-filgrastim)", "approval_status": "Approved August 2012", "company": "Teva Pharmaceutical", "specific_treatment": "severe chemotherapy-induced neutropenia"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Marqibo (vinCRIStine sulfate LIPOSOME injection)", "approval_status": "Approved August 2012", "company": "Talon Therapeutics", "specific_treatment": "Ph- acute lymphoblastic leukemia"},
{"therapeutic_areas": ["Hematology", "Oncology", "Family Medicine"], "name": "Kyprolis (carfilzomib)", "approval_status": "Approved July 2012", "company": "Onyx Pharmaceuticals", "specific_treatment": "multiple myeloma"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Inlyta (axitinib)", "approval_status": "Approved January 2012", "company": "Pfizer", "specific_treatment": "advanced renal cell carcinoma"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Iclusig (ponatinib)", "approval_status": "Approved December 2012", "company": "Ariad Pharmaceuticals", "specific_treatment": "chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia"},
{"therapeutic_areas": ["Dermatology", "Oncology", "Family Medicine"], "name": "Erivedge (vismodegib)", "approval_status": "Approved January 2012", "company": "Genentech", "specific_treatment": "basal cell carcinoma"},
{"therapeutic_areas": ["Endocrinology", "Oncology", "Family Medicine"], "name": "Cometriq (cabozantinib)", "approval_status": "Approved November 2012", "company": "Exelixis", "specific_treatment": "thyroid cancer"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Bosulif (bosutinib)", "approval_status": "Approved September 2012", "company": "Pfizer", "specific_treatment": "Ph+ chronic myelogenous leukemia"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Erwinaze (asparaginase Erwinia chrysanthemi)", "approval_status": "Approved November of 2011", "company": "Eusa Pharma", "specific_treatment": "acute lymphoblastic leukemia"},
{"therapeutic_areas": ["Oncology", "Urology"], "name": "Xofigo (radium Ra 223 dichloride)", "approval_status": "Approved May 2013", "company": "Bayer Healthcare Pharmaceuticals", "specific_treatment": "prostate cancer with bone metastases"},
{"therapeutic_areas": ["Dermatology", "Hematology", "Oncology"], "name": "Valchlor (mechlorethamine) gel", "approval_status": "Approved August 2013", "company": "Ceptaris Therapeutics", "specific_treatment": "Stage IA/IB mycosisfungoides-type cutaneous T-cell lymphoma"},
{"therapeutic_areas": ["Neurology", "Oncology", "Family Medicine"], "name": "Abstral (fentanyl sublingual tablets)", "approval_status": "Approved January 2011", "company": "ProStrakan", "specific_treatment": "breakthrough cancer pain in opioid-tolerant patients"},
{"therapeutic_areas": ["Dermatology", "Oncology"], "name": "Tafinlar (dabrafenib)", "approval_status": "Approved May 2013", "company": "GlaxoSmithKline", "specific_treatment": "unresectable or metastatic melanoma with BRAF V600E mutation"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "Stivarga (regorafenib)", "approval_status": "Approved February 2013", "company": "Bayer", "specific_treatment": "gastrointestinal stromal tumor"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Pomalyst (pomalidomide)", "approval_status": "Approved February 2013", "company": "Celgene", "specific_treatment": "relapsed and refractory multiple myeloma"},
{"therapeutic_areas": ["Dermatology", "Oncology"], "name": "Mekinist (trametinib)", "approval_status": "Approved May of 2013", "company": "GlaxoSmithKline", "specific_treatment": "unresectable or metastatic melanoma with BRAF V600E or V600K mutations"},
{"therapeutic_areas": ["Gastroenterology", "Nephrology", "Oncology", "Family Medicine"], "name": "Stivarga (regorafenib)", "approval_status": "Approved September 2012", "company": "Bayer HealthCare Pharmaceuticals", "specific_treatment": "metastatic colorectal cancer"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Imbruvica (ibrutinib)", "approval_status": "Approved November of 2013", "company": "Pharmacyclics", "specific_treatment": "mantle cell lymphoma"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Gazyva (obinutuzumab)", "approval_status": "Approved October of 2013", "company": "Genentech", "specific_treatment": "previously untreated chronic lymphocytic leukemia"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Zydelig (idelalisib)", "approval_status": "Approved July 2014", "company": "Gilead", "specific_treatment": "relapsed CLL, follicular B-cell NHL and small lymphocytic lymphoma"},
{"therapeutic_areas": ["Dermatology", "Oncology"], "name": "Opdivo (nivolumab)", "approval_status": "Approved December 2014", "company": "Bristol-Myers Squibb", "specific_treatment": "unresectable or metastatic melanoma"},
{"therapeutic_areas": ["Dermatology", "Oncology"], "name": "Keytruda (pembrolizumab)", "approval_status": "Approved September 2014", "company": "Merck", "specific_treatment": "unresectable or metastatic melanoma"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Imbruvica (ibrutinib)", "approval_status": "Approved February 2014", "company": "Pharmacyclics", "specific_treatment": "chronic lymphocytic leukemia"},
{"therapeutic_areas": ["Oncology"], "name": "Treanda (bendamustine hydrochloride)", "approval_status": "Approved October 2008", "company": "Cephalon", "specific_treatment": "Chronic lymphocytic leukemia and B-cell non-Hodgkin\u2019s lymphoma"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "Cyramza (ramucirumab)", "approval_status": "Approved April 2014", "company": "Eli Lilly", "specific_treatment": "gastric cancer"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Blincyto (blinatumomab)", "approval_status": "Approved December 2014", "company": "Amgen", "specific_treatment": "Philadelphia chromosome-negative relapsed /refractory B cell precursor acute lymphoblastic leukemia"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Beleodaq (belinostat)", "approval_status": "Approved July 2014", "company": "Spectrum Pharmaceuticals", "specific_treatment": "relapsed or refractory peripheral T-cell lymphoma"},
{"therapeutic_areas": ["Oncology"], "name": "Yondelis (trabectedin)", "approval_status": "Approved October 2015", "company": "Janssen", "specific_treatment": "liposarcoma or leiomyosarcoma"},
{"therapeutic_areas": ["Oncology"], "name": "Vistogard (uridine triacetate)", "approval_status": "Approved December 2015", "company": "Wellstat Therapeutics", "specific_treatment": "fluorouracil or capecitabine overdose"},
{"therapeutic_areas": ["Nephrology", "Oncology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Afinitor (everolimus)", "approval_status": "Approved April 2012", "company": "Novartis", "specific_treatment": "renal angiomyolipoma associated with tuberous sclerosis complex"},
{"therapeutic_areas": ["Oncology", "Pediatrics/Neonatology"], "name": "Unituxin (dinutuximab)", "approval_status": "Approved March 2015 ", "company": "United Therapeutics", "specific_treatment": "pediatrics with high-risk neuroblastoma"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "Onivyde (irinotecan liposome injection)", "approval_status": "Approved October 2015", "company": "Merrimack", "specific_treatment": "metastatic pancreatic cancer"},
{"therapeutic_areas": ["Dermatology", "Oncology"], "name": "Odomzo (sonidegib)", "approval_status": "July 2015", "company": "Novartis", "specific_treatment": "locally advanced basal cell carcinoma"},
{"therapeutic_areas": ["Oncology"], "name": "Ninlaro (ixazomib)", "approval_status": "Approved November 2015", "company": "Millennium Pharmaceuticals", "specific_treatment": "Multiple myeloma"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "Lonsurf (trifluridine and tipiracil)", "approval_status": "Approved September 2015", "company": "Taiho Oncology", "specific_treatment": "metastatic colorectal cancer "},
{"therapeutic_areas": ["Oncology"], "name": "Lenvima (lenvatinib)", "approval_status": "Approved February 2015", "company": "Eisai", "specific_treatment": "thyroid cancer"},
{"therapeutic_areas": ["Dermatology", "Oncology"], "name": "Imlygic (talimogene laherparepvec) ", "approval_status": "Approved October 2015", "company": "Amgen", "specific_treatment": "unresectable recurrent melanoma"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Farydak (panobinostat)", "approval_status": "Approved February 2015", "company": "Novartis", "specific_treatment": "Multiple myeloma"},
{"therapeutic_areas": ["Oncology"], "name": "Empliciti (elotuzumab)", "approval_status": "Approved November 2015", "company": "Bristol-Myers Squibb", "specific_treatment": "multiple myeloma patients who have received prior therapies"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Darzalex (daratumumab)", "approval_status": "Approved November 2015", "company": "Janssen Biotech", "specific_treatment": "multiple myeloma"},
{"therapeutic_areas": ["Dermatology", "Oncology"], "name": "Cotellic (cobimetinib) ", "approval_status": "Approved November 2015", "company": "Genentech", "specific_treatment": "BRAF V600E or V600K melanoma"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Venclexta (venetoclax)", "approval_status": "Approved April 2016", "company": "AbbVie", "specific_treatment": "chronic lymphocytic leukemia with 17p deletion"},
{"therapeutic_areas": ["Oncology", "Infections and Infectious Diseases"], "name": "Syndros (dronabinol oral solution)", "approval_status": "Approved July 2016", "company": "Insys Therapeutics", "specific_treatment": "anorexia associated with AIDS and nausea and vomiting associated with cancer chemotherapy"},
{"therapeutic_areas": ["Oncology"], "name": "Opdivo (nivolumab)", "approval_status": "Approved November 2016", "company": "Bristol-Myers Squibb", "specific_treatment": "recurrent or metastatic squamous cell carcinoma of the head and neck"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Opdivo (nivolumab)", "approval_status": "Approved May 2016", "company": "Bristol-Myers Squibb", "specific_treatment": "classical Hodgkin lymphoma"},
{"therapeutic_areas": ["Nephrology", "Oncology"], "name": "Lenvima (lenvatinib)", "approval_status": "Approved May 2016", "company": "Eisai", "specific_treatment": "advanced renal cell carcinoma"},
{"therapeutic_areas": ["Gastroenterology", "Oncology"], "name": "Varubi (rolapitant)", "approval_status": "Approved September 2015", "company": "Tesaro", "specific_treatment": "chemotherapy-induced nausea and vomiting"},
{"therapeutic_areas": ["Oncology"], "name": "Keytruda (pembrolizumab)", "approval_status": "Approved August 2016", "company": "Merck", "specific_treatment": "head and neck squamous cell cancer "},
{"therapeutic_areas": ["Nephrology", "Oncology"], "name": "Opdivo (nivolumab)", "approval_status": "Approved November 2015", "company": "Bristol-Myers Squibb", "specific_treatment": "advanced renal cell carcinoma"},
{"therapeutic_areas": ["Endocrinology", "Nutrition and Weight Loss"], "name": "MERIDIA", "approval_status": "Approved November 1997", "company": "Knoll Pharmaceutical", "specific_treatment": "obesity"},
{"therapeutic_areas": ["Endocrinology", "Psychiatry/Psychology", "Nutrition and Weight Loss"], "name": "Qsymia (phentermine + topiramate extended-release)", "approval_status": "Approved July 2012", "company": "Vivus", "specific_treatment": "chronic weight management"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Arzerra (ofatumumab)", "approval_status": "Approved October 2009", "company": "GlaxoSmithKline", "specific_treatment": "chronic lymphocytic leukemia"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine", "Nutrition and Weight Loss"], "name": "Bydureon (exenatide extended-release for injectable suspension)", "approval_status": "Approved January 2012", "company": "Amylin", "specific_treatment": "glycemic control in adults with type II daibetesmellitus"},
{"therapeutic_areas": ["Endocrinology", "Nutrition and Weight Loss"], "name": "Belviq (lorcaserin hydrochloride)", "approval_status": "Approved June 2012", "company": "Arena Pharmaceuticals", "specific_treatment": "weight loss management"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine", "Nutrition and Weight Loss"], "name": "Nesina (alogliptin)", "approval_status": "Approved January 2013", "company": "Takeda", "specific_treatment": "type II diabetes mellitus"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine", "Nutrition and Weight Loss"], "name": "Tanzeum (albiglutide)", "approval_status": "Approved April 2014", "company": "GlaxoSmithKline", "specific_treatment": "type II diabetes mellitus"},
{"therapeutic_areas": ["Family Medicine", "Nutrition and Weight Loss"], "name": "Saxenda (liraglutide [rDNA origin] injection)", "approval_status": "Approved December 2014", "company": "Novo Nordisk", "specific_treatment": "chronic weight management"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine", "Nutrition and Weight Loss"], "name": "Jardiance (empagliflozin) ", "approval_status": "Approved August 2014", "company": "Boehringer Ingelheim", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Family Medicine", "Nutrition and Weight Loss"], "name": "Contrave (naltrexone HCl and bupropion HCl) ", "approval_status": "Approved September 2014", "company": "Takeda Pharmaceuticals U.S.A.", "specific_treatment": "chronic  weight management "},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Self-examination breast pad", "approval_status": "Approved on December 22, 1995", "company": "Inventive Products", "specific_treatment": "breast self-examination"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Prempro & Premphase (conjugated estrogens/medroxyprogesterone acetate tablets)", "approval_status": "Approved November 1995", "company": "Wyeth", "specific_treatment": "postmenopausal hormone replacement, postmenopausal osteoporosis"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Miacalcin (calcitonin-salmon) Nasal Spray", "approval_status": "Approved on August 17, 1995", "company": "Sandoz Pharmaceuticals", "specific_treatment": "post-menopausal osteoporosis"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Fosamax (alendronate sodium)", "approval_status": "Approved on September 29, 1995", "company": "Merck", "specific_treatment": "Post-menopausal osteoporosis, Paget's disease of bone"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Ethyol (amifostine)", "approval_status": "Approved December 8, 1995", "company": "Alza", "specific_treatment": "ovarian cancer"},
{"therapeutic_areas": ["Nephrology", "Oncology"], "name": "Cabometyx (cabozantinib)", "approval_status": "Approved April 2016", "company": "Exelixis", "specific_treatment": "advanced renal cell carcinoma"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Vivelle (estradiol transdermal system)", "approval_status": "Approved March 1996", "company": "Ciba Pharmaceuticals", "specific_treatment": "menopausal symptoms"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Taxotere (Docetaxel)", "approval_status": "Approved May 1996", "company": "Rhone Poulenc Rorer", "specific_treatment": "breast cancer"},
{"therapeutic_areas": ["Hematology", "Oncology"], "name": "Revlimid (lenalidomide)", "approval_status": "Approved June 2013", "company": "Celgene", "specific_treatment": "mantle cell lymphoma"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Monistat 3 (miconazole nitrate)", "approval_status": "Approved April 1996", "company": "Johnson & Johnson", "specific_treatment": "vaginal yeast infections"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Hycamtin (topotecan hydrochloride)", "approval_status": "Approved May 1996", "company": "SmithKline Beecham", "specific_treatment": "ovarian cancer"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine", "Nutrition and Weight Loss"], "name": "Trulicity (dulaglutide)", "approval_status": "Approved September 2014", "company": "Eli Lilly", "specific_treatment": "To improve glycemic control in type II diabetics"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "FemPatch", "approval_status": "Approved December 1996", "company": "Parke-Davis", "specific_treatment": "menopausal symptoms"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Estrostep (norethindrone acetate and ethinyl estradiol)", "approval_status": "Approved October 1996", "company": "Parke-Davis", "specific_treatment": "oral contraceptive"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Arimidex (anastrozole)", "approval_status": "Approved January 1996", "company": "AstraZeneca", "specific_treatment": "post menopausal breast cancer"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Aredia (pamidronate disodium for injection)", "approval_status": "Approved August 1996", "company": "Chiron", "specific_treatment": "osteolytic bone metastases of breast cancer"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Trivora-21 and Trivora-28", "approval_status": "Approved December 1997", "company": "Watson Pharmaceuticals", "specific_treatment": "oral contraceptives"},
{"therapeutic_areas": ["Dermatology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Ortho Tri-Cyclen Tablets (norgestimate/ethinyl estradiol)", "approval_status": "Approved January 1997", "company": "Ortho-McNeil Pharmaceutical", "specific_treatment": "acne"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Oncology"], "name": "Miraluma test", "approval_status": "Approved May 1997", "company": "DuPont Merck Pharmaceutical Company", "specific_treatment": "breast imaging"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine", "Urology"], "name": "Gonal-F (follitropin alfa for injection)", "approval_status": "Approved September 1997", "company": "Serono Laboratories", "specific_treatment": "infertility"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine", "Urology"], "name": "Follistim (TM) (follitropin beta for injection)", "approval_status": "Approved September 1997", "company": "Organon", "specific_treatment": "infertility"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Floxin Tablets (ofloxacin tablets)", "approval_status": "Approved January 1997", "company": "Ortho-McNeil Pharmaceutical", "specific_treatment": "pelvic inflammatory disease (PID)"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine", "Urology"], "name": "FEMSTAT One", "approval_status": "Approved Februrary 1997", "company": "Roche", "specific_treatment": "vaginal yeast infections"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Femara (letrozole)", "approval_status": "Approved July 1997", "company": "Novartis", "specific_treatment": "breast cancer"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Evista (raloxifene hydrochloride)", "approval_status": "Approved December 1997", "company": "Eli Lilly", "specific_treatment": "osteoporosis"},
{"therapeutic_areas": ["Gastroenterology", "Musculoskeletal", "Nephrology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Seprafilm", "approval_status": "Approved August 1996", "company": "Genzyme", "specific_treatment": "reduction of scar tissue as a result of abdominal or pelvic surgery"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine", "Urology"], "name": "Fertinex (urofollitropin for injection, purified)", "approval_status": "Approved September 1996", "company": "Serono Laboratories", "specific_treatment": "For patients undergoing infertility treatments"},
{"therapeutic_areas": ["Oncology"], "name": "Gilotrif (afatinib)", "approval_status": "Approved July 2013", "company": "Boehringer Ingelheim", "specific_treatment": "metastatic non-small cell lung cancer with EGFR mutations"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Estradiol tablets", "approval_status": "Approved October 1997", "company": "Barr Laboratories", "specific_treatment": "post-menopausal osteoporosis"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Crinone 8% (progesterone gel)", "approval_status": "Approved May 1997", "company": "Wyeth", "specific_treatment": "progesterone deficiency"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Alesse (100 mcg levonorgestrel/20 mcg ethinyl estradiol tablets)", "approval_status": "Approved April 1997", "company": "Wyeth", "specific_treatment": "birth control"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Xeloda", "approval_status": "Approved April 1998", "company": "Roche", "specific_treatment": "breast cancer"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Prometrium", "approval_status": "Approved May 1998", "company": "Solvay Pharmaceuticals", "specific_treatment": "amenorrhea"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Prometrium", "approval_status": "Approved December 1998", "company": "Schering-Plough", "specific_treatment": "Gynecology"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "PREVEN ; Emergency Contraceptive Kit", "approval_status": "Approved September 1998", "company": "Gynetics", "specific_treatment": "Ob/Gyn"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Prempro", "approval_status": "Approved January 1998", "company": "Wyeth", "specific_treatment": "Hormone replacement therapy"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Mircette", "approval_status": "Approved April 1998", "company": "Organon", "specific_treatment": "oral contraception"},
{"therapeutic_areas": ["Immunology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Flagyl ER", "approval_status": "Approved December 1997", "company": "Searle", "specific_treatment": "bacterial vaginosis"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Herceptin", "approval_status": "Approved October 1998", "company": "Genentech", "specific_treatment": "Breast cancer"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Estratab (.3 mg )", "approval_status": "Approved March 1998", "company": "Solvay Pharmaceuticals", "specific_treatment": "prevention of osteoporosis"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Esclim", "approval_status": "Approved August 1998", "company": "Fournier Research", "specific_treatment": "Menopause"},
{"therapeutic_areas": ["Immunology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Cleocin (clindamycin phosphate)", "approval_status": "Approved March 1998", "company": "Pharmacia & Upjohn", "specific_treatment": "bacterial vaginosis"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Ortho-Prefest", "approval_status": "October 22, 1999", "company": "Ortho-McNeil Pharmaceutical, RW Johnson", "specific_treatment": "Treatment of vasomotor symptoms assoc. w/menopause; vulvar, vaginal atrophy; prevention of osteoporosis"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Lupron Depot (leuprolide acetate for depot suspension)", "approval_status": "Approved June 1999", "company": "TAP Pharmaceuticals", "specific_treatment": "Gynecology"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Femhrt Tablets", "approval_status": "October 15, 1999", "company": "Parke-Davis", "specific_treatment": "For the treatment of moderate to severe vasomotor symptoms associated with menopause, and the prevention of osteoporosis"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Evista (raloxifene hydrochloride)", "approval_status": "Approved September 1999", "company": "Eli Lilly", "specific_treatment": "For the treatment of osteoporosis in postmenopausal women."},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Estradiol tablets", "approval_status": "Approved December 1997", "company": "Duramed Pharmaceuticals", "specific_treatment": "hormone replacement"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Ellence", "approval_status": "Approved September 1999", "company": "Pharmacia & Upjohn", "specific_treatment": "Component of adjuvant therapy in patients with evidence of axillary node tumor involvement for primary breast cancer"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology"], "name": "Doxil (doxorubicin HCl liposome injection)", "approval_status": "Approved June 1999", "company": "Alza", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Climara", "approval_status": "Approved June 1999", "company": "Berlex Laboratories", "specific_treatment": "Obstetrics/Gynecology"},
{"therapeutic_areas": ["Immunology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Cleocin (clindamycin phosphate)", "approval_status": "Approved August 1999", "company": "Pharmacia & Upjohn", "specific_treatment": "Immunology; Ob/Gyn"},
{"therapeutic_areas": ["Neurology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Cenestin", "approval_status": "Approved July 1999", "company": "Duramed Pharmaceuticals", "specific_treatment": "Obstetrics/Gynecology"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Cenestin", "approval_status": "Approved March 1999", "company": "Duramed Pharmaceuticals", "specific_treatment": "Obstetrics/Gynecology"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Aromasin Tablets", "approval_status": "October 21, 1999", "company": "Pharmacia & Upjohn", "specific_treatment": "Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Rheumatology", "Family Medicine"], "name": "Vivelle (estradiol transdermal system)", "approval_status": "Approved August 2000", "company": "Novartis", "specific_treatment": "For the prevention of osteoporosis and treatment of other menopausal symptoms"},
{"therapeutic_areas": ["Immunology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Trivagizole 3 (clotrimazole) Vaginal Cream", "approval_status": "Approved April 2000", "company": "Taro Pharmaceuticals", "specific_treatment": "For the treatment of vaginal yeast infections"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine", "Urology"], "name": "Ovidrel (gonadotropin, chorionic human recombinant)", "approval_status": "Approved September 2000", "company": "Serono Laboratories", "specific_treatment": "Infertility"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Mirena (levonorgestrel-releasing intrauterine system)", "approval_status": "Approved December 2000", "company": "Berlex Laboratories", "specific_treatment": "Hormone-releasing system for intrauterine contraception"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Cetrotide", "approval_status": "Approved August 2000", "company": "Asta Medica", "specific_treatment": "For the prevention of premature ovulation in women undergoing controlled ovarian stimulation"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Activella (Estradiol/Norethindrone Acetate) Tablets", "approval_status": "Approved April 2000", "company": "Novo Nordisk", "specific_treatment": "Combination hormone replacement therapy for the prevention of osteoporosis and other symptoms associated with Menopause."},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Yasmin (drospirenone/ethinyl estradiol)", "approval_status": "Approved May 2001", "company": "Berlex Laboratories", "specific_treatment": "Contraception"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Ortho Evra", "approval_status": "Approved November 2001", "company": "Ortho-McNeil Pharmaceutical", "specific_treatment": "Contraception"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Estrostep (norethindrone acetate and ethinyl estradiol)", "approval_status": "Approved March 1997", "company": "Warner-Lambert", "specific_treatment": "oral contraception"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Monistat 3 (miconazole nitrate)", "approval_status": "Approved February 2001", "company": "Advanced Care Products", "specific_treatment": "Vaginal yeast infections"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Estradiol Transdermal System", "approval_status": "Approved September 1999", "company": "Wyeth", "specific_treatment": "Treatment of vulvar vaginal atrophy and vasomotor symptoms"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Rheumatology", "Family Medicine"], "name": "Bextra", "approval_status": "Approved November 2001", "company": "Pharmacia, Pfizer", "specific_treatment": "Osteoarthritis, rheumatoid arthritis and menstrual pain"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Psychiatry/Psychology"], "name": "Zoloft (sertraline HCl)", "approval_status": "Approved May 2002", "company": "Pfizer", "specific_treatment": "Mood disorders"},
{"therapeutic_areas": ["Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Vivelle-Dot (estradiol transdermal system)", "approval_status": "Approved May 2002", "company": "Novartis", "specific_treatment": "Post-menopausal osteoporosis"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Forteo (teriparatide)", "approval_status": "December 2002", "company": "Eli Lilly", "specific_treatment": "Osteoporosis"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine", "Urology"], "name": "Bravelle (urofollitropin for injection, purified)", "approval_status": "Approved May 2002", "company": "Ferring Pharmaceuticals", "specific_treatment": "Ovulation induction / infertility"},
{"therapeutic_areas": ["Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Alora", "approval_status": "Approved April 2002", "company": "Watson Pharmaceuticals", "specific_treatment": "Postmenopausal osteoporosis, Vasomotor menopausal symptoms"},
{"therapeutic_areas": ["Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Premarin (conjugated estrogens)", "approval_status": "Approved July of 2003", "company": "Wyeth", "specific_treatment": "prevention of postmenopausal osteoporosis and treatment of vasomotor menopause symptoms"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Inform HER-2/neu breast cancer test", "approval_status": "Approved January 1998", "company": "Oncor", "specific_treatment": "breast cancer prediction"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "EstroGel (estradiol gel 0.06%)", "approval_status": "Approved April 2004", "company": "Solvay Pharmaceuticals", "specific_treatment": "Menopause"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Elestrin (estradiol gel)", "approval_status": "Approved December 2006", "company": "BioSante", "specific_treatment": "Vasomotor symptoms associated with menopause"},
{"therapeutic_areas": ["Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Reclast (zoledronic acid)", "approval_status": "Approved August 2007", "company": "Novartis", "specific_treatment": "postmenopausal osteoporosis"},
{"therapeutic_areas": ["Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Evista (raloxifene hydrochloride)", "approval_status": "Approved September 2007", "company": "Eli Lilly", "specific_treatment": "the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Evamist (estradiol)", "approval_status": "Approved July 2007", "company": "Vivus", "specific_treatment": "moderate to severe vasomotor symptoms due to menopause"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Lysteda (tranexamic acid)", "approval_status": "Approved November 2009", "company": "Xanodyne Pharmaceuticals", "specific_treatment": "heavy menstrual bleeding"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Prolia (denosumab)", "approval_status": "Approved June 2010", "company": "Amgen", "specific_treatment": "postmenopausal women with osteoporosis at high risk for fracture"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Natazia (estradiol valerate + dienogest)", "approval_status": "Approved May 2010", "company": "Bayer", "specific_treatment": "contraception"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Halaven (eribulin mesylate)", "approval_status": "Approved November 2010", "company": "Eisai", "specific_treatment": "metastatic breast cancer"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "ella (ulipristal acetate)", "approval_status": "Approved August 2010", "company": "HRA Pharma", "specific_treatment": "emergency contraception"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Makena (hydroxyprogesterone caproate injection)", "approval_status": "Approved February 2011", "company": "Hologic", "specific_treatment": "preterm birth"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Seasonale, Lo Seasonale, Seasonique (ethinylestradiol + levonorgestrel)", "approval_status": "Approved September 2003", "company": "Duramed Pharmaceuticals", "specific_treatment": "contraception"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Femstat 3 (butoconazole nitrate 2%)", "approval_status": "Approved December 1995", "company": "Procter & Gamble, Roche", "specific_treatment": "vaginal yeast infections"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Perjeta (pertuzumab)", "approval_status": "Approved June 2012", "company": "Genentech", "specific_treatment": "HER2+ metastatic breast cancer"},
{"therapeutic_areas": ["Oncology"], "name": "Lartruvo (olaratumab) ", "approval_status": "Approved October 2016", "company": "Eli Lilly", "specific_treatment": "soft tissue sarcoma"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Afinitor (everolimus)", "approval_status": "Approved July 2012", "company": "Novartis", "specific_treatment": "hormone receptor-positive, HER2-negative breast cancer"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol)", "approval_status": "Approved April 2013", "company": "Teva Pharmaceutical", "specific_treatment": "contraception"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Osphena (ospemifene)", "approval_status": "Approved March 2013", "company": "Shionogi", "specific_treatment": "dyspareunia and vulvar and vaginal atrophy due to menopause"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Lo Minastrin, (norethindrone acetate, ethinyl estradiol, ferrous fumarate)", "approval_status": "Approved July 2013", "company": "Warner Chilcott", "specific_treatment": "prevention of pregnancy"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Oncology"], "name": "Kadcyla (ado-trastuzumab emtansine)", "approval_status": "Approved February 2013", "company": "Genentech", "specific_treatment": "HER2-positive metastatic breast cancer"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Diclegis (doxylamine succinate + pyridoxine hydrochloride DR tablets)", "approval_status": "Approved April 2013", "company": "Duchesnay USA", "specific_treatment": "nausea and vomiting of pregnancy"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Brisdelle (low-dose paroxetine mesylate)", "approval_status": "Approved July 2013", "company": "Noven Pharmaceuticals", "specific_treatment": "vasomotor symptoms of menopause"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine", "Infections and Infectious Diseases"], "name": "Metronidazole 1.3% Vaginal Gel", "approval_status": "Approved April 2014", "company": "Actavis, Inc.", "specific_treatment": "bacterial vaginosis"},
{"therapeutic_areas": ["Immunology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Cervarix [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant", "approval_status": "Approved October 2009", "company": "GlaxoSmithKline", "specific_treatment": "prevention of cervical cancer and cervical intraepithelial neoplasia caused by HPV types 16 and 18"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Oncology"], "name": "Lynparza (olaparib)", "approval_status": "Approved December 2014", "company": "AstraZeneca", "specific_treatment": "previously treated BRCA mutated advanced ovarian cancer"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Oncology"], "name": "Ibrance (palbociclib)", "approval_status": "Approved February 2015", "company": "Pfizer", "specific_treatment": "ER-positive, HER2-negative breast cancer"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Intrarosa (prasterone vaginal inser\u007ft)", "approval_status": "Approved November 2016", "company": "Endoceutics", "specific_treatment": "moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases", "Vaccines"], "name": "Tamiflu  capsule", "approval_status": "October 27, 1999", "company": "Roche", "specific_treatment": "For the treatment of all common strains of influenza"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Synercid I.V.", "approval_status": "Approved September 1999", "company": "Rhone Poulenc Rorer", "specific_treatment": "For serious or life-threatening infections associated w/ vancomycin-resistant Enterococcus faecium (VREF) bacteremia."},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases", "Vaccines"], "name": "Twinrix", "approval_status": "Approved May 2001", "company": "GlaxoSmithKline", "specific_treatment": "Hepatitis A and B"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Spectracef", "approval_status": "Approved August 2001", "company": "TAP Pharmaceuticals", "specific_treatment": "Bacterial infections"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases", "Vaccines"], "name": "Pediarix Vaccine", "approval_status": "Approved December 2002", "company": "GlaxoSmithKline", "specific_treatment": "Diphtheria, Tetanus,  Acellular Pertussis , Hepatitis  B, Polio"},
{"therapeutic_areas": ["Neurology", "Vaccines"], "name": "Neurontin (gabapentin)", "approval_status": "Approved May 2002", "company": "Pfizer", "specific_treatment": "Post-herpetic neuralgia (PHN)"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Vaccines"], "name": "Fluzone Preservative-free", "approval_status": "Approved September 2002", "company": "Sanofi Pasteur", "specific_treatment": "Influenza immunization in infants"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases", "Vaccines"], "name": "FluMist ( Influenza Virus Vaccine)", "approval_status": "Approved June 2003", "company": "MedImmune", "specific_treatment": "Influenza"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Infections and Infectious Diseases", "Vaccines"], "name": "Hiberix (Haemophilus b Conjugate Vaccine; Tetanus Toxoid Conjugate)", "approval_status": "August of 2009", "company": "GlaxoSmithKline", "specific_treatment": "invasive disease caused by Haemophilus influenzae type b"},
{"therapeutic_areas": ["Immunology", "Vaccines"], "name": "Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine)", "approval_status": "Approved February 2010", "company": "Wyeth", "specific_treatment": "invasive disease caused by Streptococcus pneumoniae"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Duavee (conjugated estrogens/bazedoxifene)", "approval_status": "Approved October 2013", "company": "Pfizer", "specific_treatment": "vasomotor symptoms associated with menopause and postmenopausal osteoporosis"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases", "Vaccines"], "name": "Menveo (meningitis vaccine)", "approval_status": "Approved February 2010", "company": "Novartis", "specific_treatment": "invasive meningococcal disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Vaccines"], "name": "Horizant (gabapentin enacarbil)", "approval_status": "Approved April 2011", "company": "GlaxoSmithKline", "specific_treatment": "restless legs syndrome"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Neurology", "Family Medicine", "Vaccines"], "name": "Horizant (gabapentin enacarbil)", "approval_status": "Approved June 2012", "company": "GlaxoSmithKline", "specific_treatment": "postherpetic neuralgia"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)"], "name": "NuvaRing", "approval_status": "Approved October 2001", "company": "Organon", "specific_treatment": "Female contraception"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases", "Vaccines"], "name": "VariZIG, Varicella Zoster Immune Globulin (Human)", "approval_status": "Approved January 2013", "company": "Cangene", "specific_treatment": "varicella zoster (chickenpox)"},
{"therapeutic_areas": ["Immunology", "Healthy Volunteers", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Flublok (seasonal influenza vaccine)", "approval_status": "Approved January 2013", "company": "Protein Sciences", "specific_treatment": "influenza virus subtypes A and type B"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Infections and Infectious Diseases", "Vaccines"], "name": "Bexsero (Meningococcal Group B Vaccine)", "approval_status": "Approved January 2015", "company": "Novartis", "specific_treatment": "invasive meningococcal disease caused by serogroup B"},
{"therapeutic_areas": ["Otolaryngology (Ear, Nose, Throat)", "Pediatrics/Neonatology", "Family Medicine"], "name": "Rocephin", "approval_status": "Approved January 1998", "company": "Roche", "specific_treatment": "Pediatric otitis media"},
{"therapeutic_areas": ["Endocrinology", "Oncology", "Otolaryngology (Ear, Nose, Throat)"], "name": "Ethyol (amifostine)", "approval_status": "Approved June 1999", "company": "US Bioscience, Alza", "specific_treatment": "Oncology"},
{"therapeutic_areas": ["Gastroenterology", "Otolaryngology (Ear, Nose, Throat)", "Family Medicine"], "name": "Protonix (pantoprazole sodium) Delayed-Release Tablets", "approval_status": "Approved February 2000", "company": "Wyeth", "specific_treatment": "Short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD)"},
{"therapeutic_areas": ["Neurology", "Otolaryngology (Ear, Nose, Throat)", "Family Medicine"], "name": "Depakote ER (divalproex sodium)", "approval_status": "Approved August 2000", "company": "Abbott Laboratories", "specific_treatment": "For the prophylaxis (prevention) of migraine headaches in adults"},
{"therapeutic_areas": ["Immunology", "Otolaryngology (Ear, Nose, Throat)", "Pediatrics/Neonatology", "Infections and Infectious Diseases"], "name": "Veramyst (fluticasone furoate)", "approval_status": "Approved April 2007", "company": "GlaxoSmithKline", "specific_treatment": "seasonal and perennial allergic rhinitis"},
{"therapeutic_areas": ["Immunology", "Otolaryngology (Ear, Nose, Throat)", "Pediatrics/Neonatology"], "name": "Moxatag (amoxicillin)", "approval_status": "Approved January 2008", "company": "MiddleBrooke Pharmaceuticals", "specific_treatment": "tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics"},
{"therapeutic_areas": ["Immunology", "Ophthalmology", "Otolaryngology (Ear, Nose, Throat)", "Infections and Infectious Diseases"], "name": "Astepro (azelastine hydrochloride nasal spray)", "approval_status": "Approved October 2008", "company": "Meda Pharmaceuticals Inc", "specific_treatment": "seasonal and perennial allergic rhinitis"},
{"therapeutic_areas": ["Immunology", "Otolaryngology (Ear, Nose, Throat)"], "name": "Oravig (miconazole)", "approval_status": "Approved April 2010", "company": "Strativa Pharmaceuticals", "specific_treatment": "oropharyngeal candidiasis"},
{"therapeutic_areas": ["Oncology", "Otolaryngology (Ear, Nose, Throat)", "Family Medicine"], "name": "Vandetanib (vandetanib)", "approval_status": "Approved April 2011", "company": "AstraZeneca", "specific_treatment": "thyroid cancer"},
{"therapeutic_areas": ["Otolaryngology (Ear, Nose, Throat)", "Family Medicine", "Infections and Infectious Diseases"], "name": "Xtoro (finafloxacin otic suspension) 0.3%", "approval_status": "Approved December 2014", "company": "Alcon", "specific_treatment": "acute otitis externa"},
{"therapeutic_areas": ["Otolaryngology (Ear, Nose, Throat)", "Pediatrics/Neonatology", "Family Medicine"], "name": "Otiprio (ciprofloxacin otic suspension)", "approval_status": "Approved December 2015", "company": "Otonomy", "specific_treatment": "pediatrics with bilateral otitis media with effusion undergoing tympanostomy tube placement"},
{"therapeutic_areas": ["Oncology", "Orthopedics/Orthopedic Surgery"], "name": "Xgeva (denosumab)", "approval_status": "Approved June 2013", "company": "Amgen", "specific_treatment": "giant cell tumor of bone"},
{"therapeutic_areas": ["Immunology", "Musculoskeletal", "Rheumatology", "Family Medicine", "Orthopedics/Orthopedic Surgery"], "name": "Otezla (apremilast)", "approval_status": "Approved March 2014", "company": "Celgene", "specific_treatment": "psoriatic arthritis"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Orthopedics/Orthopedic Surgery", "Genetic Disease"], "name": "Strensiq (asfotase alfa)", "approval_status": "Approved October 2015", "company": "Alexion", "specific_treatment": "hypophosphatasia"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases", "Vaccines"], "name": "Flucelvax, Influenza Virus Vaccine", "approval_status": "Approved November 2012", "company": "Novartis", "specific_treatment": "influenza virus subtypes A and type B"},
{"therapeutic_areas": ["Neurology", "Ophthalmology", "Sleep"], "name": "Hetlioz (tasimelteon)", "approval_status": "January 2014", "company": "Vanda Pharmaceuticals", "specific_treatment": "non-24-hour sleep-wake disorder in the totally blind"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)", "Oncology", "Family Medicine"], "name": "Femara (letrozole)", "approval_status": "Approved January 2001", "company": "Novartis", "specific_treatment": "Hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases", "Vaccines"], "name": "Vaxchora (Cholera Vaccine, Live, Oral)", "approval_status": "Approved June 2016", "company": "PaxVax", "specific_treatment": "Cholera"},
{"therapeutic_areas": ["Endocrinology", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Addyi (flibanserin)", "approval_status": "Approved August 2015", "company": "Sprout Pharmaceuticals", "specific_treatment": "premenopausal women with generalized hypoactive sexual desire disorder"},
{"therapeutic_areas": ["Hematology", "Trauma (Emergency, Injury, Surgery)"], "name": "Wilate (von Willebrand Factor/Coagulation Factor VIII Complex (Human)", "approval_status": "Approved December of 2009", "company": "Octapharma", "specific_treatment": "von Willebrand disease"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Trauma (Emergency, Injury, Surgery)", "Family Medicine"], "name": "Lyrica (pregabalin)", "approval_status": "Approved June 2012", "company": "Pfizer", "specific_treatment": "neuropathic pain associated with spinal cord injury"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Vaccines"], "name": "Zosyn (sterile piperacillin sodium/tazobactam sodium)", "approval_status": "Approved May 1996", "company": "Wyeth", "specific_treatment": "pneumonia"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Vancenase AQ 84 mcg Double Strength", "approval_status": "Approved June 1996", "company": "Schering-Plough", "specific_treatment": "allergic and non-allergic rhinitis"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Vaccines"], "name": "Tripedia (Diptheria and Tetanus Toxoids and Acellular Pertussis Vaccine Absorbed)", "approval_status": "Approved August 1996", "company": "Connaught Laboratories", "specific_treatment": "whooping cough"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "Tavist (clemastine fumarate)", "approval_status": "Approved November 1996", "company": "Sandoz Pharmaceuticals", "specific_treatment": "cold symptoms, including sneezing and runny nose"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "RespiGam (Respiratory Syncitial Virus Immune Globulin Intravenous)", "approval_status": "Approved January 1996", "company": "MedImmune", "specific_treatment": "RSV, bronchopulmonary dysplasia"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Genetic Disease"], "name": "Pulmozyme (dornase alfa)", "approval_status": "Approved December 1996", "company": "Genentech", "specific_treatment": "cystic fibrosis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Nasacort AQ (triamcinolone acetonide) Nasal Spray", "approval_status": "Approved May 1996", "company": "Rhone Poulenc Rorer", "specific_treatment": "allergic rhinitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate)", "approval_status": "Approved August 1996", "company": "Schering-Plough", "specific_treatment": "nasal congestion"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Claritin Syrup (loratadine)", "approval_status": "Approved October 1996", "company": "Schering-Plough", "specific_treatment": "seasonal allergies in children"},
{"therapeutic_areas": ["Neurology", "Psychiatry/Psychology", "Family Medicine", "Sleep"], "name": "Intermezzo (zolpidem tartrate sublingual tablet)", "approval_status": "Approved November 2011", "company": "Transcept Pharmaceuticals", "specific_treatment": "insomnia"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Azmacort (triamcinolone acetonide) Inhalation Aerosol", "approval_status": "Approved November 1996", "company": "Rhone Poulenc Rorer", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Augmentin (amoxicillin/clavulanate)", "approval_status": "Approved February 1996", "company": "SmithKline Beecham", "specific_treatment": "sinusitis, bronchitis, pneumonia"},
{"therapeutic_areas": ["Neurology", "Trauma (Emergency, Injury, Surgery)", "Family Medicine"], "name": "Exparel (bupivacaine liposome injectable suspension)", "approval_status": "Approved November 2011", "company": "Pacira Pharmaceuticals", "specific_treatment": "postsurgical analgesia"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Astelin nasal spray", "approval_status": "Approved November 1996", "company": "Wallace Laboratories", "specific_treatment": "seasonal allergic rhinitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Allegra (fexofenadine hydrochloride)", "approval_status": "Approved July 1996", "company": "Hoechst Marion Roussel", "specific_treatment": "seasonal allergic rhinitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Accolate", "approval_status": "Approved October 1996", "company": "AstraZeneca", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Zyflo (Zileuton)", "approval_status": "Approved January 1997", "company": "Abbott Laboratories", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Vanceril 84 mcg Double Strength (beclomethasone dipropionate, 84 mcg) Inhalation Aerosol", "approval_status": "Approved January 1997", "company": "Schering-Plough", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Breathe Right", "approval_status": "Approved June 1996", "company": "CNS", "specific_treatment": "breathing difficulties due to deviated nasal septum"},
{"therapeutic_areas": ["Trauma (Emergency, Injury, Surgery)"], "name": "OsmoCyte Pillow Wound Dressing", "approval_status": "Approved December 1996", "company": "ProCyte", "specific_treatment": "chronic and acute wounds"},
{"therapeutic_areas": ["Dermatology", "Trauma (Emergency, Injury, Surgery)"], "name": "Iamin", "approval_status": "Approved February 1996", "company": "ProCyte", "specific_treatment": "wounds"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "Atrovent (ipratropium bromide)", "approval_status": "Approved January 1996", "company": "Boehringer Ingelheim", "specific_treatment": "runny nose due to allergies and the common cold"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Serevent", "approval_status": "Approved September 1997", "company": "GlaxoSmithKline", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine", "Vaccines"], "name": "Zagam (sparfloxacin) tablets", "approval_status": "Approved January 1997", "company": "Rhone Poulenc Rorer", "specific_treatment": "community-acquired pneumonia (CAP) and chronic bronchitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Raxar (grepafloxacin)", "approval_status": "Approved November 1997", "company": "GlaxoSmithKline", "specific_treatment": "chronic bronchitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Metaprotereol Sulfate Inhalation Solution, 5%", "approval_status": "Approved March 1997", "company": "Morton Grove Pharmaceuticals", "specific_treatment": "bronchial asthma and reversible bronchospasm"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Flovent Rotadisk", "approval_status": "Approved November 1997", "company": "GlaxoSmithKline", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Genetic Disease"], "name": "Tobi", "approval_status": "Approved December 1997", "company": "PathoGenesis", "specific_treatment": "cystic fibrosis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Claritin RediTabs (10 mg loratadine rapidly-disintegrating tablet)", "approval_status": "Approved January 1997", "company": "Schering-Plough", "specific_treatment": "seasonal allergy symptoms"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Tilade (nedocromil sodium)", "approval_status": "Approved November 1997", "company": "Rhone Poulenc Rorer", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "Synagis", "approval_status": "Approved June 1998", "company": "MedImmune", "specific_treatment": "respiratory syncytial virus (RSV)"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Tilade (nedocromil sodium)", "approval_status": "Approved April 1997", "company": "Rhone Poulenc Rorer", "specific_treatment": "mild-to-moderate bronchial asthma in children ages six to eleven"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Singulair", "approval_status": "Approved February 1998", "company": "Merck", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases"], "name": "Sclerosol Intrapleural Aerosol", "approval_status": "Approved January 1998", "company": "Bryan Corporation", "specific_treatment": "malignant pleural effusions"},
{"therapeutic_areas": ["Ophthalmology", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "OcuHist", "approval_status": "Approved January 1996", "company": "Pfizer", "specific_treatment": "itching and redness of the eye"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases"], "name": "Infasurf", "approval_status": "Approved July 1998.", "company": "ONY", "specific_treatment": "Respiratory Distress Syndrome (RDS)"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Flonase Nasal Spray", "approval_status": "Approved November 1997", "company": "GlaxoSmithKline", "specific_treatment": "allergic rhinitis"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Pulmonary/Respiratory Diseases"], "name": "Dynabac", "approval_status": "Approved March 1998", "company": "Sanofi-aventis", "specific_treatment": "acute bacterial exacerbations"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases"], "name": "Curosurf", "approval_status": "Approved October 1998", "company": "Dey Laboratories", "specific_treatment": "Pediatric Respiratory Distress Syndrome"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Cipro (ciprofloxacin HCl)", "approval_status": "Approved June 1997", "company": "Bayer", "specific_treatment": "acute sinusitis"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Clemastine fumarate syrup", "approval_status": "Approved March 1998", "company": "Morton Grove Pharmaceuticals", "specific_treatment": "allergic rhinitis"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Allegra-D", "approval_status": "Approved March 1998", "company": "Hoechst Marion Roussel", "specific_treatment": "nasal congestion due to seasonal allergy"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "Ceftin (cefuroxime axetil)", "approval_status": "Approved September 1997", "company": "GlaxoSmithKline", "specific_treatment": "acute bronchitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Tikosyn Capsules", "approval_status": "Approved October 1999", "company": "Pfizer", "specific_treatment": "For the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter."},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Tilade (nedocromil sodium)", "approval_status": "Approved April 1997", "company": "Rhone Poulenc Rorer", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Rhinocort Aqua Nasal Spray", "approval_status": "Approved October 1999", "company": "AstraZeneca", "specific_treatment": "Management of nasal symptoms of seasonal or perennial allergic rhinitis in adults and children six years of age or older"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Proventil HFA Inhalation Aerosol", "approval_status": "Approved June 1999", "company": "3M Pharmaceuticals", "specific_treatment": "Pulmonary/Respiratory Diseases"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Accolate", "approval_status": "Approved September 1999", "company": "AstraZeneca", "specific_treatment": "Asthma in pediatric patients"},
{"therapeutic_areas": ["Immunology", "Otolaryngology (Ear, Nose, Throat)", "Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Tri-Nasal Spray (triamcinolone acetonide spray)", "approval_status": "Approved February 2000", "company": "Muro Pharmaceutical", "specific_treatment": "Allergic rhinitis"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Nephrology", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Cefazolin and Dextrose USP", "approval_status": "Approved July 2000", "company": "B Braun Medical", "specific_treatment": "Various bacterial infections, septicemia, endocarditis, and perioperative prophylaxis"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Genetic Disease"], "name": "Pulmozyme (dornase alfa)", "approval_status": "Approved March 1998", "company": "Genentech", "specific_treatment": "cystic fibrosis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Priftin", "approval_status": "Approved June 1998", "company": "Hoechst Marion Roussel", "specific_treatment": "pulmonary tuberculosis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Advair (fluticasone propionate and salmeterol)", "approval_status": "Approved August 2000", "company": "GlaxoSmithKline", "specific_treatment": "asthma and chronic obstructive pulmonary disease "},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Ventolin HFA (albuterol sulfate inhalation aerosol)", "approval_status": "Approved April 2001", "company": "GlaxoSmithKline", "specific_treatment": "Asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Tracleer (bosentan)", "approval_status": "Approved November 2001", "company": "Actelion", "specific_treatment": "Pulmonary arterial hypertension"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "NasalCrom Nasal Spray", "approval_status": "Approved April 2001", "company": "Pharmacia & Upjohn", "specific_treatment": "Allergic Rhinitis"},
{"therapeutic_areas": ["Dermatology", "Nephrology", "Obstetrics/Gynecology (Women\u2019s Health)", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Invanz", "approval_status": "Approved November 2001", "company": "Merck", "specific_treatment": "Bacterial infections"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Foradil Aerolizer (formoterol fumarate inhalation powder)", "approval_status": "Approved February 2001 (asthma, bronchospasm); September 2001 (COPD)", "company": "Novartis", "specific_treatment": "COPD, asthma and bronchospasm"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "DuoNeb (albuterol sulfate and ipratropium bromide)", "approval_status": "Approved March 2001", "company": "Dey Laboratories", "specific_treatment": "Bronchospasm associated with COPD for patients who require more than one bronchodilator"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Avelox I.V. (moxifloxacin hydrochloride)", "approval_status": "Approved November 2001", "company": "Bayer", "specific_treatment": "Susceptible strains of sinusitis, bronchitis, pneumonia, skin structure infections"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Xopenex", "approval_status": "Approved February 2002", "company": "Sepracor", "specific_treatment": "Reversible obstructive airway disease"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Qvar (beclomethasone dipropionate)", "approval_status": "Approved May 2002", "company": "Ivax", "specific_treatment": "Asthma"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Clarinex", "approval_status": "Approved February 2002", "company": "Schering-Plough", "specific_treatment": "Allergic rhinitis; Chronic ideopathic urticaria"},
{"therapeutic_areas": ["Hematology", "Pulmonary/Respiratory Diseases"], "name": "Zemaira (alpha1-proteinase inhibitor)", "approval_status": "Approved July 2003", "company": "Aventis Behring", "specific_treatment": "Alpha1-proteinase inhibitor deficiency"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Xolair (omalizumab)", "approval_status": "Approved June 2003", "company": "Genentech", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Cafcit Injection", "approval_status": "Approved September 1999", "company": "Roxane Laboratories", "specific_treatment": "For the short term treatment of apnea of prematurity in infants between 28 and "},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Iressa (gefitinib)", "approval_status": "Approved May 2003", "company": "AstraZeneca", "specific_treatment": "Non-Small-Cell Lung Cancer"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases"], "name": "Aldurazyme (laronidase)", "approval_status": "Approved May 2003", "company": "Genzyme", "specific_treatment": "Mucopolysaccharidosis I"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Spiriva HandiHaler (tiotropium bromide)", "approval_status": "Approved February 2004", "company": "Boehringer Ingelheim", "specific_treatment": "Chronic Obstructive Pulmonary Disease (COPD)"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases"], "name": "Ketek (telithromycin)", "approval_status": "Approved April 2004", "company": "Sanofi-aventis", "specific_treatment": "Respiratory Infections"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Biaxin XL (clarithromycin extended-release tablets)", "approval_status": "Approved March 2000", "company": "Abbott Laboratories", "specific_treatment": "Acute Bacterial Exacerbation of Chronic Bronchitis (AECB) and Acute Maxillary Sinusitis"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Otolaryngology (Ear, Nose, Throat)", "Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Xyzal (levocetirizine dihydrochloride)", "approval_status": "Approved May 2007", "company": "UCB", "specific_treatment": "seasonal and perennial allergic rhinitis and urticaria"},
{"therapeutic_areas": ["Otolaryngology (Ear, Nose, Throat)", "Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Patanase (olopatadine hydrochloride)", "approval_status": "Approved April 2008", "company": "Alcon", "specific_treatment": "seasonal allergic rhinitis"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Alvesco (ciclesonide)", "approval_status": "Approved January 2008", "company": "Nycomed", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Teflaro (ceftaroline fosamil)", "approval_status": "November 2010", "company": "Cerexa", "specific_treatment": "bacterial skin infections and bacterial pneumonia"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Dulera (mometasone furoate + formoterol fumarate dihydrate)", "approval_status": "Approved June 2010", "company": "Merck", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Xalkori (crizotinib)", "approval_status": "Approved August of 2011", "company": "Pfizer", "specific_treatment": "ALK+ non-small cell lung cancer"},
{"therapeutic_areas": ["Immunology", "Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Daliresp (roflumilast)", "approval_status": "Approved February 2011", "company": "Forest Pharmaceuticals", "specific_treatment": "chronic obstructive pulmonary disease"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Arcapta (indacaterol maleate inhalation powder)", "approval_status": "Approved July 2011", "company": "Novartis", "specific_treatment": "airflow obstruction resulting from chronic obstructive pulmonary disease"},
{"therapeutic_areas": ["Nephrology", "Obstetrics/Gynecology (Women\u2019s Health)", "Pulmonary/Respiratory Diseases"], "name": "Tequin", "approval_status": "December, 1999", "company": "Bristol-Myers Squibb", "specific_treatment": "Community-acquired respiratory tract infections"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "Tudorza Pressair (aclidinium bromide inhalation powder)", "approval_status": "Approved July 2012", "company": "Forest Laboratories", "specific_treatment": "maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Surfaxin (lucinactant)", "approval_status": "Approved March 2012", "company": "Discovery Laboratories", "specific_treatment": "respiratory distress syndrome in premature infants"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Sirturo (bedaquiline)", "approval_status": "Approved December 2012", "company": "Janssen Therapeutics", "specific_treatment": "multi-drug resistant tuberculosis"},
{"therapeutic_areas": ["Immunology", "Musculoskeletal", "Pulmonary/Respiratory Diseases", "Rheumatology", "Family Medicine", "Orthopedics/Orthopedic Surgery"], "name": "Rayos (prednisone) delayed-release tablets", "approval_status": "Approved July of 2012", "company": "Horizon Pharma", "specific_treatment": "certain inflammatory diseases, including arthritis, COPD, asthma and  psoriatic conditions"},
{"therapeutic_areas": ["Obstetrics/Gynecology (Women\u2019s Health)", "Family Medicine"], "name": "Natazia (estradiol valerate and estradiol valerate/dienogest)", "approval_status": "Approved March 2012", "company": "Bayer", "specific_treatment": "heavy menstrual bleeding"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Genetic Disease"], "name": "Kalydeco (ivacaftor)", "approval_status": "Approved January of 2012", "company": "Vertex Pharmaceuticals", "specific_treatment": "cystic fibrosis with the G551D mutation in the CFTR gene"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Brovana (arformoterol tartrate)", "approval_status": "Approved in October 2006", "company": "Sepracor", "specific_treatment": "Chronic Obstructive Pulmonary Disease"},
{"therapeutic_areas": ["Otolaryngology (Ear, Nose, Throat)", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "Dymista (azelastine hydrochloride and fluticasone propionate)", "approval_status": "Approved May 2012", "company": "Meda Pharmaceuticals Inc", "specific_treatment": "seasonal allergic rhinitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Infections and Infectious Diseases"], "name": "Vibativ (telavancin)", "approval_status": "Approved June 2013", "company": "Theravance", "specific_treatment": "hospital-acquired and ventilator-associated bacterial pneumonia caused by "},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Anoro Ellipta (umeclidinium and vilanterol inhalation powder)", "approval_status": "Approved December of 2013", "company": "GlaxoSmithKline", "specific_treatment": "chronic obstructive pulmonary disease"},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Genetic Disease"], "name": "Cayston (aztreonam for inhalation solution)", "approval_status": "Approved February 2010", "company": "Gilead", "specific_treatment": "cystic fibrosis patients with Pseudomonas aeruginosa"},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases"], "name": "Zykadia (ceritinib)", "approval_status": "Approved April 2014", "company": "Novartis", "specific_treatment": "ALK+ metastatic non-small cell lung cancer"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Striverdi Respimat (olodaterol)", "approval_status": "Approved July 2014", "company": "Boehringer Ingelheim", "specific_treatment": "chronic obstructive pulmonary  disease "},
{"therapeutic_areas": ["Immunology", "Otolaryngology (Ear, Nose, Throat)", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Ragwitek (Short Ragweed Pollen Allergen Extract)", "approval_status": "Approved April 2014", "company": "Merck", "specific_treatment": "short ragweed pollen-induced allergic rhinitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Ofev (nintedanib)", "approval_status": "Approved October 2014", "company": "Boehringer Ingelheim", "specific_treatment": "idiopathic pulmonary  fibrosis "},
{"therapeutic_areas": ["Immunology", "Pulmonary/Respiratory Diseases"], "name": "Incruse Ellipta (umeclidinium inhalation powder)", "approval_status": "Approved May 2014", "company": "GlaxoSmithKline", "specific_treatment": "chronic obstructive pulmonary disease"},
{"therapeutic_areas": ["Immunology", "Otolaryngology (Ear, Nose, Throat)", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Grastek (Timothy Grass Pollen Allergen Extract)", "approval_status": "Approved April 2014", "company": "Merck", "specific_treatment": "grass pollen-induced allergic rhinitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Esbriet (pirfenidone)", "approval_status": "Approved October 2014", "company": "InterMune", "specific_treatment": "idiopathic pulmonary  fibrosis "},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Arnuity Ellipta (fluticasone furoate inhalation powder)", "approval_status": "Approved August 2014", "company": "GlaxoSmithKline", "specific_treatment": "asthma"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Utibron Neohaler (indacaterol and glycopyrrolate)", "approval_status": "Approved October 2015", "company": "Novartis", "specific_treatment": "long term, maintenance treatment of airflow obstruction in patients with COPD"},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Abraxane (paclitaxel protein-bound particles for injectable suspension)", "approval_status": "Approved October 2012", "company": "Celgene", "specific_treatment": "non-small cell lung cancer"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Devices", "Family Medicine"], "name": "Breo Ellipta (fluticasone furoate and vilanterol inhalation powder)", "approval_status": "Approved May 2013", "company": "GlaxoSmithKline", "specific_treatment": "chronic obstructive pulmonary disease"},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases"], "name": "Portrazza (necitumumab) ", "approval_status": "Approved November 2015", "company": "Eli Lilly", "specific_treatment": " metastatic squamous non-small cell lung cancer"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases"], "name": "Orkambi (lumacaftor and ivacaftor)", "approval_status": "Approved July 2015", "company": "Vertex Pharmaceuticals", "specific_treatment": "cystic fibrosis"},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases"], "name": "Opdivo (nivolumab)", "approval_status": "Approved March 2015 ", "company": "Bristol-Myers Squibb", "specific_treatment": "metastatic squamous non-small cell lung cancer"},
{"therapeutic_areas": ["Immunology", "Ophthalmology", "Otolaryngology (Ear, Nose, Throat)", "Pulmonary/Respiratory Diseases", "Healthy Volunteers", "Family Medicine"], "name": "Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract)", "approval_status": "Approved April 2014", "company": "Greer Labs", "specific_treatment": "grass pollen-induced allergic rhinitis with or without conjunctivitis"},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases"], "name": "Keytruda (pembrolizumab)", "approval_status": "Approved October 2015", "company": "Merck", "specific_treatment": "PD-L1 positive advanced non-small cell lung cancer"},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases"], "name": "Alecensa (alectinib)", "approval_status": "Approved December 2015", "company": "Roche", "specific_treatment": "ALK-positive, metastatic non-small cell lung cancer "},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases", "Urology"], "name": "Tecentriq (atezolizumab)", "approval_status": "Approved May 2016", "company": "Genentech", "specific_treatment": "urothelial carcinoma and metastatic non-small cell lung cancer"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Cinqair (reslizumab)", "approval_status": "Approved March 2016", "company": "Teva Pharmaceuticals", "specific_treatment": "severe asthma"},
{"therapeutic_areas": ["Immunology", "Otolaryngology (Ear, Nose, Throat)", "Pediatrics/Neonatology", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "Qnasl (beclomethasone dipropionate) nasal aerosol", "approval_status": "Approved March 2012", "company": "Teva Pharmaceutical", "specific_treatment": "seasonal and perennial allergic rhinitis"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Bevespi Aerosphere (glycopyrrolate and formoterol fumarate)", "approval_status": "Approved April 2016", "company": "AstraZeneca", "specific_treatment": "chronic obstructive pulmonary disease"},
{"therapeutic_areas": ["Immunology", "Pharmacology/Toxicology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Lamisil (terbinafine hydrochloride) Tablets", "approval_status": "Approved May 1996", "company": "Sandoz Pharmaceuticals", "specific_treatment": "nail fungal infections"},
{"therapeutic_areas": ["Dermatology", "Neurology", "Pharmacology/Toxicology"], "name": "Iontocaine", "approval_status": "Approved May 1996", "company": "Iomed", "specific_treatment": "dermal surgery"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Stiolto Respimat (tiotropium bromide and olodaterol) ", "approval_status": "Approved May 2015", "company": "Boehringer Ingelheim", "specific_treatment": "maintenance of  chronic obstructive pulmonary disease"},
{"therapeutic_areas": ["Neurology", "Pharmacology/Toxicology"], "name": "Oxycodone with Acetaminophen 5mg/325mg", "approval_status": "Approved November 1997", "company": "Watson Pharmaceuticals", "specific_treatment": "analgesic"},
{"therapeutic_areas": ["Dermatology", "Otolaryngology (Ear, Nose, Throat)", "Pediatrics/Neonatology", "Pharmacology/Toxicology", "Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Omnicef", "approval_status": "Approved December 1997", "company": "Warner-Lambert", "specific_treatment": "bacteria causing pulmonary, throat, and skin infections"},
{"therapeutic_areas": ["Neurology", "Pharmacology/Toxicology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Genetic Disease"], "name": "Galzin (zinc acetate)", "approval_status": "Approved January 1997", "company": "Teva Pharmaceutical", "specific_treatment": "Wilson\u2019s disease"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pharmacology/Toxicology"], "name": "Antizol Injection", "approval_status": "Approved December 1997", "company": "Orphan Medical", "specific_treatment": "ethylene glycol poisoning"},
{"therapeutic_areas": ["Pediatrics/Neonatology", "Pharmacology/Toxicology"], "name": "AneuVysion Assay", "approval_status": "Approved October 1997", "company": "Vysis", "specific_treatment": "chromosomal abnormalities"},
{"therapeutic_areas": ["Pharmacology/Toxicology"], "name": "Raplon", "approval_status": "Approved August 1999", "company": "Organon", "specific_treatment": "Pharmacology"},
{"therapeutic_areas": ["Pharmacology/Toxicology", "Psychiatry/Psychology"], "name": "Subutex/Suboxone (buprenorphine/naloxone)", "approval_status": "Approved October 2002", "company": "Reckitt Benckiser", "specific_treatment": "Opiate Dependence"},
{"therapeutic_areas": ["Nephrology", "Pharmacology/Toxicology"], "name": "Mesnex", "approval_status": "Approved March 2002", "company": "Bristol-Myers Squibb, Baxter Healthcare", "specific_treatment": "Bladder complications caused by Ifex (ifosfamide)"},
{"therapeutic_areas": ["Pharmacology/Toxicology", "Family Medicine"], "name": "Campral (acamprosate calcium)", "approval_status": "Approved August, 2004", "company": "Forest Laboratories", "specific_treatment": "Alcohol dependence"},
{"therapeutic_areas": ["Dermatology", "Gastroenterology", "Immunology", "Pulmonary/Respiratory Diseases"], "name": "Tygacil (tigecycline)", "approval_status": "Approved 2005", "company": "Wyeth", "specific_treatment": "complicated skin and skin structure and intra-abdominal infections and bacterial pneumonia"},
{"therapeutic_areas": ["Gastroenterology", "Oncology", "Pharmacology/Toxicology"], "name": "Sancuso (granisetron)", "approval_status": "Approved September 2008", "company": "ProStrakan", "specific_treatment": "chemotherapy-induced nausea and vomiting"},
{"therapeutic_areas": ["Oncology", "Pharmacology/Toxicology"], "name": "Fusilev (levoleucovorin)", "approval_status": "Approved March of 2008", "company": "Spectrum Pharmaceuticals", "specific_treatment": "For rescue after high-dose methotrexate therapy in osteosarcoma and to reduce the toxicity of methotrexate"},
{"therapeutic_areas": ["Ophthalmology", "Pharmacology/Toxicology"], "name": "Akten (lidocaine hydrochloride)", "approval_status": "Approved October 2008", "company": "Akorn", "specific_treatment": "anesthesia during ophthalmologic procedures"},
{"therapeutic_areas": ["Immunology", "Pharmacology/Toxicology", "Family Medicine", "Infections and Infectious Diseases", "Vaccines"], "name": "Trovan", "approval_status": "Approved December 1997", "company": "Pfizer", "specific_treatment": "bacterial infections"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases", "Family Medicine", "Infections and Infectious Diseases"], "name": "Tavist (clemastine fumarate)", "approval_status": "Approved March 2001", "company": "Novartis", "specific_treatment": "Cold and Allergy"},
{"therapeutic_areas": ["Immunology", "Pharmacology/Toxicology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Egrifta (tesamorelin for injection)", "approval_status": "Approved November 2010", "company": "Theratechnologies", "specific_treatment": "reduction of excess abdominal fat in HIV-infected patients with lipodystrophy"},
{"therapeutic_areas": ["Neurology", "Pharmacology/Toxicology", "Family Medicine"], "name": "Oxecta (oxycodone HCl)", "approval_status": "Approved June 2011", "company": "Pfizer", "specific_treatment": "acute and chronic moderate to severe pain"},
{"therapeutic_areas": ["Nephrology", "Pharmacology/Toxicology", "Family Medicine"], "name": "Voraxaze (glucarpidase)", "approval_status": "Approved January 2012", "company": "BTG International", "specific_treatment": "toxic plasma methotrexate concentrations in patients with impaired renal function"},
{"therapeutic_areas": ["Hematology", "Pharmacology/Toxicology", "Trauma (Emergency, Injury, Surgery)"], "name": "Kcentra (Prothrombin Complex Concentrate)", "approval_status": "Approved May 2013", "company": "CSL Behring", "specific_treatment": "reversal of vitamin K antagonist therapy-induced coagulation factor deficiency"},
{"therapeutic_areas": ["Immunology", "Pharmacology/Toxicology", "Family Medicine"], "name": "Myalept (metreleptin for injection)", "approval_status": "Approved February of 2014", "company": "Bristol-Myers Squibb", "specific_treatment": "lipodystrophy"},
{"therapeutic_areas": ["Gastroenterology", "Neurology", "Pharmacology/Toxicology"], "name": "Movantik (naloxegol)", "approval_status": "Approved September 2014", "company": "AstraZeneca", "specific_treatment": "opiod-induced constipation in adults with chronic non-cancer pain"},
{"therapeutic_areas": ["Pharmacology/Toxicology", "Psychiatry/Psychology", "Family Medicine"], "name": "Bunavail (buprenorphine and naloxone)", "approval_status": "Approved June 2014", "company": "BioDelivery Sciences", "specific_treatment": "maintenance treatment of opioid dependence"},
{"therapeutic_areas": ["Pulmonary/Respiratory Diseases"], "name": "Nucala (mepolizumab)", "approval_status": "Approved November 2015", "company": "GlaxoSmithKline", "specific_treatment": "severe asthma"},
{"therapeutic_areas": ["Pharmacology/Toxicology"], "name": "Bridion (sugammadex)", "approval_status": "Approved December 2015", "company": "Merck", "specific_treatment": "reversal of neuromuscular blockade induced by rocuronium and vecuronium in adults undergoing surgery"},
{"therapeutic_areas": ["Oncology", "Pharmacology/Toxicology"], "name": "Sustol (granisetron)", "approval_status": "Approved August 2016", "company": "Heron Therapeutics", "specific_treatment": "prevention of chemotherapy-induced nausea and vomiting"},
{"therapeutic_areas": ["Dermatology", "Family Medicine", "Infections and Infectious Diseases", "Podiatry"], "name": "Mentax (1% butenafine HCl cream)", "approval_status": "Approved December 1997", "company": "Penederm", "specific_treatment": "athlete's foot"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Infections and Infectious Diseases", "Podiatry"], "name": "Condylox Gel 0.5% (pokofilox)", "approval_status": "Approved March 1997", "company": "Oclassen Pharmaceuticals", "specific_treatment": "external genital and perianal warts"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases", "Podiatry"], "name": "Aldara (imiquimod)", "approval_status": "Approved March 1997", "company": "3M Pharmaceuticals", "specific_treatment": "external genital and perianal warts"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases", "Podiatry"], "name": "Lotrisone (clotrimazole/betamethasone diproprionate) lotion", "approval_status": "Approved December 2000", "company": "Schering-Plough", "specific_treatment": "Symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Family Medicine", "Infections and Infectious Diseases", "Podiatry"], "name": "Lamisil (terbinafine hydrochloride) Solution, 1%", "approval_status": "Approved March 2000", "company": "Novartis", "specific_treatment": "For the treatment of interdigital-type pedis (athlete's foot), tinea cruris (jock itch) and tinea corporis (ringworm)"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases", "Podiatry"], "name": "Veregen (kunecatechins)", "approval_status": "Approved October 2006", "company": "Medigene", "specific_treatment": "External genital and perianal warts"},
{"therapeutic_areas": ["Dermatology", "Infections and Infectious Diseases", "Podiatry"], "name": "Luzu (luliconazole) Cream 1%", "approval_status": "November of 2013", "company": "Valeant Pharmaceuticals", "specific_treatment": "interdigital tinea pedis, tinea cruris, and tinea corporis"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Prinivil or Zestril (Lisinopril)", "approval_status": "Approved November 24, 1995", "company": "Merck, Zeneca", "specific_treatment": "hypertension, heart failure, acute myocardial infarction"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Corvert Injection (ibutilide fumarate injection)", "approval_status": "Approved December 1995", "company": "Pharmacia & Upjohn", "specific_treatment": "irregular contractions of the heart"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology"], "name": "Androderm (Testosterone Transdermal System)", "approval_status": "Approved on September 29, 1995", "company": "TheraTech", "specific_treatment": "hypogonadism"},
{"therapeutic_areas": ["Gastroenterology", "Oncology", "Pharmacology/Toxicology", "Trauma (Emergency, Injury, Surgery)"], "name": "Zuplenz (ondansetron oral soluble film)", "approval_status": "Approved July 2010", "company": "Strativa Pharmaceuticals", "specific_treatment": "post-operative, chemotherapy and radiotherapy induced nausea and vomiting"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Tiazac (diltiazem hydrochloride)", "approval_status": "Approved February 1996", "company": "Forest Laboratories", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Teczem (enalapril maleate/diltiazem malate)", "approval_status": "Approved October 1996", "company": "Hoechst Marion Roussel", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Oncology", "Pharmacology/Toxicology"], "name": "Kytril (granisetron) tablets", "approval_status": "Approved November 1997", "company": "SmithKline Beecham", "specific_treatment": "nausea and vomiting associated with chemotherapy"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Procanbid (procainamide hydrochloride extended-release tablets)", "approval_status": "Approved January 1996", "company": "Warner-Lambert", "specific_treatment": "ventricular arrhythmias"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Pravachol (pravastatin sodium)", "approval_status": "Approved April 1996", "company": "Bristol-Myers Squibb", "specific_treatment": "heart disease"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Hematology", "Family Medicine"], "name": "Pravachol (pravastatin sodium)", "approval_status": "Approved July 1996", "company": "Bristol-Myers Squibb", "specific_treatment": "cholesterol-lowering"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Mavik (trandolapril)", "approval_status": "Approved May 1996", "company": "Knoll Pharmaceutical", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Toprol-XL (metoprolol succinate)", "approval_status": "Approved January 1995", "company": "AstraZeneca", "specific_treatment": "hypertension, angina pectoris and heart failure"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Lipitor (atorvastatin calcium)", "approval_status": "Approved December 1996", "company": "Pfizer", "specific_treatment": "cardiovascular disease, hyperlipidemia and dyslipidemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Pulmonary/Respiratory Diseases"], "name": "Covera-HS (verapamil)", "approval_status": "Approved January 1996", "company": "GD Searle, Alza", "specific_treatment": "hypertension, angina"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Zocor", "approval_status": "Approved November 1997", "company": "Merck", "specific_treatment": "high triglyceride levels"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Gastroenterology", "Hematology", "Nephrology", "Neurology", "Oncology", "Pulmonary/Respiratory Diseases"], "name": "Visipaque (iodixanol)", "approval_status": "Approved April 1996", "company": "Nycomed", "specific_treatment": "diagnosis of disease in major organs"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Warfarin Sodium tablets", "approval_status": "Approved March 1997", "company": "Barr Laboratories", "specific_treatment": "Anticoagulant, or \"blood thinner\" to keep blood clots from forming or getting larger"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Retavase (reteplase)", "approval_status": "Approved November 1996", "company": "Boehringer Mannheim Corporation", "specific_treatment": "patients suffering from heart attack"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine", "Urology"], "name": "REPRONEX(menotropins for injection, USP)", "approval_status": "Approved February 1997", "company": "Ferring Pharmaceuticals", "specific_treatment": "Treatment for infertility"},
{"therapeutic_areas": ["Gastroenterology", "Oncology", "Pharmacology/Toxicology"], "name": "Akynzeo (netupitant and palonosetron)", "approval_status": "Approved October 2014", "company": "Helsinn", "specific_treatment": "chemotherapy-induced nausea and vomiting"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Posicor", "approval_status": "Approved June 1997", "company": "Roche", "specific_treatment": "hypertension and chronic stable angina pectoris"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Plavix (clopidogrel bisulfate)", "approval_status": "Approved November 1997", "company": "Sanofi-aventis, Bristol-Myers Squibb", "specific_treatment": "atherosclerosis"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Pindolol", "approval_status": "Approved April 1997", "company": "Teva Pharmaceutical", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Pentoxifylline", "approval_status": "Approved July 1997", "company": "Faulding, Mylan Laboratories", "specific_treatment": "chronic occlusive arterial disease"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Normiflo", "approval_status": "Approved May 1997", "company": "Wyeth", "specific_treatment": "Deep venous thrombosis"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Microzide (hydrochlorothiazide)", "approval_status": "Approved January 1997", "company": "Watson Pharmaceuticals", "specific_treatment": "mild-to moderate hypertension"},
{"therapeutic_areas": ["Oncology", "Pulmonary/Respiratory Diseases"], "name": "Tagrisso (osimertinib)", "approval_status": "Approved November 2015", "company": "AstraZeneca", "specific_treatment": "EGFR T790M mutation positive non-small cell lung cancer"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Lexxel (enalapril maleate-felodipine ER)", "approval_status": "Approved January 1997", "company": "Astra Merck", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Lescol (fluvastatin sodium)", "approval_status": "Approved September 1997", "company": "Novartis", "specific_treatment": "coronary atherosclerosis"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Nephrology", "Family Medicine", "Urology"], "name": "EDEX", "approval_status": "Approved June 1997", "company": "Schwarz Pharma", "specific_treatment": "erectile dysfunction"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Teveten (eprosartan mesylate)", "approval_status": "Approved December 1997", "company": "SmithKline Beecham", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Diovan (valsartan)", "approval_status": "Approved January 1997", "company": "Ciba Pharmaceuticals", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "ProAmatine (midodrine)", "approval_status": "Approved September 1996", "company": "Roberts Pharmaceutical", "specific_treatment": "hypotension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "ReoPro", "approval_status": "Approved November 1997", "company": "Centocor Ortho Biotech", "specific_treatment": "cardiac ischemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Cardizem (R)  (Diltiazem HC1 for injection) Monvial (R)", "approval_status": "Approved September 1997", "company": "Hoechst Marion Roussel", "specific_treatment": "atrial fibrillation"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Captopril and hydrochlorotiazide", "approval_status": "Approved May 1997", "company": "Mylan Laboratories", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology"], "name": "Baycol (cerivastatin sodium)", "approval_status": "Approved June 1997; withdrawn 8/8/01", "company": "Bayer", "specific_treatment": "Hypercholesterolemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine", "Urology"], "name": "Muse", "approval_status": "Approved October 1996", "company": "Vivus", "specific_treatment": "impotence"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Tricor (fenofibrate)", "approval_status": "Approved February 1998", "company": "Abbott Laboratories", "specific_treatment": "high triglyceride levels"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Tiazac (diltiazem hydrochloride)", "approval_status": "Approved February 1998", "company": "Forest Laboratories", "specific_treatment": "chronic stable angina"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Rythmol", "approval_status": "Approved January 1998", "company": "Knoll Pharmaceutical", "specific_treatment": "Paroxysmal atrial fibrillation"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Integrilin", "approval_status": "Approved May 1998", "company": "COR Therapeutics, Key Pharmaceuticals", "specific_treatment": "For the treatment of acute coronary syndrome"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Diovan HCT (valsartan)", "approval_status": "Approved March 1998", "company": "Novartis", "specific_treatment": "second-line treatment of hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Immunology"], "name": "CellCept", "approval_status": "Approved February 1998", "company": "Roche", "specific_treatment": "prevention of organ rejection inpatients undergoing heart transplants"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Agrylin (anagrelide HCL)", "approval_status": "Approved December 1998", "company": "Roberts Pharmaceutical", "specific_treatment": "Cardiology"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Mevacor (lovastatin) tablets", "approval_status": "Approved March 1999", "company": "Merck", "specific_treatment": "Cardiology"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Lescol (fluvastatin sodium) capsules, Rx", "approval_status": "Approved June 1999", "company": "Novartis", "specific_treatment": "Cardiology"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Nitrostat (nitroglycerin) Tablets", "approval_status": "Approved May 2000", "company": "Parke-Davis", "specific_treatment": "For the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Lescol XL (fluvastatin sodium) tablet, extended release", "approval_status": "Approved October 2000", "company": "Novartis", "specific_treatment": "For the use as an adjunct to diet to reduce elevated total cholesterol"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "DynaCirc CR", "approval_status": "Approved February 1997", "company": "Novartis", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Hematology"], "name": "Innohep (tinzaparin sodium) injectable", "approval_status": "Approved July 2000", "company": "DuPont Merck Pharmaceutical Company", "specific_treatment": "Deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Corlopam", "approval_status": "Approved September 1997", "company": "Neurex", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Betapace AF Tablet", "approval_status": "Approved February 2000", "company": "Berlex Laboratories", "specific_treatment": "For the prolongation of time to recurrence of symptomatic AFIB/AFL"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Atacand (candesartan cilexetil)", "approval_status": "Approved September 2000", "company": "AstraZeneca", "specific_treatment": "For the treatment of hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine", "Urology"], "name": "Viagra", "approval_status": "Approved March 1998", "company": "Pfizer", "specific_treatment": "impotence"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Hematology"], "name": "Argatroban Injection", "approval_status": "Approved June 2000", "company": "Texas Biotechnology Corporation, SmithKline Beecham", "specific_treatment": "Heparin-induced thrombocytopenia and thrombosis syndrome"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Angiomax (bivalirudin)", "approval_status": "Approved December 2000", "company": "The Medicines Company", "specific_treatment": "As an anticoagulant in conjunction with aspirin"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Tricor (fenofibrate)", "approval_status": "Approved September 2001", "company": "Abbott Laboratories", "specific_treatment": "Primary hypercholesterolemia, mixed lipidemia and hypertriglyceridemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Obstetrics/Gynecology (Women\u2019s Health)"], "name": "Micardis (telmisartan)", "approval_status": "Approved November 1998", "company": "Boehringer Ingelheim", "specific_treatment": "Cardiology"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology"], "name": "Natrecor (nesiritide)", "approval_status": "Approved August 2001", "company": "Scios", "specific_treatment": "Acutely decompensated congestive heart failure"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Diovan (valsartan)", "approval_status": "Approved January 1997 (capsules); July 2001 (tablets)", "company": "Novartis", "specific_treatment": "Hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Advicor (extended-release niacin/lovastatin)", "approval_status": "Approved December 2001", "company": "Kos Pharmaceuticals", "specific_treatment": "Cholesterol disorders"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Remodulin (treprostinil)", "approval_status": "Approved May 2002", "company": "United Therapeutics", "specific_treatment": "pulmonary arterial hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Plavix (clopidogrel bisulfate)", "approval_status": "Approved February 2002", "company": "Sanofi-aventis", "specific_treatment": "Acute coronary syndrome"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Inspra (eplerenone tablets)", "approval_status": "Approved September 2002", "company": "Pharmacia & Upjohn", "specific_treatment": "Hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Imagent (perflexane lipid microspheres)", "approval_status": "Approved June 2002", "company": "Alliance Pharmaceutical", "specific_treatment": "Ultrasound contrast agent"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Altocor (lovastatin) Extended-Release Tablets", "approval_status": "Approved June 2002", "company": "Andrx", "specific_treatment": "Hypercholesterolemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Micardis HCT (telmisartan and hydrochlorothiazide)", "approval_status": "Approved November 2000", "company": "Boehringer Ingelheim", "specific_treatment": "Hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Crestor (rosuvastatin  calcium)", "approval_status": "Approved August 2003", "company": "AstraZeneca", "specific_treatment": "Hypercholesterolemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Caduet (amlodipine/atorvastatin)", "approval_status": "Approved January 2004", "company": "Pfizer", "specific_treatment": "Hypertension/Angina"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Verapamil", "approval_status": "Approved December 1997", "company": "IVAX", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "BiDil (isosorbide dinitrate/hydralazine hydrochloride)", "approval_status": "Approved June, 2005", "company": "NitroMed", "specific_treatment": "Heart Failure"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Ranexa (ranolazine)", "approval_status": "Approved January 2006", "company": "CV Therapeutics", "specific_treatment": "Chronic Angina"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Tekturna (aliskiren)", "approval_status": "Approved March 2007", "company": "Novartis", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Hematology", "Family Medicine"], "name": "Soliris (eculizumab)", "approval_status": "Approved March 2007", "company": "Alexion", "specific_treatment": "paroxysmal nocturnal hemoglobinuria"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Letairis (ambrisentan)", "approval_status": "Approved June 2007", "company": "Gilead", "specific_treatment": "pulmonary arterial hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology"], "name": "Fenofibrate", "approval_status": "Approved August 2007", "company": "LifeCycle Pharma", "specific_treatment": "hyperlipidemia, dyslipidemia and hypertriglyceridemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Azor (amlodipine besylate; olmesartan medoxomil)", "approval_status": "Approved September 2007", "company": "Daiichi Sankyo", "specific_treatment": "Hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Trilipix (fenofibric acid)", "approval_status": "Approved December 2008", "company": "Abbott Laboratories", "specific_treatment": "dyslipidemia, hypertriglyceridemia and hyperlipidemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Cleviprex (clevidipine)", "approval_status": "Approved August 2008", "company": "The Medicines Company", "specific_treatment": "hypertension when oral therapy is not feasible or not desirable"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Teveten (eprosartan mesylate plus hydrochlorothiazide)", "approval_status": "Approved November 2001", "company": "Unimed Pharmaceuticals", "specific_treatment": "Hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Multaq (dronedarone)", "approval_status": "Approved July 2009", "company": "Sanofi-aventis", "specific_treatment": "paroxysmal or persistent atrial fibrillation or atrial flutter"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Livalo (pitavastatin)", "approval_status": "Approved August 2009", "company": "Kowa Company", "specific_treatment": "primary hyperlipidemia and mixed dyslipidemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Hematology"], "name": "Efient (prasugrel)", "approval_status": "Approved July 2009", "company": "Eli Lilly", "specific_treatment": "prevention of thrombotic cardiovascular complications in acute coronary syndromes"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Hematology", "Trauma (Emergency, Injury, Surgery)"], "name": "Atryn (antithrombin recombinant lyophilized powder for reconstitution)", "approval_status": "Approved January 2009", "company": "GTC BioTherapeutics", "specific_treatment": "peri-operative and peri-partum thromboembolic events"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Adcirca (tadalafil)", "approval_status": "Approved May 2009", "company": "Eli Lilly", "specific_treatment": "pulmonary arterial hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Tribenzor (olmesartan medoxomil + amlodipine + hydrochlorothiazide)", "approval_status": "Approved July 2010", "company": "Daiichi Sankyo", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Tekamlo (aliskiren + amlodipine)", "approval_status": "Approved August 2010", "company": "Novartis", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Pradaxa (dabigatran etexilate mesylate)", "approval_status": "Approved October 2010", "company": "Boehringer Ingelheim", "specific_treatment": "risk reduction of stroke and embolism due to atrial fibrillation"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Amturnide (aliskiren + amlodipine + hydrochlorothiazide)", "approval_status": "Approved December 2010", "company": "Novartis", "specific_treatment": "uncontrolled hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Hematology", "Neurology", "Family Medicine", "Urology"], "name": "Levitra (vardenafil)", "approval_status": "Approved September 2003", "company": "Bayer, GlaxoSmithKline", "specific_treatment": "Erectile Dysfunction"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Hematology", "Family Medicine"], "name": "Xarelto (rivaroxaban)", "approval_status": "Approved July 2011", "company": "Bayer", "specific_treatment": "prophylaxis of deep vein thrombosis during knee or hip replacement surgery"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Edarbyclor (azilsartan medoxomil and chlorthalidone)", "approval_status": "Approved December of 2011", "company": "Takeda", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Edarbi (azilsartan medoxomil)", "approval_status": "Approved February 2011", "company": "Takeda", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Brilinta (ticagrelor)", "approval_status": "Approved July 2011", "company": "AstraZeneca", "specific_treatment": "reduction of thrombotic events in patients with acute coronary syndrome"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Vascepa (icosapent ethyl)", "approval_status": "Approved July of 2012", "company": "Amarin Pharmaceuticals", "specific_treatment": "hypertriglyceridemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Genetic Disease"], "name": "Juxtapid (lomitapide)", "approval_status": "Approved December of 2012", "company": "Aegerion Pharmaceuticals", "specific_treatment": "homozygous familial hypercholesterolemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Diltiazem HCL, Extended-Release Capsules", "approval_status": "Approved January 2000", "company": "Biovail Laboratories", "specific_treatment": "Indicated for the treatment of hypertension; for use alone or in combination with other anti-hypertensive medications"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Dermatology"], "name": "Varithena (polidocanol injectable foam)", "approval_status": "November 2013", "company": "BTG plc", "specific_treatment": "varicose veins"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Pulmonary/Respiratory Diseases"], "name": "Opsumit (macitentan)", "approval_status": "Approved October 2013", "company": "Actelion Pharmaceuticals", "specific_treatment": "pulmonary arterial hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Hematology", "Neurology"], "name": "Nymalize (nimodipine)", "approval_status": "Approved May 2013", "company": "Arbor Pharmaceuticals", "specific_treatment": "reduction of incidence and severity of ischemic deficits following subarachnoid hemorrhage"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Pediatrics/Neonatology", "Genetic Disease"], "name": "Kynamro (mipomersen sodium)", "approval_status": "Approved January 2013", "company": "Genzyme", "specific_treatment": "homozygous familial hypercholesterolemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Pulmonary/Respiratory Diseases", "Family Medicine"], "name": "Tyvaso (treprostinil)", "approval_status": "Approved July 2009", "company": "United Therapeutics", "specific_treatment": "pulmonary arterial hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Hematology"], "name": "Zontivity (vorapaxar)", "approval_status": "Approved May 2014", "company": "Merck", "specific_treatment": "reduction of thrombotic cardiovascular events"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Epanova (omega-3-carboxylic acids)", "approval_status": "Approved May 2014", "company": "AstraZeneca", "specific_treatment": "hypertriglyceridemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Uptravi (selexipag)", "approval_status": "Approved December 2015", "company": "Actelion Pharmaceuticals", "specific_treatment": "pulmonary arterial hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Savaysa (edoxaban)", "approval_status": "Approved January 2015", "company": "Daiichi Sankyo", "specific_treatment": "deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Repatha (evolocumab) ", "approval_status": "Approved August 2015", "company": "Amgen", "specific_treatment": "high cholesterol"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Endocrinology", "Family Medicine"], "name": "Benicar", "approval_status": "Approved April 2002", "company": "Daiichi Sankyo", "specific_treatment": "Hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Praluent (alirocumab)", "approval_status": "Approved July 2015", "company": "Sanofi Aventis", "specific_treatment": "heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Xarelto (rivaroxaban)", "approval_status": "Approved November 2011", "company": "Janssen Pharmaceuticals", "specific_treatment": "stroke and systemic embolism resulting from atrial fibrillation"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Pediatrics/Neonatology", "Genetic Disease"], "name": "Kanuma (sebelipase alfa)", "approval_status": "Approved December 2015", "company": "Alexion", "specific_treatment": "Lysosomal Acid Lipase (LAL) deficiency"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Entresto (sacubitril and valsartan)", "approval_status": "Approved July 2015", "company": "Novartis", "specific_treatment": "chronic heart failure"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Corlanor (ivabradine)", "approval_status": "Approved April 2015", "company": "Amgen", "specific_treatment": "chronic heart failure"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Yosprala (aspirin and omeprazole)", "approval_status": "Approved September 2016", "company": "Aralez Pharmaceuticals", "specific_treatment": "prevention of cardiovascular and cerebrovascular events"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Neurology"], "name": "Eliquis (apixaban)", "approval_status": "Approved December 2012", "company": "Bristol-Myers Squibb", "specific_treatment": "stroke and systemic embolism resulting from nonvalvular atrial fibrillation"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Kengreal (cangrelor) ", "approval_status": "Approved June 2015", "company": "The Medicines Company", "specific_treatment": "For reducing periprocedural thrombotic events"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases"], "name": "Prestalia (perindopril arginine and amlodipine besylate)", "approval_status": "Approved January 2015", "company": "Symplmed Pharmaceuticals", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Liptruzet (ezetimibe and atorvastatin)", "approval_status": "Approved May 2013", "company": "Merck", "specific_treatment": "hyperlipidemia"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Pulmonary/Respiratory Diseases"], "name": "Adempas (riociguat)", "approval_status": "Approved October 2013", "company": "Bayer Healthcare Pharmaceuticals", "specific_treatment": "Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension"},
{"therapeutic_areas": ["Neurology"], "name": "Briviact (brivaracetam)", "approval_status": "Approved February 2016", "company": "UCB", "specific_treatment": "partial onset seizures related to epilepsy"},
{"therapeutic_areas": ["Cardiology/Vascular Diseases", "Family Medicine"], "name": "Byvalson (nebivolol and valsartan)", "approval_status": "Approved June 2016", "company": "Allergan", "specific_treatment": "hypertension"},
{"therapeutic_areas": ["Infections and Infectious Diseases"], "name": "Nasonex Nasal Spray", "approval_status": "Approved January 1999", "company": "Schering-Plough", "specific_treatment": "Immunology/Allergy"},
{"therapeutic_areas": ["Neurology"], "name": "Rilutek (riluzole)", "approval_status": "Approved December 1995", "company": "Rhone Poulenc Rorer", "specific_treatment": "amyotrophic lateral sclerosis"},
{"therapeutic_areas": ["Internal Medicine", "Genetic Disease"], "name": "Cerdelga (eliglustat)", "approval_status": "Approved August 2014", "company": "Genzyme", "specific_treatment": "certain adult patients with Gaucher disease type 1"},
{"therapeutic_areas": ["Gastroenterology", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Protonix (pantoprazole sodium) Delayed Release Tablets", "approval_status": "Approved April 2002", "company": "Wyeth", "specific_treatment": "Gastroesophageal disorders"},
{"therapeutic_areas": ["Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Xifaxan (rifaximin)", "approval_status": "Approved May 2004", "company": "Salix Pharmaceuticals", "specific_treatment": "Travelers\u2019 Diarrhea"},
{"therapeutic_areas": ["Gastroenterology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Genetic Disease"], "name": "Zenpep (pancrelipase)", "approval_status": "Approved August 2009", "company": "Eurand", "specific_treatment": "pancreatic insufficiency due to cystic fibrosis or other conditions"},
{"therapeutic_areas": ["Nephrology"], "name": "Cipro (ciprofloxacin HCl)", "approval_status": "Approved April 1996", "company": "Bayer", "specific_treatment": "cystitis"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Prilosec (omeprazole)", "approval_status": "Approved March 1996", "company": "Astra Merck", "specific_treatment": "gastric ulcers"},
{"therapeutic_areas": ["Immunology", "Family Medicine"], "name": "Oral Cytovene", "approval_status": "Approved December 1996", "company": "Roche", "specific_treatment": "CMV"},
{"therapeutic_areas": ["Hematology"], "name": "Vidaza (azacitidine)", "approval_status": "Approved May 2004", "company": "Pharmion Corporation", "specific_treatment": "Myelodysplastic Syndrome"},
{"therapeutic_areas": ["Endocrinology", "Hematology"], "name": "Glyburide Tablets", "approval_status": "Approved December 1997", "company": "Mova Pharmaceutical", "specific_treatment": "blood-glucose lowering agent"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Family Medicine"], "name": "OxyContin (oxycodone HCl controlled-release)", "approval_status": "Approved May 1996", "company": "Purdue Pharma", "specific_treatment": "pain associated with musculoskeletal conditions"},
{"therapeutic_areas": ["Hematology", "Genetic Disease"], "name": "AlphaNine SD Coagulation Factor IX (Human)", "approval_status": "Approved July 1996", "company": "Alpha Therapeutic Corporation", "specific_treatment": "Hemophilia B"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal"], "name": "Skelid (tiludronate disodium)", "approval_status": "Approved March 1997", "company": "Sanofi-aventis", "specific_treatment": "Paget\u2019s disease"},
{"therapeutic_areas": ["Musculoskeletal", "Family Medicine"], "name": "Etodolac", "approval_status": "Approved May 1998", "company": "Faulding", "specific_treatment": "osteoarthritis and pain"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal", "Genetic Disease"], "name": "Saizen", "approval_status": "Approved May 1996", "company": "Ares-Serono", "specific_treatment": "growth hormone deficiency, Turner Syndrome"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal"], "name": "Testim", "approval_status": "Approved October 2002", "company": "Auxilium Pharmaceuticals", "specific_treatment": "Low Testosterone"},
{"therapeutic_areas": ["Musculoskeletal"], "name": "Naglazyme (galsulfase)", "approval_status": "Approved May 2005", "company": "BioMarin Pharmaceuticals", "specific_treatment": "Mucopolysaccharidosis VI"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Prilosec (omeprazole)/Biaxin (clarithromycin) Combination Therapy", "approval_status": "Approved April 1996", "company": "Astra Merck, Abbott Laboratories", "specific_treatment": "duodenal ulcers"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Prilosec (omeprazole)", "approval_status": "Approved December 1996", "company": "Astra Merck", "specific_treatment": "symptoms associated with gastroesophageal reflux disease (GERD)"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Avonex (Interferon Beta 1-A)", "approval_status": "Recommended for Approval in December 1995", "company": "Biogen IDEC", "specific_treatment": "multiple sclerosis"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Urso", "approval_status": "Approved December 1997", "company": "Axcan", "specific_treatment": "primary biliary cirrhosis"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Ranitidine Tablets", "approval_status": "Approved September 1997", "company": "Apotex", "specific_treatment": "ulcers"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Ranitidine Capsules", "approval_status": "Approved October 1997", "company": "Geneva Pharmaceuticals", "specific_treatment": "heartburn"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Prochloroperazine", "approval_status": "Approved May 1997", "company": "Duramed Pharmaceuticals", "specific_treatment": "nausea"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Prevpac", "approval_status": "Approved December 1997", "company": "TAP Pharmaceuticals", "specific_treatment": "duodenal ulcers"},
{"therapeutic_areas": ["Musculoskeletal"], "name": "Atracurium Besylate Injection", "approval_status": "Approved April 1997", "company": "Faulding", "specific_treatment": "muscle relaxant"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal"], "name": "Somavert (pegvisomant)", "approval_status": "Approved March 2003", "company": "Pharmacia & Upjohn", "specific_treatment": "Acromegaly"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Zantac 75 Efferdose", "approval_status": "Approved March 1998", "company": "GlaxoSmithKline", "specific_treatment": "heartburn"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Tazorac topical gel", "approval_status": "Approved June 1997", "company": "Allergan", "specific_treatment": "psoriasis, acne vulgaris"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Precose (acarbose)", "approval_status": "Approved September 6, 1995", "company": "Bayer", "specific_treatment": "non-insulin-dependent diabetes mellitus"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Axid AR (nizatidine", "approval_status": "Approved May 1996", "company": "Whitehall-Robins Healthcare", "specific_treatment": "heartburn, acid indigestion, sour stomach"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Amaryl (Glimepiride)", "approval_status": "Approved December 1995", "company": "Hoechst Marion Roussel", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Humalog (insulin lispro)", "approval_status": "Approved June 1996", "company": "Eli Lilly", "specific_treatment": "type 1 and type 2 diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Glyset (miglitol)", "approval_status": "Approved December 1996", "company": "Bayer", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Differin (adapalene gel) Gel, 0.1%", "approval_status": "Approved June 1996", "company": "Galderma Laboratories", "specific_treatment": "acne"},
{"therapeutic_areas": ["Dental and Oral Health", "Family Medicine"], "name": "DentiPatch (lidocaine transoral delivery system)", "approval_status": "Approved May 1996", "company": "Noven Pharmaceuticals", "specific_treatment": "pain from oral injections, soft tissue dental procedures"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Retin-A Micro (tretinoin gel) microsphere, 0.1%", "approval_status": "Approved February 1997", "company": "Advanced Polymer Systems", "specific_treatment": "acne"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Propecia", "approval_status": "Approved December 1997", "company": "Merck", "specific_treatment": "male baldness"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Prandin", "approval_status": "Approved December 1997", "company": "Novo Nordisk", "specific_treatment": "Type II diabetes"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Minoxidil Topical Solution 2% for Women", "approval_status": "Approved April 1997", "company": "Alpharma", "specific_treatment": "general thinning of scalp hair"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Cimetidine Hydrochloride Oral Solution", "approval_status": "Approved October 1997", "company": "Hi-Tech Pharmacal", "specific_treatment": "heartburn"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Glipizide Tablets", "approval_status": "Approved September 1997", "company": "Duramed Pharmaceuticals", "specific_treatment": "diabetes"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Dermagraft-TC", "approval_status": "Approved October 1997", "company": "Advanced Tissue Sciences", "specific_treatment": "burns"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Asacol (mesalamine)", "approval_status": "Approved August 1997", "company": "Procter & Gamble", "specific_treatment": "ulcerative colitits"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Clindamycin Phosphate Topical Solution USP 1%", "approval_status": "Approved July 1997", "company": "Morton Grove Pharmaceuticals", "specific_treatment": "acne vulgaris"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Avita Gel", "approval_status": "Approved January 1997", "company": "Penederm", "specific_treatment": "acne"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Sulfamylon", "approval_status": "Approved June 1998", "company": "Mylan Laboratories", "specific_treatment": "Burn Wounds"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Noritate", "approval_status": "Approved January 1998", "company": "Dermik Laboratories", "specific_treatment": "Rosacea"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Glyburide Tablets", "approval_status": "Approved July 1998.", "company": "Mylan Laboratories", "specific_treatment": "Diabetes Mellitus"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Glucagon", "approval_status": "Approved October 1998", "company": "Eli Lilly", "specific_treatment": "Diabetes"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Protopic (tacrolimus) ointment", "approval_status": "Approved December 2000", "company": "Fujisawa Healthcare", "specific_treatment": "Moderate to severe atopic dermatitis"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "NovoLog (insulin aspart)", "approval_status": "Approved June 2000", "company": "Novo Nordisk", "specific_treatment": "Diabetes Mellitus"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Clindamycin phosphate topical gel", "approval_status": "Approved November 2000", "company": "Target Research Associates", "specific_treatment": "Acne vulgaris"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Benzamycin (erythromycin 3%-benzoyl peroxide 5% topical gel)", "approval_status": "Approved November 2000", "company": "Dermik Laboratories", "specific_treatment": "Acne vulgaris"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Novolog Mix 70/30", "approval_status": "Approved November 2001", "company": "Novo Nordisk", "specific_treatment": "Diabetes"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Finevin", "approval_status": "Approved May 2001", "company": "Berlex Laboratories", "specific_treatment": "Acne"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Estrostep (norethindrone acetate and ethinyl estradiol)", "approval_status": "Approved July 2001", "company": "Pfizer", "specific_treatment": "Acne vulgaris"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Elidel", "approval_status": "Approved December 2001", "company": "Novartis", "specific_treatment": "Atopic dermatitis"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Metaglip (glipizide/metformin HCl)", "approval_status": "Approved October 2002", "company": "Bristol-Myers Squibb", "specific_treatment": "Type 2 Diabetes"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Finacea (azelaic acid) Gel, 15%", "approval_status": "January 2003", "company": "Berlex Laboratories", "specific_treatment": "Inflammatory papules and pustules of mild to moderate rosacea."},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Symlin (pramlintide)", "approval_status": "Approved March 2005", "company": "Amylin Pharmaceuticals", "specific_treatment": "Diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Byetta (exenatide)", "approval_status": "Approved April, 2005", "company": "Amylin/Eli Lilly", "specific_treatment": "Type 2 Diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "ACTOplus met (pioglitazone hydrochloride and metformin hydrochloride)", "approval_status": "Approved August of 2005", "company": "Takeda", "specific_treatment": "type 2 diabetes"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Verdeso (desonide)", "approval_status": "Approved September 2006", "company": "Connetics Corporation", "specific_treatment": "atopic dermatitis"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Januvia (sitagliptin phosphate)", "approval_status": "Approved October 2006", "company": "Merck", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Welchol (colesevelam hydrochloride)", "approval_status": "Approved January 2008", "company": "Daiichi Sankyo", "specific_treatment": "glycemic control in type 2 diabetes mellitus"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Onglyza (saxagliptin)", "approval_status": "Approved July 2009", "company": "Bristol-Myers Squibb", "specific_treatment": "type 2 diabetes mellitus"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Cycloset, bromocriptine mesylate", "approval_status": "Approved May 2009", "company": "VeroScience", "specific_treatment": "type 2 diabetes mellitus"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Victoza (liraglutide)", "approval_status": "Approved January 2010", "company": "Novo Nordisk", "specific_treatment": "type 2 diabetes mellitus"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Tradjenta (linagliptin)", "approval_status": "Approved May 2011", "company": "Boehringer Ingelheim", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Juvisync (sitagliptin and simvastatin)", "approval_status": "Approved October 2011", "company": "Merck", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Korlym (mifepristone)", "approval_status": "Approved February 2012", "company": "Corcept Therapeutics", "specific_treatment": "hyperglycemia in adults with endogenous Cushing\u2019s syndrome"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Jentadueto (linagliptin plus metformin hydrochloride)", "approval_status": "Approved February 2012", "company": "Eli Lilly", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Invokana (canagliflozin)", "approval_status": "Approved April 2013", "company": "Janssen Pharmaceuticals", "specific_treatment": "type II diabetes mellitus"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Natesto, (testosterone) nasal gel", "approval_status": "Approved May 2014", "company": "Trimel Pharmaceuticals", "specific_treatment": "deficiency or absence of endogenous testosterone"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Farxiga (dapagliflozin)", "approval_status": "January of 2014", "company": "Bristol-Myers Squibb", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Aveed (testosterone undecanoate) injection", "approval_status": "Approved March 2014", "company": "Endo Pharmaceuticals", "specific_treatment": "hypogonadism"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Afrezza (insulin human) Inhalation Powder", "approval_status": "Approved June 2014", "company": "Mannkind", "specific_treatment": "diabetes mellitus"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Kybella  (deoxycholic acid)", "approval_status": "Approved April 2015", "company": "Kythera Biopharma", "specific_treatment": "submental fat"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Enstilar (calcipotriene and betamethasone dipropionate)", "approval_status": "Approved October 2015", "company": "LEO Pharmaceuticals", "specific_treatment": "psoriasis"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Xultophy 100/3.6 (insulin degludec and liraglutide injection)", "approval_status": "Approved November 2016", "company": "Novo Nordisk", "specific_treatment": "inadequately controlled type II diabetes"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Soliqua 100/33 (insulin glargine and lixisenatide injection)", "approval_status": "Approved November 2016", "company": "Sanofi Aventis", "specific_treatment": "inadequately controlled type II diabetes"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Prilosec (omeprazole)", "approval_status": "Approved January 1998", "company": "Astra Merck", "specific_treatment": "Heartburn"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "PREVACID(R) (lansopraxole)", "approval_status": "Approved April 1998", "company": "TAP Pharmaceuticals", "specific_treatment": "heartburn"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Cimetidine Hydrochloride Oral Solution", "approval_status": "Approved June 1998", "company": "Pharmaceutical Formulations", "specific_treatment": "heartburn"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Prevpac", "approval_status": "Approved February 1999", "company": "TAP Pharmaceuticals", "specific_treatment": "Gastroenterology"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Visicol Tablet", "approval_status": "Approved September 2000", "company": "Inkine Pharmaceutical", "specific_treatment": "For cleansing of the bowel as a preparation for colonoscopy, in adults 18 years of age and older"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Pepcid Complete", "approval_status": "Approved October 2000", "company": "Merck", "specific_treatment": "Heartburn associated with acid indigestion and sour stomach"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Colazal (balsalazide disodium)", "approval_status": "Approved July 2000", "company": "Salix Pharmaceuticals", "specific_treatment": "Mild to moderately active ulcerative colitis"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Protonix (pantoprazole sodium) Intravenous Formulation", "approval_status": "Approved March 2001", "company": "Wyeth", "specific_treatment": "Gastroesophageal reflux disease"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Nexium (esomeprazole magnesium)", "approval_status": "Approved February 2001", "company": "AstraZeneca", "specific_treatment": "Duodenal ulcer disease, erosive esophagitis, and gastroesophageal reflux disease"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Entocort EC (budesonide)", "approval_status": "Approved October 2001", "company": "AstraZeneca", "specific_treatment": "Crohn's disease"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Canasa (mesalamine)", "approval_status": "Approved January 2001", "company": "Axcan", "specific_treatment": "Ulcerative proctitis"},
{"therapeutic_areas": ["Endocrinology", "Family Medicine"], "name": "Avandamet (rosiglitazone maleate and metformin HCl)", "approval_status": "Approved October 2002", "company": "GlaxoSmithKline", "specific_treatment": "Type 2 Diabetes"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Amitiza (lubiprostone)", "approval_status": "Approved January 2006", "company": "Sucampo/Takeda", "specific_treatment": "Constipation"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Entereg (alvimopan)", "approval_status": "Approved May 2008", "company": "GlaxoSmithKline", "specific_treatment": "postoperative ileus"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Cimzia (certolizumab pegol)", "approval_status": "Approved April 2008", "company": "UCB", "specific_treatment": "Crohn's disease"},
{"therapeutic_areas": ["Dermatology", "Family Medicine"], "name": "Klaron (sodium sulfacet amide lotion ) Lotion, 10%", "approval_status": "Approved February 1997", "company": "Dermik Laboratories", "specific_treatment": "acne"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Metozolv ODT (metoclopramide hydrochloride)", "approval_status": "Approved September of 2009", "company": "Salix Pharmaceuticals", "specific_treatment": "gastroesophageal reflux and diabetic gastroparesis"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Pancreaze (pancrelipase)", "approval_status": "Approved April of 2010", "company": "Johnson & Johnson", "specific_treatment": "exocrine pancreatic insufficiency"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Cimetadine Hydrochloride Oral Solution 300mg/5ml", "approval_status": "Approved October 1997", "company": "Morton Grove Pharmaceuticals", "specific_treatment": "gastric ulcer and GERD"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Gattex (teduglutide)", "approval_status": "Approved December 2012", "company": "NPS Pharmaceuticals", "specific_treatment": "short bowel syndrome"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Uceris (budesonide)", "approval_status": "Approved January 2013", "company": "Santarus", "specific_treatment": "ulcerative colitis"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Xifaxan (rifaximin)", "approval_status": "Approved May 2015 ", "company": "Salix Pharmaceuticals", "specific_treatment": "irritable bowel syndrome with diarrhea "},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Viberzi (eluxadoline)", "approval_status": "Approved May 2015", "company": "Actavis", "specific_treatment": "irritable bowel syndrome with diarrhea"},
{"therapeutic_areas": ["Musculoskeletal", "Family Medicine"], "name": "Boniva (ibandronate)", "approval_status": "Approved May, 2003 -- UPDATED: NEW FORMULATION APPROVED MARCH, 2005", "company": "Roche / GlaxoSmithKline", "specific_treatment": "Osteoporosis"},
{"therapeutic_areas": ["Endocrinology", "Musculoskeletal"], "name": "Somatuline Depot (lanreotide acetate)", "approval_status": "Approved August 2007", "company": "Beaufour Ipsen", "specific_treatment": "acromegaly"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Cipro (ciprofloxacin) I.V. and Cipro (ciprofloxacin HCI) tablets", "approval_status": "Approved December 1996", "company": "Bayer", "specific_treatment": "complicated intra-abdominal infections"},
{"therapeutic_areas": ["Musculoskeletal"], "name": "Savella (milnacipran hydrochloride)", "approval_status": "Approved January 2009", "company": "Forest Laboratories", "specific_treatment": "fibromyalgia"},
{"therapeutic_areas": ["Musculoskeletal"], "name": "Xiaflex (collagenase clostridium histolyticum)", "approval_status": "Approved February 2010", "company": "Auxilium Pharmaceuticals", "specific_treatment": "Dupuytren\u2019s contracture"},
{"therapeutic_areas": ["Musculoskeletal"], "name": "Xeomin (incobotulinumtoxinA)", "approval_status": "Approved July 2010", "company": "Merz Pharmaceutical", "specific_treatment": "cervical dystonia and blepharospasm"},
{"therapeutic_areas": ["Musculoskeletal", "Family Medicine"], "name": "Gilenya (fingolimod)", "approval_status": "Approved September 2010", "company": "Novartis", "specific_treatment": "relapsing multiple sclerosis"},
{"therapeutic_areas": ["Musculoskeletal", "Family Medicine"], "name": "Aubagio (teriflunomide)", "approval_status": "Approved September 2012", "company": "Sanofi Aventis", "specific_treatment": "multiple sclerosis"},
{"therapeutic_areas": ["Hematology", "Genetic Disease"], "name": "BeneFIX (coagulation Factor IX (recombinant))", "approval_status": "Approved February 1997", "company": "Genetics Institute", "specific_treatment": "hemophilia B"},
{"therapeutic_areas": ["Endocrinology", "Hematology"], "name": "Glyburide Tablets", "approval_status": "Approved December 1997", "company": "Roche", "specific_treatment": "blood-glucose lowering agent"},
{"therapeutic_areas": ["Hematology"], "name": "Agrylin (anagrelide HCL)", "approval_status": "Approved March 1997", "company": "Roberts Pharmaceutical", "specific_treatment": "thrombocythemia"},
{"therapeutic_areas": ["Hematology"], "name": "Refludan", "approval_status": "Approved March 1998", "company": "Hoechst Marion Roussel", "specific_treatment": "heparin-induced thrombocytopenia type II"},
{"therapeutic_areas": ["Hematology", "Musculoskeletal", "Family Medicine"], "name": "Lovenox (enoxaparin sodium) Injection", "approval_status": "Approved February 1998", "company": "Rhone Poulenc Rorer", "specific_treatment": "prevention of blood clots following hip-replacement surgery"},
{"therapeutic_areas": ["Hematology"], "name": "Lovenox (enoxaparin sodium) Injection", "approval_status": "Approved May 1997", "company": "Rhone Poulenc Rorer", "specific_treatment": "deep vein thrombosis"},
{"therapeutic_areas": ["Hematology"], "name": "Lovenox (enoxaparin sodium) Injection", "approval_status": "Approved January 1999", "company": "Rhone Poulenc Rorer", "specific_treatment": "Hematology"},
{"therapeutic_areas": ["Hematology"], "name": "Fragmin", "approval_status": "Approved March 1999", "company": "Pharmacia & Upjohn", "specific_treatment": "Hematology"},
{"therapeutic_areas": ["Hematology"], "name": "Ferrlecit", "approval_status": "Approved February 1999", "company": "R&D Laboratories", "specific_treatment": "Anemia"},
{"therapeutic_areas": ["Hematology"], "name": "Arixtra", "approval_status": "Approved December 2001", "company": "Organon, Sanofi-Synthelabo", "specific_treatment": "Deep vein thrombosis prophylaxis"},
{"therapeutic_areas": ["Musculoskeletal"], "name": "Reclast (zoledronic acid)", "approval_status": "Approved April 2007", "company": "Novartis", "specific_treatment": "Paget's disease"},
{"therapeutic_areas": ["Hematology"], "name": "Revlimid (lenalidomide)", "approval_status": "Approved December 2005", "company": "Celgene", "specific_treatment": "Myelodysplastic Syndromes"},
{"therapeutic_areas": ["Hematology"], "name": "Dacogen (decitabine)", "approval_status": "Approved May 2006", "company": "MGI Pharma", "specific_treatment": "Myelodysplastic Syndromes"},
{"therapeutic_areas": ["Hematology"], "name": "Kuvan (sapropterin dihydrochloride)", "approval_status": "Approved December 2007", "company": "BioMarin Pharmaceuticals", "specific_treatment": "hyperphenylalaninemia due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria"},
{"therapeutic_areas": ["Hematology"], "name": "Nplate (romiplostim)", "approval_status": "Approved August 2008", "company": "Amgen", "specific_treatment": "thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura"},
{"therapeutic_areas": ["Hematology"], "name": "Samsca (tolvaptan)", "approval_status": "Approved May of 2009", "company": "Otsuka", "specific_treatment": "hyponatremia"},
{"therapeutic_areas": ["Hematology"], "name": "Jakafi (ruxolitinib)", "approval_status": "Approved November 2011", "company": "Incyte", "specific_treatment": "myelofibrosis"},
{"therapeutic_areas": ["Hematology"], "name": "Droxia", "approval_status": "Approved March 1998", "company": "Bristol-Myers Squibb", "specific_treatment": "sickle-cell anemia"},
{"therapeutic_areas": ["Endocrinology", "Hematology", "Musculoskeletal"], "name": "Actonel", "approval_status": "Approved April 1998", "company": "Procter & Gamble, Hoechst Marion Roussel", "specific_treatment": "Paget's Disease"},
{"therapeutic_areas": ["Hematology", "Genetic Disease"], "name": "Tretten (Coagulation Factor XIII A-Subunit [Recombinant])", "approval_status": "Approved December of 2013", "company": "Novo Nordisk", "specific_treatment": "congenital factor XIII (FXIII) A-subunit deficiency"},
{"therapeutic_areas": ["Hematology"], "name": "Rixubis (Coagulation Factor IX (Recombinant)]", "approval_status": "Approved June 2013", "company": "Baxter International", "specific_treatment": "routine prophylaxis and control of hemophilia B"},
{"therapeutic_areas": ["Hematology"], "name": "Ruconest (C1 esterase inhibitor [recombinant])", "approval_status": "Approved July 2014", "company": "Pharming Group", "specific_treatment": "hereditary  angioedema"},
{"therapeutic_areas": ["Hematology"], "name": "Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence]", "approval_status": "Approved October 2014", "company": "Baxter", "specific_treatment": "acquired hemophilia A"},
{"therapeutic_areas": ["Hematology"], "name": "Eloctate [Antihemophilic Factor (Recombinant), Fc Fusion  Protein] ", "approval_status": "Approved June 2014", "company": "Biogen IDEC.", "specific_treatment": "hemophillia A"},
{"therapeutic_areas": ["Hematology"], "name": "Veltassa (patiromer)", "approval_status": "Approved October 2015", "company": "Relypsa", "specific_treatment": "hyperkalemia"},
{"therapeutic_areas": ["Hematology"], "name": "Promacta (eltrombopag)", "approval_status": "Approved November 2008", "company": "GlaxoSmithKline", "specific_treatment": "thrombocytopenia"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine"], "name": "Aciphex (rabeprazole sodium)", "approval_status": "Approved February 2002", "company": "Elan Pharmaceuticals", "specific_treatment": "Symptomatic gastroesophageal reflux disease"},
{"therapeutic_areas": ["Endocrinology", "Hematology"], "name": "Natpara (parathyroid hormone) ", "approval_status": "Approved January 2015", "company": "NPS Pharmaceuticals", "specific_treatment": "hypocalcemia in patients with hypoparathyroidism"},
{"therapeutic_areas": ["Hematology", "Family Medicine", "Genetic Disease"], "name": "Ferriprox (deferiprone)", "approval_status": "Approved October 2011", "company": "Apotex", "specific_treatment": "transfusional iron overload due to thalassemia"},
{"therapeutic_areas": ["Endocrinology", "Gastroenterology", "Hematology", "Musculoskeletal", "Family Medicine", "Genetic Disease"], "name": "Elelyso (taliglucerase alfa)", "approval_status": "Approved May 2012", "company": "Pfizer", "specific_treatment": "Gaucher disease"},
{"therapeutic_areas": ["Gastroenterology"], "name": "Rectiv (nitroglycerin) ointment 0.4%", "approval_status": "Approved June 2011", "company": "ProStrakan", "specific_treatment": "chronic anal fissure"},
{"therapeutic_areas": ["Immunology"], "name": "Albenza (albendazole)", "approval_status": "Approved June 1996", "company": "SmithKline Beecham", "specific_treatment": "parasitic infections"},
{"therapeutic_areas": ["Immunology"], "name": "Stromectol (ivermectin)", "approval_status": "Approved March 1997", "company": "Merck", "specific_treatment": "nondisseminated intestinal threadworm"},
{"therapeutic_areas": ["Hematology"], "name": "Nuwiq (recombinant Factor VIII)", "approval_status": "Approved September 2015", "company": "Octapharma", "specific_treatment": "hemophilia A"},
{"therapeutic_areas": ["Immunology"], "name": "Acyclovir Capsules", "approval_status": "Approved April 1997", "company": "Teva Pharmaceutical", "specific_treatment": "anti-viral treatment"},
{"therapeutic_areas": ["Hematology"], "name": "Idelvion (Coagulation Factor IX (Recombinant), Albumin Fusion Protein)", "approval_status": "Approved March 2016", "company": "CSL Behring", "specific_treatment": "hemophilia B"},
{"therapeutic_areas": ["Immunology"], "name": "Vistide (cidofovir)", "approval_status": "Approved March 1999", "company": "Gilead", "specific_treatment": "Infectious Diseases"},
{"therapeutic_areas": ["Immunology"], "name": "Relenza", "approval_status": "Approved July 1999", "company": "GlaxoSmithKline", "specific_treatment": "Immunology/Infectious Diseases"},
{"therapeutic_areas": ["Immunology"], "name": "Panretin Gel", "approval_status": "Approved June 1999", "company": "Ligand Pharmaceuticals", "specific_treatment": "Infectious Diseases"},
{"therapeutic_areas": ["Immunology"], "name": "Norvir (ritonavir)", "approval_status": "Approved June 1999", "company": "Abbott Laboratories", "specific_treatment": "Immunology/Infectious Diseases"},
{"therapeutic_areas": ["Immunology"], "name": "Famvir (famciclovir)", "approval_status": "Approved January 1999", "company": "SmithKline Beecham", "specific_treatment": "Infectious Diseases"},
{"therapeutic_areas": ["Immunology"], "name": "Agenerase  (amprenavir)", "approval_status": "Approved April 1999", "company": "GlaxoSmithKline", "specific_treatment": "Immunology/Infectious Diseases"},
{"therapeutic_areas": ["Endocrinology", "Hematology"], "name": "Glucagon", "approval_status": "Approved September 1998", "company": "Eli Lilly", "specific_treatment": "Endocrinology, Hematology"},
{"therapeutic_areas": ["Hematology", "Immunology", "Family Medicine"], "name": "Gastrocrom Oral Concentrate (cromolyn sodium)", "approval_status": "Approved April 1996", "company": "Rhone Poulenc Rorer", "specific_treatment": "mastocytosis"},
{"therapeutic_areas": ["Immunology"], "name": "Rapamune (sirolimus) oral solution", "approval_status": "Approved September 1999", "company": "Wyeth", "specific_treatment": "To prevent organ rejection in patients receiving renal transplants"},
{"therapeutic_areas": ["Immunology"], "name": "Evoxac", "approval_status": "Approved January 2000", "company": "SnowBrand Pharmaceuticals", "specific_treatment": "Indicated for the symptoms of dry mouth in patients with Sjogren's Syndrome"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Family Medicine"], "name": "Amevive (alefacept)", "approval_status": "Approved January 2003", "company": "Biogen IDEC", "specific_treatment": "Psoriasis"},
{"therapeutic_areas": ["Immunology"], "name": "Tindamax, tinidazole", "approval_status": "Approved May, 2004", "company": "Presutti Laboratories", "specific_treatment": "Protozoal infections"},
{"therapeutic_areas": ["Immunology"], "name": "Rotateq (rotavirus vaccine, live oral pentavalent)", "approval_status": "Approved February 2006", "company": "Merck", "specific_treatment": "Rotavirus"},
{"therapeutic_areas": ["Dermatology", "Immunology"], "name": "Extina (ketoconazole)", "approval_status": "Approved June 2007", "company": "Stiefel", "specific_treatment": "seborrheic dermatitis"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Family Medicine"], "name": "Tysabri (natalizumab)", "approval_status": "Approved January 2008", "company": "Biogen IDEC", "specific_treatment": "Crohn's disease"},
{"therapeutic_areas": ["Immunology", "Genetic Disease"], "name": "Kalbitor (ecallantide)", "approval_status": "Approved November 2009", "company": "Dyax", "specific_treatment": "hereditary angioedema"},
{"therapeutic_areas": ["Immunology"], "name": "Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed)", "approval_status": "Approved March 2009", "company": "Intercell AG", "specific_treatment": "Japanese encephalitis virus"},
{"therapeutic_areas": ["Immunology"], "name": "Coartem (artemether/lumefantrine)", "approval_status": "Approved April 2009", "company": "Novartis", "specific_treatment": "malaria infections due to Plasmodium falciparum"},
{"therapeutic_areas": ["Immunology"], "name": "Rid Mousse", "approval_status": "Approved March 2000", "company": "Soltec Research", "specific_treatment": "For the treatment of head, pubic (crab), and body lice"},
{"therapeutic_areas": ["Immunology", "Musculoskeletal", "Family Medicine"], "name": "Tecfidera (dimethyl fumarate)", "approval_status": "Approved March 2013", "company": "Biogen Idec", "specific_treatment": "relapsing multiple sclerosis"},
{"therapeutic_areas": ["Immunology"], "name": "Malarone (atovaquone; proguanil hydrochloride) Tablet", "approval_status": "Approved July 2000", "company": "GlaxoSmithKline", "specific_treatment": "Malaria"},
{"therapeutic_areas": ["Hematology", "Immunology"], "name": "Sylvant (siltuximab)", "approval_status": "Approved April 2014", "company": "Janssen Biotech", "specific_treatment": "multicentric Castleman\u2019s disease"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Family Medicine"], "name": "Otezla (apremilast)", "approval_status": "Approved September 2014", "company": "Celgene", "specific_treatment": "moderate to severe plaque psoriasis"},
{"therapeutic_areas": ["Immunology"], "name": "HyQvia [Immune Globulin Infusion 10% (Human) with Recombinant  Human Hyaluronidase]", "approval_status": "Approved September 2014", "company": "Baxter", "specific_treatment": "Primary Immunodeficiency"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Family Medicine"], "name": "Entyvio (vedolizumab)", "approval_status": "Approved May of 2014", "company": "Millenium Pharmaceuticals", "specific_treatment": "adults with ulcerative colitis and Crohn's disease"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Family Medicine"], "name": "Cosentyx (secukinumab)", "approval_status": "Approved January 2015", "company": "Novartis", "specific_treatment": "plaque psoriasis"},
{"therapeutic_areas": ["Dermatology", "Immunology"], "name": "Taltz (ixekizumab)", "approval_status": "Approved March 2016", "company": "Eli Lilly", "specific_treatment": "plaque psoriasis"},
{"therapeutic_areas": ["Dental and Oral Health", "Immunology", "Family Medicine"], "name": "Aphthasol", "approval_status": "Approved December 1997", "company": "Block Drug Company", "specific_treatment": "canker sores"},
{"therapeutic_areas": ["Hematology", "Immunology"], "name": "Afstyla (Antihemophilic Factor (Recombinant), Single Chain)", "approval_status": "Approved May 2016", "company": "CSL Behring", "specific_treatment": "hemophillia A"},
{"therapeutic_areas": ["Endocrinology", "Gastroenterology", "Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Viokace (pancrelipase) tablets", "approval_status": "Approved March 2012", "company": "Aptalis Pharma", "specific_treatment": null},
{"therapeutic_areas": ["Endocrinology", "Gastroenterology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Genetic Disease"], "name": "Ultresa (pancrelipase) delayed-release capsules", "approval_status": "Approved March 2012", "company": "Aptalis Pharma", "specific_treatment": "exocrine pancreatic insufficiency"},
{"therapeutic_areas": ["Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Ocaliva (obeticholic acid)", "approval_status": "Approved May 2016", "company": "Intercept Pharmaceuticals", "specific_treatment": "primary biliary cholangitis"},
{"therapeutic_areas": ["Hepatology (Liver, Pancreatic, Gall Bladder)"], "name": "Defitelio (defibrotide sodium)", "approval_status": "Approved March 2016", "company": "Jazz Pharmaceuticals", "specific_treatment": "hepatic veno-occlusive disease  with renal or pulmonary dysfunction following HSCT"},
{"therapeutic_areas": ["Endocrinology", "Nephrology"], "name": "Zenapax", "approval_status": "Approved December 1997", "company": "Roche", "specific_treatment": "rejection of kidney transplants"},
{"therapeutic_areas": ["Endocrinology", "Nephrology"], "name": "Prograf", "approval_status": "Approved April 1997", "company": "Fujisawa Healthcare", "specific_treatment": "kidney transplant rejection"},
{"therapeutic_areas": ["Gastroenterology", "Immunology"], "name": "Simponi (golimumab)", "approval_status": "Aproved May 2013", "company": "Janssen Biotech", "specific_treatment": "ulcerative colitis"},
{"therapeutic_areas": ["Endocrinology", "Immunology", "Nephrology"], "name": "Simulect", "approval_status": "Approved May 1998", "company": "Novartis", "specific_treatment": "acute organ transplant rejection"},
{"therapeutic_areas": ["Nephrology"], "name": "RenaGelRenagel (sevelamer hydrochloride)", "approval_status": "Approved November 1998", "company": "GelTex Pharmaceuticals", "specific_treatment": "Urology"},
{"therapeutic_areas": ["Endocrinology", "Nephrology"], "name": "Proscar", "approval_status": "Approved April 1998", "company": "Merck", "specific_treatment": "reducing the need for prostate surgery"},
{"therapeutic_areas": ["Nephrology"], "name": "Ditropan XL (oxybutynin chloride)", "approval_status": "Approved December 1998", "company": "Alza", "specific_treatment": "Urology"},
{"therapeutic_areas": ["Nephrology"], "name": "Detrol (tolterodine tartrate)", "approval_status": "Approved March 1998", "company": "Pharmacia & Upjohn", "specific_treatment": "overactive bladder"},
{"therapeutic_areas": ["Nephrology"], "name": "Levaquin", "approval_status": "Approved July 1999", "company": "RW Johnson", "specific_treatment": "Urology"},
{"therapeutic_areas": ["Nephrology"], "name": "Ditropan XL (oxybutynin chloride)", "approval_status": "Approved June 1999", "company": "Alza", "specific_treatment": "Urology"},
{"therapeutic_areas": ["Hematology", "Nephrology", "Family Medicine"], "name": "Venofer (iron sucrose injection)", "approval_status": "Approved November 2000", "company": "Luitpold Pharmaceuticals", "specific_treatment": "Iron deficiency anemia in patients undergoing chronic hemodialysis"},
{"therapeutic_areas": ["Hematology", "Nephrology", "Family Medicine"], "name": "Renagel (sevelamer hydrochloride)", "approval_status": "Approved July of 2000", "company": "Genzyme", "specific_treatment": "the control of serum phosphorus in patients with chronic kidney disease on dialysis"},
{"therapeutic_areas": ["Hematology"], "name": "Praxbind (idarucizumab)", "approval_status": "Approved October 2015", "company": "Boehringer Ingelheim", "specific_treatment": "reversal of the anticoagulant effects of dabigatran"},
{"therapeutic_areas": ["Immunology", "Nephrology"], "name": "Rapamune (sirolimus) Tablets", "approval_status": "Approved August 2000", "company": "Wyeth", "specific_treatment": "Prevention of organ rejection in patients receiving kidney transplants"},
{"therapeutic_areas": ["Endocrinology", "Nephrology"], "name": "Hectorol (Doxercalciferol) Injection", "approval_status": "Approved April 2000", "company": "Bone Care International", "specific_treatment": "For the reduction of iPTH levels in mgmt. of secondary hyperparathyroidism in patients undergoing chronic renal dialysis"},
{"therapeutic_areas": ["Nephrology"], "name": "Detrol LA (tolterodine tartrate)", "approval_status": "Approved December 2000", "company": "Pharmacia & Upjohn", "specific_treatment": "Overactive Bladder"},
{"therapeutic_areas": ["Nephrology"], "name": "PhosLo", "approval_status": "Approved April 2001", "company": "Braintree Laboratories", "specific_treatment": "Hyperphosphetemia"},
{"therapeutic_areas": ["Gastroenterology", "Nephrology"], "name": "Oxytrol (oxybutynin transdermal system)", "approval_status": "Approved March 2003", "company": "Watson Pharmaceuticals", "specific_treatment": "Overactive Bladder"},
{"therapeutic_areas": ["Endocrinology", "Nephrology"], "name": "Fabrazyme (agalsidase beta)", "approval_status": "Approved April 2003", "company": "Genzyme", "specific_treatment": "Fabry Disease"},
{"therapeutic_areas": ["Nephrology"], "name": "Vesicare (solifenacin succinate)", "approval_status": "Approved November, 2004", "company": "Yamanouchi, GlaxoSmithKline", "specific_treatment": "Overactive bladder"},
{"therapeutic_areas": ["Endocrinology", "Nephrology"], "name": "Zemplar", "approval_status": "Approved April 1998", "company": "Abbott Laboratories", "specific_treatment": "secondary hyperparathyroidism associated with chronic renal failure"},
{"therapeutic_areas": ["Nephrology"], "name": "Fosrenol, lanthanum carbonate", "approval_status": "Approved October, 2004", "company": "Shire Pharmaceuticals", "specific_treatment": "Hyperphosphatemia"},
{"therapeutic_areas": ["Nephrology"], "name": "Vaprisol (conivaptan)", "approval_status": "Approved December 2005", "company": "Astellas Pharma US, Inc", "specific_treatment": "Hyponatremia"},
{"therapeutic_areas": ["Nephrology", "Family Medicine"], "name": "Renvela (sevelamer carbonate)", "approval_status": "Approved October 2007", "company": "Genzyme", "specific_treatment": "control of serum phosphorus in patients with chronic kidney disease on dialysis"},
{"therapeutic_areas": ["Hematology", "Nephrology"], "name": "Mircera (methoxy polyethylene glycol-epoetin beta)", "approval_status": "Approved November 2007", "company": "Roche", "specific_treatment": "anemia associated with chronic renal failure"},
{"therapeutic_areas": ["Nephrology"], "name": "Toviaz (fesoterodine fumarate)", "approval_status": "Approved October 2008", "company": "Pfizer", "specific_treatment": "overactive bladder"},
{"therapeutic_areas": ["Nephrology"], "name": "Gelnique (oxybutynin chloride)", "approval_status": "Approved January 2009", "company": "Watson Pharmaceuticals", "specific_treatment": "overactive bladder"},
{"therapeutic_areas": ["Hematology", "Nephrology"], "name": "Feraheme (ferumoxytol)", "approval_status": "Approved June 2009", "company": "AMAG", "specific_treatment": "iron deficiency anemia associated with chronic kidney disease"},
{"therapeutic_areas": ["Immunology", "Nephrology"], "name": "Zortress (everolimus)", "approval_status": "Approved May 2010", "company": "Novartis", "specific_treatment": "organ rejection following kidney transplant"},
{"therapeutic_areas": ["Hematology", "Nephrology", "Family Medicine"], "name": "Soliris (eculizumab)", "approval_status": "Approved September 2011", "company": "Alexion", "specific_treatment": "atypical hemolytic uremic syndrome"},
{"therapeutic_areas": ["Nephrology"], "name": "Renagel (sevelamer hydrochloride)", "approval_status": "Approved July 2000", "company": "GelTex Pharmaceuticals", "specific_treatment": "Hyperphosphatemia in patients on dialysis"},
{"therapeutic_areas": ["Immunology", "Nephrology", "Family Medicine"], "name": "Nulojix (belatacept)", "approval_status": "Approved June 2011", "company": "Bristol-Myers Squibb", "specific_treatment": "organ rejection following kidney transplant"},
{"therapeutic_areas": ["Hematology", "Nephrology", "Family Medicine"], "name": "Omontys (peginesatide)", "approval_status": "Approved March 2012", "company": "Affymax", "specific_treatment": "anemia due to chronic kidney disease"},
{"therapeutic_areas": ["Immunology", "Family Medicine"], "name": "Benlysta (belimumab)", "approval_status": "Approved March 2011", "company": "Human Genome Sciences", "specific_treatment": "systemic lupus erythematosus"},
{"therapeutic_areas": ["Nephrology"], "name": "Sanctura (trospium chloride)", "approval_status": "Approved May, 2004", "company": "Indevus Pharmaceuticals", "specific_treatment": "Overactive bladder"},
{"therapeutic_areas": ["Immunology", "Nephrology"], "name": "Envarsus XR (tacrolimus extended-release)", "approval_status": "Approved July 2015", "company": "Veloxis", "specific_treatment": "prophylaxis of organ rejection in kidney transplant patients "},
{"therapeutic_areas": ["Nephrology"], "name": "Rayaldee (calcifediol) ", "approval_status": "Approved June 2016", "company": "Opko Health", "specific_treatment": "treatment of secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Zerit (stavudine)", "approval_status": "Approved December 22, 1995", "company": "Bristol-Myers Squibb", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Valtrex (valacyclovir HCl)", "approval_status": "Approved  December 1995", "company": "GlaxoSmithKline", "specific_treatment": "herpes simplex"},
{"therapeutic_areas": ["Nephrology"], "name": "Procysbi (cysteamine bitartrate)", "approval_status": "Approved May 2013", "company": "Raptor Pharmaceuticals", "specific_treatment": "nephropathic cystinosis"},
{"therapeutic_areas": ["Hematology", "Nephrology"], "name": "Injectafer (ferric carboxymaltose injection)", "approval_status": "Approved July 2013", "company": "Luitpold Pharmaceuticals", "specific_treatment": "iron deficiency anemia"},
{"therapeutic_areas": ["Nephrology"], "name": "Auryxia (Ferric citrate)", "approval_status": "Approved September 2014", "company": "Keryx Biopharma", "specific_treatment": "hyperphosphatemia in patients with chronic kidney disease"},
{"therapeutic_areas": ["Endocrinology", "Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Epivir (lamivudine)", "approval_status": "Approved on November 17, 1995", "company": "GlaxoSmithKline", "specific_treatment": "AIDS/HIV infection"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Clarithromycin (Biaxin)", "approval_status": "Approved December 1995", "company": "Abbott Laboratories", "specific_treatment": "AIDS-related Mycobacterium avium complex"},
{"therapeutic_areas": ["Nephrology"], "name": "Zurampic (lesinurad)", "approval_status": "Approved December 2015", "company": "AstraZeneca", "specific_treatment": "hyperuricemia associated with gout "},
{"therapeutic_areas": ["Immunology", "Family Medicine"], "name": "Apthasol (Amlexanox)", "approval_status": "Approved May 1996", "company": "Access Pharmaceuticals", "specific_treatment": "canker sores"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Videx (didanosine)", "approval_status": "Approved June 1996", "company": "Bristol-Myers Squibb", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Dermatology", "Infections and Infectious Diseases"], "name": "IvyBlock", "approval_status": "Approved September 1996", "company": "EnviroDerm Pharmaceuticals", "specific_treatment": "skin protectant for poison ivy, poison oak, and poison sumac"},
{"therapeutic_areas": ["Nephrology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Elmiron (pentosan polysulfate sodium)", "approval_status": "Approved October 1996", "company": "IVAX", "specific_treatment": "interstitial cystitis"},
{"therapeutic_areas": ["Endocrinology", "Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Confide", "approval_status": "Approved May 1996", "company": "Johnson & Johnson", "specific_treatment": "HIV"},
{"therapeutic_areas": ["Endocrinology", "Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Western blot confirmatory device", "approval_status": "Approved in December 1995", "company": "Epitope", "specific_treatment": "HIV testing"},
{"therapeutic_areas": ["Dermatology", "Infections and Infectious Diseases"], "name": "Mentax (1% butenafine HCl cream)", "approval_status": "Approved January 1997", "company": "Penederm", "specific_treatment": "tinea corporis (ringworm) and tinea cruris (groin fungus)"},
{"therapeutic_areas": ["Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Intron A (interferon alfa-2b, recombinant)", "approval_status": "Approved March 1997", "company": "Schering-Plough", "specific_treatment": "Hepatitis C"},
{"therapeutic_areas": ["Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "INFERGEN (interferon alfacon-1)", "approval_status": "Approved October 1997", "company": "Amgen", "specific_treatment": "hepatitis C"},
{"therapeutic_areas": ["Endocrinology", "Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Invirase (saquinavir)", "approval_status": "Approved on December 7, 1995", "company": "Roche", "specific_treatment": "HIV/AIDS"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Famvir (famciclovir)", "approval_status": "Approved September 17, 1997", "company": "SmithKline Beecham", "specific_treatment": "herpes simplex"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Combivir", "approval_status": "Approved September 1997", "company": "GlaxoSmithKline", "specific_treatment": "AIDS, HIV Infection"},
{"therapeutic_areas": ["Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Zithromax (azithromycin)", "approval_status": "Approved June 1996", "company": "Pfizer", "specific_treatment": "Mycobacterium avium complex (MAC)"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Viramune (nevirapine)", "approval_status": "Approved June 1996", "company": "Boehringer Ingelheim", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Trizivir (abacavir sulfate; lamivudine; zidovudine AZT) Tablet", "approval_status": "Approved November 2000", "company": "GlaxoSmithKline", "specific_treatment": "HIV Infection"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Crixivan (Indinavir sulfate)", "approval_status": "Approved March 1996", "company": "Merck", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Kaletra Capsules and Oral Solution", "approval_status": "Approved September 2000", "company": "Abbott Laboratories", "specific_treatment": "For the treatment of HIV-1 infection in adults and pediatric patients age six months and older"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Rescriptor Tablets (delavirdine mesylate tablets)", "approval_status": "Approved April 1997", "company": "Pharmacia & Upjohn", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "ABREVA (docosanol)", "approval_status": "Approved July 2000", "company": "AVANIR PHARMACEUTICALS", "specific_treatment": "oral-facial herpes simplex"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Xigris (drotrecogin alfa [activated])", "approval_status": "Approved November 2001", "company": "Eli Lilly", "specific_treatment": "Severe sepsis"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Viread (tenofovir disoproxil fumarate)", "approval_status": "Approved October 2001", "company": "Gilead", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Rebetol (ribavirin)", "approval_status": "Approved July 2001", "company": "Schering-Plough", "specific_treatment": "Hepatitis C"},
{"therapeutic_areas": ["Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Peg-Intron (peginterferon alfa-2b)", "approval_status": "Approved January 2001", "company": "Schering-Plough", "specific_treatment": "Chronic hepatitis C"},
{"therapeutic_areas": ["Dermatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Lamisil Solution, 1%", "approval_status": "Approved March 2001", "company": "Novartis", "specific_treatment": "Dermatologic infections"},
{"therapeutic_areas": ["Dermatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Bactroban Cream", "approval_status": "Approved December 1997", "company": "SmithKline Beecham", "specific_treatment": "secondarily infected traumatic skin lesions"},
{"therapeutic_areas": ["Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "REBETRON (TM) Combination Therapy", "approval_status": "Approved June 1998", "company": "Schering-Plough", "specific_treatment": "hepatitis C"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Vfend (voriconazole)", "approval_status": "Approved May 2002", "company": "Pfizer", "specific_treatment": "Fungal infections"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Lotronex (alosetron HCL) Tablets", "approval_status": "Approved February 2000", "company": "GlaxoSmithKline", "specific_treatment": "For non-constipated women with IBS who experience diarrhea as their predominant bowel symptom"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Pegasys (peginterferon alfa-2a)", "approval_status": "Approved October 2002", "company": "Roche", "specific_treatment": "Hepatitis C"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Children's Motrin Cold", "approval_status": "Approved August 2000", "company": "McNeil Consumer Products", "specific_treatment": "For the temporary relief of common cold symptoms"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Hepsera (adefovir dipivoxil)", "approval_status": "Approved September 2002", "company": "Gilead", "specific_treatment": "Chronic Hepatitis B"},
{"therapeutic_areas": ["Dermatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Botox Cosmetic (botulinum toxin type A)", "approval_status": "Approved April 2002", "company": "Allergan", "specific_treatment": "Brow furrow / frown lines"},
{"therapeutic_areas": ["Hematology", "Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Reyataz (atazanavir sulfate)", "approval_status": "Approved July 2003", "company": "Bristol-Myers Squibb", "specific_treatment": "HIV Infection"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Fuzeon (enfuvirtide)", "approval_status": "Approved March 2003", "company": "Trimeris, Roche", "specific_treatment": "HIV Infection"},
{"therapeutic_areas": ["Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Baraclude (entecavir)", "approval_status": "Approved March, 2005", "company": "Bristol-Myers Squibb", "specific_treatment": "Hepatitis B"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Aptivus (tipranavir)", "approval_status": "Approved June, 2005", "company": "Boehringer Ingelheim", "specific_treatment": "HIV Infection"},
{"therapeutic_areas": ["Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Tyzeka (telbivudine)", "approval_status": "Approved October 2006", "company": "Idenix Pharma", "specific_treatment": "hepatitis B virus"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Cancidas", "approval_status": "Approved January 2001", "company": "Merck", "specific_treatment": "Life-threatening fungal infections"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Noxafil (posaconazole)", "approval_status": "Approved in September 2006", "company": "Schering-Plough", "specific_treatment": "Fungal infections"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Eraxis (anidulafungin)", "approval_status": "Approved February 2006", "company": "Pfizer", "specific_treatment": "Fungal infections"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Selzentry (maraviroc)", "approval_status": "Approved August 2007", "company": "Pfizer", "specific_treatment": "CCR5-tropic HIV-1"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Isentress (raltegravir)", "approval_status": "Approved October 2007", "company": "Merck", "specific_treatment": "HIV-1"},
{"therapeutic_areas": ["Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Viread (tenofovir disoproxil fumarate)", "approval_status": "Approved August 2008", "company": "Gilead", "specific_treatment": "hepatitis B"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Intelence (etravirine)", "approval_status": "Approved January 2008", "company": "Tibotec", "specific_treatment": "HIV-1"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Lexiva (fosamprenavir calcium)", "approval_status": "Approved October 2003", "company": "GlaxoSmithKline", "specific_treatment": "HIV Infection"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Victrelis (boceprevir)", "approval_status": "Approved May 2011", "company": "Merck", "specific_treatment": "chronic hepatitis C genotype 1"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Fortovase", "approval_status": "Approved November 1997", "company": "Roche", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Firazyr (icatibant)", "approval_status": "Approved August of 2011", "company": "Shire Pharmaceuticals", "specific_treatment": "acute attacks of hereditary angioedema"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Edurant (rilpivirine)", "approval_status": "Approved May 2011", "company": "Tibotec", "specific_treatment": "HIV-1"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Prezista (darunavir)", "approval_status": "Approved June 2006", "company": "Tibotec", "specific_treatment": "HIV Infections"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Dificid (fidaxomicin)", "approval_status": "Approved May 2011", "company": "Optimer Pharmaceuticals", "specific_treatment": "Clostridium difficile-associated diarrhea"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate)", "approval_status": "Approved August of 2011", "company": "Gilead", "specific_treatment": "HIV-1 in treatment-naive adults"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate)", "approval_status": "Approved August 2012", "company": "Gilead", "specific_treatment": "HIV-1 infection"},
{"therapeutic_areas": ["Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Sustiva", "approval_status": "Approved February 2002", "company": "Bristol-Myers Squibb", "specific_treatment": "HIV infection"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Linzess (linaclotide)", "approval_status": "Approved August 2012", "company": "Forest Labs and Ironwood Pharmaceuticals", "specific_treatment": "irritable bowel syndrome with constipation and chronic idiopathic constipation"},
{"therapeutic_areas": ["Infections and Infectious Diseases"], "name": "Abthrax (raxibacumab)", "approval_status": "Approved December of 2012", "company": "GlaxoSmithKline", "specific_treatment": "anthrax"},
{"therapeutic_areas": ["Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Sovaldi (sofosbuvir)", "approval_status": "December of 2013", "company": "Gilead Sciences", "specific_treatment": "hepatitis C"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Sitavig (acyclovir) buccal tablets", "approval_status": "Approved April 2013", "company": "BioAlliance Pharma", "specific_treatment": "recurrent herpes labialis"},
{"therapeutic_areas": ["Family Medicine", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Olysio (simeprevir)", "approval_status": "November of 2013", "company": "Janssen Therapeutics", "specific_treatment": "hepatitis C"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Vibativ (telavancin)", "approval_status": "Approved September 2009", "company": "Theravance", "specific_treatment": "complicated skin and skin structure infections"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Triumeq (abacavir, dolutegravir, and lamivudine)", "approval_status": "Approved August 2014", "company": "ViiV HealthCare", "specific_treatment": "HIV-1"},
{"therapeutic_areas": ["Dermatology", "Infections and Infectious Diseases"], "name": "Sivextro (tedizolid phosphate) ", "approval_status": "Approved June 2014", "company": "Cubist Pharmaceuticals", "specific_treatment": "acute bacterial skin and skin structure  infections"},
{"therapeutic_areas": ["Family Medicine", "Infections and Infectious Diseases"], "name": "Rapivab (peramivir injection)", "approval_status": "Approved December 2014", "company": "Biocryst", "specific_treatment": "treatment of acute uncomplicated influenza in adults"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Incivek (telaprevir)", "approval_status": "Approved May 2011", "company": "Vertex Pharmaceuticals", "specific_treatment": "genotype 1 chronic hepatitis C"},
{"therapeutic_areas": ["Dermatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Kerydin (tavaborole)", "approval_status": "Approved July 2014", "company": "Anacor", "specific_treatment": "onychomycosis of the toenails"},
{"therapeutic_areas": ["Dermatology", "Infections and Infectious Diseases"], "name": "Jublia (efinaconazole) 10% topical gel", "approval_status": "Approved June 2014", "company": "Valeant Pharmaceuticals", "specific_treatment": "onychomycosis of the toenails"},
{"therapeutic_areas": ["Infections and Infectious Diseases"], "name": "Impavido (miltefosine)", "approval_status": "Approved March 2014", "company": "Knight Therapeutics", "specific_treatment": "visceral, cutaneous and mucosal leishmanias"},
{"therapeutic_areas": ["Nephrology", "Infections and Infectious Diseases"], "name": "Harvoni (ledipasvir and sofosbuvir)", "approval_status": "Approved October 2014", "company": "Gilead", "specific_treatment": "hepatitis C"},
{"therapeutic_areas": ["Gastroenterology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Zelnorm (tegaserod maleate) Tablets", "approval_status": "Approved July 2002", "company": "Novartis", "specific_treatment": "irritable bowel syndrome (IBS)"},
{"therapeutic_areas": ["Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Technivie, (ombitasvir, paritaprevir and ritonavir)", "approval_status": "Approved July 2015", "company": "Abbvie", "specific_treatment": "chronic HCV genotype 4"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Prezcobix (darunavir and cobicistat)", "approval_status": "Approved January 2015", "company": "Janssen", "specific_treatment": "HIV-1 infection"},
{"therapeutic_areas": ["Gastroenterology", "Immunology", "Infections and Infectious Diseases"], "name": "Mytesi (crofelemer)", "approval_status": "Approved December 2012", "company": "Napo Pharmaceuticals", "specific_treatment": "non-infectious diarrhea in adults with HIV/AIDS"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)", "approval_status": "Approved November 2015", "company": "Gilead Sciences", "specific_treatment": "HIV-1 infection"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Evotaz (atazanavir and cobicistat) ", "approval_status": "Approved January 2015", "company": "Bristol-Myers Squibb", "specific_treatment": "HIV-1 infection"},
{"therapeutic_areas": ["Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Daklinza (daclatasvir) ", "approval_status": "Approved July 2015", "company": "Bristol-Myers Squibb", "specific_treatment": "chronic HCV genotype 3"},
{"therapeutic_areas": ["Family Medicine", "Infections and Infectious Diseases"], "name": "Cresemba (isavuconazonium sulfate) ", "approval_status": "Approved March 2015 ", "company": "Astellas", "specific_treatment": "invasive aspergillosis and invasive mucormycosis"},
{"therapeutic_areas": ["Gastroenterology", "Infections and Infectious Diseases"], "name": "Zinplava (bezlotoxumab)", "approval_status": "Approved October 2016", "company": "Merck", "specific_treatment": "recurrent Clostridium difficile infection in patients receiving antibacterial treatment"},
{"therapeutic_areas": ["Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Zepatier (elbasvir and grazoprevir)", "approval_status": "Approved January 2016", "company": "Merck", "specific_treatment": " chronic HCV genotypes 1 or 4 "},
{"therapeutic_areas": ["Hepatology (Liver, Pancreatic, Gall Bladder)", "Infections and Infectious Diseases"], "name": "Vemlidy (tenofovir alafenamide)", "approval_status": "Approved November 2016", "company": "Gilead Sciences", "specific_treatment": "chronic hepatitis B "},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide)", "approval_status": "Approved March 2016", "company": "Gilead Sciences", "specific_treatment": "HIV-1 infection"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Epclusa (sofosbuvir and velpatasvir) ", "approval_status": "Approved June 2016", "company": "Gilead Sciences", "specific_treatment": "hepatitis C"},
{"therapeutic_areas": ["Dermatology", "Infections and Infectious Diseases"], "name": "Orbactiv (oritavancin)", "approval_status": "Approved August 2014", "company": "The Medicines Company", "specific_treatment": "acute bacterial skin and skin structure  infections"},
{"therapeutic_areas": ["Infections and Infectious Diseases"], "name": "Anthim (obiltoxaximab)", "approval_status": "Approved March 2016", "company": "Elusys Therapeutics", "specific_treatment": "inhalational anthrax "},
{"therapeutic_areas": ["Musculoskeletal", "Neurology"], "name": "Zanaflex (tizanidine hydrochloride)", "approval_status": "Approved December 1996", "company": "Elan Pharmaceuticals", "specific_treatment": "muscle spasticity"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Tegretol XR (carbamazepine)", "approval_status": "Approved May 1996", "company": "Ciba-Geigy", "specific_treatment": "epileptic seizures"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Depakote (divalproex sodium)", "approval_status": "Approved June 1996", "company": "Abbott Laboratories", "specific_treatment": "epilepsy"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Topamax (topiramate)", "approval_status": "Approved January 1997", "company": "Ortho-McNeil Pharmaceutical", "specific_treatment": "partial onset seizures"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Selegiline tablets", "approval_status": "Approved January 1997", "company": "Teva Pharmaceutical", "specific_treatment": "Parkinson\u2019s disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Requip (ropinirole hydrochloride)", "approval_status": "Approved September 1997", "company": "SmithKline Beecham", "specific_treatment": "Parkinson's Disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Pramipexole", "approval_status": "Approved July 1997", "company": "Pharmacia & Upjohn", "specific_treatment": "Parkinson's Disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg)", "approval_status": "Approved February 1997", "company": "Watson Pharmaceuticals", "specific_treatment": "moderate pain"},
{"therapeutic_areas": ["Nephrology", "Infections and Infectious Diseases"], "name": "Viekira Pak (ombitasvir, paritaprevir, ritonavir and dasabuvir) tablets", "approval_status": "Approved December 2014", "company": "Abbvie", "specific_treatment": " genotype 1 chronic hepatitis C virus"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Migranal", "approval_status": "Approved December 1997", "company": "Novartis", "specific_treatment": "migraine"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Imitrex (sumatriptan) nasal spray", "approval_status": "Approved November 1997", "company": "GlaxoSmithKline", "specific_treatment": "migraine"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Imitrex (sumatriptan) injection and tablets", "approval_status": "Approved August 1997", "company": "GlaxoSmithKline", "specific_treatment": "migraine headaches"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Copaxone", "approval_status": "Approved January 1997", "company": "Teva Pharmaceutical", "specific_treatment": "Relapsing-remitting multiple sclerosis"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Carbatrol", "approval_status": "Approved September 1997", "company": "Elan Pharmaceuticals", "specific_treatment": "anticonvulsant and trigeminal neuralgia"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Zomig (zolmitriptan)", "approval_status": "Approved November 1997", "company": "AstraZeneca", "specific_treatment": "migraine"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Tasmar", "approval_status": "Approved January 1998", "company": "Roche", "specific_treatment": "Parkinson's Disease"},
{"therapeutic_areas": ["Neurology"], "name": "Oxycodone and Aspirin", "approval_status": "Approved March 1998", "company": "Watson Pharmaceuticals", "specific_treatment": "analgesic"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Maxalt", "approval_status": "Approved June 1998", "company": "Merck", "specific_treatment": "Migraine Headaches"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Excedrin Migraine", "approval_status": "Approved January 1998", "company": "Bristol-Myers Squibb", "specific_treatment": "Mild-to-moderate migraine"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Clonazepam", "approval_status": "Approved January 1998", "company": "Watson Pharmaceuticals", "specific_treatment": "anticonvulsant"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Amerge", "approval_status": "Approved February 1998", "company": "GlaxoSmithKline", "specific_treatment": "acute migraine"},
{"therapeutic_areas": ["Neurology"], "name": "Lidoderm Patch (lidocaine patch 5% )", "approval_status": "Approved June 1999", "company": "Hind Health Care", "specific_treatment": "Neurology"},
{"therapeutic_areas": ["Neurology"], "name": "Lamictal (lamotrigine) Chewable Dispersible Tablets", "approval_status": "Approved June 1999", "company": "GlaxoSmithKline", "specific_treatment": "Neurology"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Keppra", "approval_status": "Approved November 1999", "company": "UCB", "specific_treatment": "Antiepileptic drug indicated in the treatment of partial onset seizures in adults with epilepsy"},
{"therapeutic_areas": ["Immunology", "Infections and Infectious Diseases"], "name": "Descovy (emtricitabine and tenofovir alafenamide)", "approval_status": "Approved April 2016", "company": "Gilead", "specific_treatment": "HIV-1 infection"},
{"therapeutic_areas": ["Endocrinology", "Hematology", "Neurology", "Family Medicine"], "name": "Aggrenox", "approval_status": "Approved November 1999", "company": "Boehringer Ingelheim", "specific_treatment": "Indicated for the prevention of stroke in patients who have experienced a previous stroke or a TIA (mini-stroke)"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Zonegran (zonisamide) Capsules", "approval_status": "Approved March 2000", "company": "Dainippon Pharmaceutical", "specific_treatment": "Adjunctive therapy for treatment of partial seizures in adults with epilepsy"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Novantrone (mitoxantrone hydrochloride)", "approval_status": "Approved October 2000", "company": "Immunex", "specific_treatment": "Reduction of neurologic disability and/or the frequency of clinical relapses in patients with multiple sclerosis"},
{"therapeutic_areas": ["Dermatology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Dalvance (dalbavancin)", "approval_status": "Approved May 2014", "company": "Durata Therapeutics", "specific_treatment": "acute bacterial skin and skin structure infections"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Neurontin (gabapentin) oral solution", "approval_status": "Approved March 2000", "company": "Parke-Davis", "specific_treatment": "Adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults w/ epilepsy"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Lamictal Chewable Dispersible Tablets", "approval_status": "Approved August 1998", "company": "GlaxoSmithKline", "specific_treatment": "Epilepsy"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Zomig (zolmitriptan)", "approval_status": "Approved February 2001", "company": "AstraZeneca", "specific_treatment": "Migraine"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Ultracet (acetaminophen and tramadol HCl)", "approval_status": "Approved August 2001", "company": "Ortho-McNeil Pharmaceutical", "specific_treatment": "Acute pain"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Reminyl (galantamine hydrobromide)", "approval_status": "Approved February 2001", "company": "Janssen Pharmaceuticals", "specific_treatment": "Mild to moderate dementia of the Alzheimer's type"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Mirapex", "approval_status": "Approved June 1997", "company": "Pharmacia & Upjohn, Boehringer Ingelheim", "specific_treatment": "Parkinson\u2019s Disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Bayer Extra Strength Asprin", "approval_status": "Approved October 2001", "company": "Bayer", "specific_treatment": "Migraine"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Axert (almotriptan malate) tablets", "approval_status": "Approved May 2001", "company": "Pharmacia & Upjohn", "specific_treatment": "Migraine with or without aura in adults"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Relpax (eletriptan hydrobromide)", "approval_status": "Approved December 2002", "company": "Pfizer", "specific_treatment": "Migraine Headaches"},
{"therapeutic_areas": ["Immunology", "Family Medicine"], "name": "Carrington patch", "approval_status": "Approved May 1996", "company": "Carrington Laboratories", "specific_treatment": "canker sores, oral wounds, mouth sores, ulcers, and injuries"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Exelon (rivastigmine tartrate)", "approval_status": "Approved April 2000", "company": "Novartis", "specific_treatment": "Indicated for the treatment of mild to moderate dementia of the Alzheimer's type"},
{"therapeutic_areas": ["Infections and Infectious Diseases"], "name": "Fluad (trivalent influenza vaccine)", "approval_status": "Approved November 2015", "company": "Seqirus", "specific_treatment": "influenza A and B"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Namenda (memantine HCl)", "approval_status": "Approved October 2003", "company": "Forest Laboratories", "specific_treatment": "Alzheimer's Disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Lyrica (pregabalin)", "approval_status": "Approved December 2004", "company": "Pfizer", "specific_treatment": "Neuropathic Pain"},
{"therapeutic_areas": ["Neurology"], "name": "Lunesta (eszopiclone)", "approval_status": "Approved December 2004", "company": "Sepracor", "specific_treatment": "Insomnia"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Apokyn (apomorphine hydrochloride)", "approval_status": "Approved April, 2004", "company": "Mylan Laboratories", "specific_treatment": "Parkinson's Disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Tysabri (natalizumab)", "approval_status": "Approved November 2004 -- Updated: Suspended February 2005--Updated: sBLA", "company": "Elan Pharmaceuticals / Biogen Idec", "specific_treatment": "Multiple Sclerosis"},
{"therapeutic_areas": ["Neurology"], "name": "Xyrem (sodium oxybate)", "approval_status": "Approved July 2002", "company": "Orphan Medical", "specific_treatment": "Cataplexy associated with narcolepsy"},
{"therapeutic_areas": ["Neurology"], "name": "Rozerem (ramelteon)", "approval_status": "Approved July, 2005", "company": "Takeda", "specific_treatment": "Insomnia"},
{"therapeutic_areas": ["Neurology"], "name": "Nuvigil (armodafinil)", "approval_status": "Approved June 2007", "company": "Cephalon", "specific_treatment": "excessive sleepiness"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Neupro (rotigotine)", "approval_status": "Approved May 2007", "company": "Schwarz Pharma", "specific_treatment": "Parkinson's disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Exelon (rivastigmine tartrate)", "approval_status": "Approved July 2007", "company": "Novartis", "specific_treatment": "Alzheimer's and Parkinson's disease-related dementia"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology"], "name": "Xenazine (tetrabenazine)", "approval_status": "Approved August 2008", "company": "Prestwick Pharma", "specific_treatment": "chorea due to Huntington's disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Vimpat (lacosamide)", "approval_status": "Approved October 2008", "company": "Schwarz Pharma", "specific_treatment": "partial-onset seizures in adults with epilepsy"},
{"therapeutic_areas": ["Neurology"], "name": "Nucynta (tapentadol)", "approval_status": "Approved November 2008", "company": "Ortho-McNeil Pharmaceutical", "specific_treatment": "acute pain"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Family Medicine"], "name": "Avinza (morphine sulfate)", "approval_status": "Approved March 2002", "company": "Elan Pharmaceuticals", "specific_treatment": "Chronic pain"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Zipsor (diclofenac potassium)", "approval_status": "Approved June 2009", "company": "Xanodyne Pharmaceuticals", "specific_treatment": "mild to moderate acute pain"},
{"therapeutic_areas": ["Immunology", "Neurology"], "name": "Qutenza (capsaicin)", "approval_status": "Approved November 2009", "company": "NeurogesX", "specific_treatment": "neuropathic pain associated with postherpetic neuralgia"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Family Medicine"], "name": "Extavia (Interferon beta-l b)", "approval_status": "Approved August of 2009", "company": "Novartis", "specific_treatment": "relapsing multiple sclerosis"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Embeda (morphine sulfate and naltrexone hydrochloride)", "approval_status": "Approved August of 2009", "company": "King Pharmaceuticals", "specific_treatment": "moderate to severe pain"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Cambia (diclofenac potassium for oral solution)", "approval_status": "Approved June of 2009", "company": "Kowa Pharmaceuticals", "specific_treatment": "migraine attacks"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Frova (frovatriptan succinate)", "approval_status": "Approved November 2001", "company": "Elan Pharmaceuticals", "specific_treatment": "Migraine attacks"},
{"therapeutic_areas": ["Hematology", "Neurology", "Genetic Disease"], "name": "Vpriv (velaglucerase alfa for injection)", "approval_status": "Approved March 2010", "company": "Shire Pharmaceuticals", "specific_treatment": "Gaucher disease"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Sprix (ketorolac tromethamine)", "approval_status": "Approved May 2010", "company": "Roxro Pharma", "specific_treatment": "moderate to severe pain"},
{"therapeutic_areas": ["Neurology"], "name": "Nuedexta (dextromethorphan hydrobromide and quinidine sulfate)", "approval_status": "Approved October 2010", "company": "Avanir Pharmaceuticals", "specific_treatment": "pseudobulbar affect"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Comtan", "approval_status": "October 19, 1999", "company": "Novartis", "specific_treatment": "For Parkinson's patients being treated with levodopa therapy who experience end-of-dose \"wearing off\""},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Exalgo (hydromorphone hydrochloride) extended release", "approval_status": "Approved March 2010", "company": "Alza", "specific_treatment": "moderate to severe pain"},
{"therapeutic_areas": ["Nephrology", "Neurology"], "name": "Carbaglu (carglumic acid)", "approval_status": "Approved March 2010", "company": "Recordati", "specific_treatment": "hyperammonemia"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Butrans (buprenorphine) Transdermal System", "approval_status": "Approved July 2010", "company": "Purdue Pharma", "specific_treatment": "chronic pain"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Family Medicine"], "name": "Botox (onabotulinumtoxinA)", "approval_status": "Approved March 2010", "company": "Allergan", "specific_treatment": "upper limb spasticity"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Botox (onabotulinumtoxinA)", "approval_status": "Approved October 2010", "company": "Allergan", "specific_treatment": "chronic migraine"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Family Medicine"], "name": "Ampyra (dalfampridine)", "approval_status": "Approved January 2010", "company": "Acorda", "specific_treatment": "walking in patients with multiple sclerosis"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Rebif (interferon beta-1a)", "approval_status": "Approved March 2002", "company": "Serono Laboratories", "specific_treatment": "Multiple sclerosis"},
{"therapeutic_areas": ["Neurology", "Family Medicine", "Genetic Disease"], "name": "Potiga (ezogabine)", "approval_status": "Approved June 2011", "company": "Valeant Pharmaceuticals", "specific_treatment": "partial-onset seizures"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Family Medicine"], "name": "Neupro (Rotigotine Transdermal System)", "approval_status": "Approved April 2012", "company": "UCB", "specific_treatment": "Restless Legs Syndrome"},
{"therapeutic_areas": ["Neurology"], "name": "Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules", "approval_status": "Approved October 2013", "company": "Zogenix", "specific_treatment": "severe pain"},
{"therapeutic_areas": ["Neurology"], "name": "Lusedra (fospropofol disodium)", "approval_status": "Approved December of 2008", "company": "Elan Pharmaceuticals", "specific_treatment": "sedation and anesthesia"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Xartemis XR (oxycodone hydrochloride and acetaminophen) extended release", "approval_status": "Approved March 2014", "company": "Mallinckrodt Pharmaceuticals", "specific_treatment": "management of acute pain"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Tivorbex (indomethacin)", "approval_status": "Approved February of 2014", "company": "Iroko Pharmaceuticals", "specific_treatment": "acute pain"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology", "Family Medicine"], "name": "Targiniq ER (oxycodone hydrochloride + naloxone hydrochloride) extended-release tablets", "approval_status": "Approved July 2014", "company": "Purdue Pharma", "specific_treatment": "severe chronic pain"},
{"therapeutic_areas": ["Immunology", "Musculoskeletal", "Neurology", "Family Medicine"], "name": "Plegridy (peginterferon beta-1a)", "approval_status": "Approved August 2014", "company": "Biogen IDEC.", "specific_treatment": "relapsing multiple sclerosis"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Northera (droxidopa)", "approval_status": "Approved February 2014", "company": "Chelsea Therapeutics", "specific_treatment": "neurogenic orthostatic hypotension"},
{"therapeutic_areas": ["Neurology"], "name": "Namzaric (memantine hydrochloride extended-release + donepezil hydrochloride)", "approval_status": "Approved December 2014", "company": "Forest Laboratories", "specific_treatment": "moderate to severe dementia of the Alzheimer's type"},
{"therapeutic_areas": ["Nephrology", "Neurology"], "name": "Xifaxan (rifaximin)", "approval_status": "Approved March 2010", "company": "Salix Pharmaceuticals", "specific_treatment": "hepatic encephalopathy"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Dyloject (diclofenac sodium) Injection", "approval_status": "Approved December 2014", "company": "Hospira", "specific_treatment": "mild, moderate or severe pain"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Belsomra (suvorexant)", "approval_status": "Approved August 2014", "company": "Merck", "specific_treatment": "insomnia"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology"], "name": "Vivlodex (meloxicam) ", "approval_status": "Approved October 2015", "company": "Iroko Pharmaceuticals", "specific_treatment": "osteoarthritis pain"},
{"therapeutic_areas": ["Neurology"], "name": "Rytary (carbidopa and levodopa) extended-release capsules", "approval_status": "Approved January 2015", "company": "Impax Labs", "specific_treatment": "Parkinson's disease"},
{"therapeutic_areas": ["Neurology"], "name": "Duopa (carbidopa and levodopa) enteral suspension ", "approval_status": "Approved January 2015", "company": "Abbvie", "specific_treatment": "motor fluctuations in patients with advanced Parkinson's disease"},
{"therapeutic_areas": ["Neurology"], "name": "Belbuca (buprenorphine) ", "approval_status": "Approved October 2015", "company": "Endo Pharmaceuticals", "specific_treatment": "severe pain"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology"], "name": "Zinbryta (daclizumab) ", "approval_status": "Approved May 2016", "company": "Biogen", "specific_treatment": "relapsing multiple sclerosis"},
{"therapeutic_areas": ["Neurology", "Family Medicine"], "name": "Onzetra Xsail (sumatriptan nasal powder) ", "approval_status": "Approved January 2016", "company": "Avanir", "specific_treatment": "migraine"},
{"therapeutic_areas": ["Neurology"], "name": "Nuplazid (pimavanserin)", "approval_status": "Approved April 2016", "company": "Acadia Pharmaceuticals", "specific_treatment": "hallucinations and delusions associated with Parkinson\u2019s disease"},
{"therapeutic_areas": ["Neurology"], "name": "Carnexiv (carbamazepine)", "approval_status": "Approved October 2016", "company": "Lundbeck", "specific_treatment": "seizures"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology"], "name": "Lemtrada (alemtuzumab)", "approval_status": "Approved November 2014", "company": "Genzyme", "specific_treatment": "multiple sclerosis"},
{"therapeutic_areas": ["Endocrinology"], "name": "Adlyxin (lixisenatide)", "approval_status": "Approved July 2016", "company": "Sanofi Aventis", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Neurology"], "name": "Troxyca ER (oxycodone + naltrexone)", "approval_status": "Approved August 2016", "company": "Pfizer", "specific_treatment": "severe pain"},
{"therapeutic_areas": ["Endocrinology"], "name": "Levoxyl", "approval_status": "Approved May 2001", "company": "Jones Pharma", "specific_treatment": "Thyroid disease; Hypothyroidism"},
{"therapeutic_areas": ["Endocrinology"], "name": "Synthroid (levothyroxine sodium)", "approval_status": "Approved July 2002", "company": "Abbott Laboratories", "specific_treatment": "Hypothyroidism and suppression of thyroid-stimulating hormone"},
{"therapeutic_areas": ["Dermatology", "Immunology", "Neurology", "Family Medicine", "Infections and Infectious Diseases"], "name": "Gralise (gabapentin)", "approval_status": "Approved February 2011", "company": "Abbott Laboratories", "specific_treatment": "postherpetic neuralgia"},
{"therapeutic_areas": ["Endocrinology"], "name": "Increlex (mecasermin)", "approval_status": "Approved August 2005", "company": "Tercica", "specific_treatment": "Growth Failure"},
{"therapeutic_areas": ["Endocrinology"], "name": "Fortesta (testosterone gel)", "approval_status": "Approved December 2010", "company": "Endo Pharmaceuticals", "specific_treatment": "hypogonadism"},
{"therapeutic_areas": ["Endocrinology"], "name": "Signifor (pasireotide diaspartate)", "approval_status": "Approved December of 2012", "company": "Novartis", "specific_treatment": "Cushing's disease"},
{"therapeutic_areas": ["Endocrinology"], "name": "Humatrope (somatropin [rDNA origin] for injection)", "approval_status": "Approved August 1996", "company": "Eli Lilly", "specific_treatment": "Somatropin Deficiency Syndrome"},
{"therapeutic_areas": ["Endocrinology"], "name": "Desmopressin Acetate (DDAVP)", "approval_status": "Approved February 1996", "company": "Rhone Poulenc Rorer", "specific_treatment": "central diabetes insipidus"},
{"therapeutic_areas": ["Endocrinology"], "name": "Testoderm TTS CIII", "approval_status": "Approved December 1997", "company": "Alza", "specific_treatment": "testosterone deficiency"},
{"therapeutic_areas": ["Endocrinology"], "name": "Novothyrox (levothyroxine sodium)", "approval_status": "Approved May 2002", "company": "Genpharm", "specific_treatment": "Hypothyroidism and suppression of thyroid-stimulating hormone"},
{"therapeutic_areas": ["Endocrinology"], "name": "Levo-T (levothyroxine sodium)", "approval_status": "Approved March 2002", "company": "Mova Pharmaceutical", "specific_treatment": "Hypothyroidism"},
{"therapeutic_areas": ["Endocrinology"], "name": "Xenical/Orlistat Capsules", "approval_status": "Approved April 1999", "company": "Roche", "specific_treatment": "Endocrinology"},
{"therapeutic_areas": ["Endocrinology"], "name": "Xigduo XR (dapagliflozin + metformin hydrochloride)", "approval_status": "Approved October 2014", "company": "AstraZeneca", "specific_treatment": "glycemic control in adults with type II diabetes"},
{"therapeutic_areas": ["Endocrinology"], "name": "Nutropin (somatropin-rDNA origin)", "approval_status": "Approved January 1996", "company": "Genentech", "specific_treatment": "liquid growth hormone"},
{"therapeutic_areas": ["Endocrinology"], "name": "Cernevit", "approval_status": "Approved April 1999.", "company": "Baxter Healthcare", "specific_treatment": "Diet/Nutrition"},
{"therapeutic_areas": ["Endocrinology"], "name": "ACTOS", "approval_status": "Approved July 1999", "company": "Takeda", "specific_treatment": "Endocrinology"},
{"therapeutic_areas": ["Dental and Oral Health"], "name": "Periostat (doxycycline hyclate)", "approval_status": "Approved October 1998", "company": "CollaGenex  Pharmaceuticals", "specific_treatment": "Dental"},
{"therapeutic_areas": ["Dental and Oral Health"], "name": "Atridox", "approval_status": "Approved September 1998", "company": "Atrix Laboratories", "specific_treatment": "Periodontal disease"},
{"therapeutic_areas": ["Dental and Oral Health"], "name": "Atridox", "approval_status": "Approved January 1999", "company": "Atrix Laboratories", "specific_treatment": "Dental/Maxillofacial Surgery"},
{"therapeutic_areas": ["Dental and Oral Health"], "name": "Periostat (doxycycline hyclate)", "approval_status": "Approved February 2001", "company": "CollaGenex  Pharmaceuticals", "specific_treatment": "Periodontal disease"},
{"therapeutic_areas": ["Dental and Oral Health"], "name": "Arestin (minocycline hydrochloride)", "approval_status": "Approved February 2001", "company": "OraPharma", "specific_treatment": "Periodontal disease"},
{"therapeutic_areas": ["Endocrinology"], "name": "Nutropin (somatropin-rDNA origin)", "approval_status": "Approved December 1997", "company": "Genentech", "specific_treatment": "growth hormone deficiency"},
{"therapeutic_areas": ["Endocrinology"], "name": "Dostinex Tablets (cabergoline tablets)", "approval_status": "Approved January 1997", "company": "Pharmacia & Upjohn", "specific_treatment": "hyperprolactinemic disorders"},
{"therapeutic_areas": ["Dermatology"], "name": "Ameluz (aminolevulinic acid hydrochloride)", "approval_status": "Approved May 2016", "company": "Biofrontera Pharma", "specific_treatment": "actinic keratoses"},
{"therapeutic_areas": ["Endocrinology"], "name": "Vogelxo (testosterone) gel", "approval_status": "Approved June 2014", "company": "Upsher-Smith", "specific_treatment": "For males with a deficiency or absence of endogenous  testosterone"},
{"therapeutic_areas": ["Dermatology"], "name": "Renova (tretinoin emollient cream)", "approval_status": "Approved December 1995", "company": "Johnson & Johnson", "specific_treatment": "facial wrinkles, brown spots, and surface roughness of the skin"},
{"therapeutic_areas": ["Dermatology"], "name": "Thalomid", "approval_status": "Approved July 1998", "company": "Celgene", "specific_treatment": "Dermatology"},
{"therapeutic_areas": ["Dermatology"], "name": "MetroLotion", "approval_status": "Approved November 1998", "company": "Galderma Laboratories", "specific_treatment": "Dermatology"},
{"therapeutic_areas": ["Dermatology"], "name": "Lustra", "approval_status": "Approved January 1998", "company": "Medicis Pharmaceutical", "specific_treatment": "ultraviolet-induced skin discolorations"},
{"therapeutic_areas": ["Dermatology"], "name": "Luxiq (betamethasone valerate) Foam", "approval_status": "Approved June 1999", "company": "Connetics Corporation", "specific_treatment": "Dermatology"},
{"therapeutic_areas": ["Endocrinology"], "name": "Avandia (rosiglitazone maleate)", "approval_status": "Approved June 1999", "company": "SmithKline Beecham", "specific_treatment": "Endocrinology"},
{"therapeutic_areas": ["Dermatology"], "name": "Lamisil (terbinafine hydrochloride) Dermagel, 1%", "approval_status": "Approved March 1999", "company": "Novartis", "specific_treatment": "Dermatology"},
{"therapeutic_areas": ["Dermatology"], "name": "Skin Exposure Reduction Paste Against Chemical Warfare Agents (SERPACWA)", "approval_status": "Approved February 2000", "company": "US Army Medical Research, Material Command", "specific_treatment": "For use in conjunction with MOPP gear to reduce the absorption of chemical warfare agents through the skin"},
{"therapeutic_areas": ["Dermatology"], "name": "Chloraprep (chlorhexidine gluconate)", "approval_status": "Approved July 2000", "company": "MEDI FLEX HOSP PRODUCTS", "specific_treatment": "Preoperative skin preparation"},
{"therapeutic_areas": ["Dermatology"], "name": "Zyclara (imiquimod)", "approval_status": "Approved March 2010", "company": "Graceway", "specific_treatment": "actinic keratoses"},
{"therapeutic_areas": ["Dermatology"], "name": "Mirvaso (brimonidine)", "approval_status": "Approved August 2013", "company": "Galderma Labs", "specific_treatment": "facial erythema of rosacea"},
{"therapeutic_areas": ["Dermatology"], "name": "Soolantra (ivermectin) cream, 1%", "approval_status": "Approved December 2014", "company": "Galderma Labs", "specific_treatment": "inflammatory lesions of rosacea"},
{"therapeutic_areas": ["Dermatology"], "name": "Eucrisa\u007f (crisaborole) ointment", "approval_status": "Approved December 2016", "company": "Pfizer", "specific_treatment": "atopic dermatitis\u007f"},
{"therapeutic_areas": ["Endocrinology"], "name": "Signifor LAR (pasireotide)", "approval_status": "Approved December 2014", "company": "Novartis", "specific_treatment": "acromegaly"},
{"therapeutic_areas": ["Neurology"], "name": "Aptiom (eslicarbazepine acetate)", "approval_status": "Approved November 2013", "company": "Sunovion Pharmaceuticals", "specific_treatment": "partial-onset seizures"},
{"therapeutic_areas": ["Endocrinology"], "name": "Tresiba (insulin degludec injection)", "approval_status": "Approved September 2015", "company": "Novo Nordisk", "specific_treatment": "glycemic control in adults with diabetes mellitus"},
{"therapeutic_areas": ["Endocrinology"], "name": "AndroGel testosterone gel", "approval_status": "Approved February 2000", "company": "Unimed Pharmaceuticals", "specific_treatment": "For replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone"},
{"therapeutic_areas": ["Dermatology"], "name": "laViv (azficel-T)", "approval_status": "Approved June 2011", "company": "Fibrocell Science", "specific_treatment": "nasolabial fold wrinkles"},
{"therapeutic_areas": ["Musculoskeletal", "Neurology"], "name": "Myobloc", "approval_status": "Approved December 2000", "company": "Elan Pharmaceuticals", "specific_treatment": "Cervical dystonia"},
{"therapeutic_areas": ["Endocrinology"], "name": "Synjardy (empagliflozin and metformin hydrochloride) ", "approval_status": "Approved August 2015", "company": "Boehringer Ingelheim", "specific_treatment": "type II diabetes"},
{"therapeutic_areas": ["Endocrinology"], "name": "Genotropin (somatropin) lyophilized powder", "approval_status": "Approved November 1997", "company": "Pharmacia & Upjohn", "specific_treatment": "growth hormone deficiency"}
]